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Abstract 
The first chapter of this thesis consists of two related projects that explore novel reactivity of 
donor-acceptor cyclopropanes, specifically 2-substituted cyclopropane 1,1-diesters. The first 
project involves the nucleophilic ring opening of donor-acceptor cyclopropanes with 
potassium organotrifluoroborates. It was found that during the ring opening of the 
cyclopropane, the diesters of the cyclopropane formed a malonyl-BF2 complex. The complex 
could then be hydrolyzed to afford substituted malonates. The reaction was limited to aryl 
cyclopropanes and potassium alkynyltrifluoroborates. The second project in this chapter 
explores modifying the Kerr group’s previous synthesis of tetrahydro-1,2-oxazines, such that 
geminal allyl, methyl esters are now on the tetrahydro-1,2-oxazine. This allows for a one-pot 
dehydrocarbonylation/dehydration procedure to access pyrroles.  
The second chapter of this thesis describes efforts towards the total synthesis of two natural 
products via Diels-Alder of quinoid species. The first project describes the formal synthesis 
of indole containing fargesine utilizing the Kerr group’s Diels-Alder/Plieninger indolization 
sequence. A Pinnick oxidation, followed by a Curtius rearrangement was required to 
complete the formal synthesis. The second project describes efforts towards benzofuranone 
containing fumimycin. The benzofuranone would be accessed by the Diels-Alder of requisite 
benzoquinone ketal and diene. Following a similar protocol to the Kerr group’s modified 
Plieninger indolization sequence could allow access to the core of fumimycin. Despite many 
alternative routes, formation of the benzofuranone core eluded this study. 
 
Keywords: donor-acceptor cyclopropanes, nucleophilic ring opening, potassium 
organotrifluoroborates, annulation, tetrahydro-1,2-oxazines, pyrroles, total synthesis, Diels-
Alder, Plieninger indolization sequence, fargesine, fumimycin 
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Chapter 1 - Novel Reactions of Donor-Acceptor 
Cyclopropanes 
1 Chapter introduction 
Chapter one explores new reactivity of donor-acceptor cyclopropanes and is divided into 
two sections: the ring opening of donor-acceptor cyclopropanes by organotrifluoroborate 
salts, and the synthesis of pyrroles from the annulation reaction between donor-acceptor 
cyclopropanes, and nitrones. A general introduction to donor-acceptor cyclopropanes is 
discussed followed by the introduction and results for each section. The work towards the 
ring opening of donor-acceptor cyclopropanes by organotrifluoroborate salts was 
developed independently, while the pyrrole synthesis was done in collaboration with 
William Humenny, Katarina Sapeta, and Avedis Karadeolian. The results in Section 1.5.4 
have been published in a peer reviewed journal.1 Reproduced in part with permission 
from Humenny, W.J.; Kyriacou, P.; Sapeta, K.; Karadeolian, A.; Kerr, M.A. Angew. 
Chem. Int. Ed. 2012, 51, 11088-11091. Copyright 2012 Wiley-VCH Verlag GmbH & Co. 
KGaA, Weinheim. 
1.1 Introduction to donor-acceptor cyclopropanes 
1.1.1 Structure and reactivity of cyclopropanes 
The goal of a synthetic chemist is to access complex molecules, ideally from inexpensive 
and simple starting materials. Cyclopropanes, while structurally simple, have proven to 
be an important tool for chemists to accomplish this goal.2 Due to the high ring strain of 
cyclopropanes (115 kJ/mol),3 they react similarly to olefins than other cycloalkanes.4 The 
high ring strain of a cyclopropane can further be exploited by the addition of acceptor, 
donor, or donor and acceptor substituents on the cyclopropane (Scheme 1-1).  
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Scheme 1-1 The reactivity of acceptor (1), donor (2), and donor-acceptor (3) 
cyclopropanes 
Acceptor substituted cyclopropanes (acceptor = electron withdrawing group (EWG)) are 
activated by increasing the electrophilic nature of the cyclopropane, allowing for homo-
Michael addition ring opening reactions (Scheme 1-1, entry 1). The incipient anion 
formed upon bond cleavage is also stabilized by the acceptor group. When a donating 
substituent (donor = electron donating group (EDG)) is on a cyclopropane, the 
nucleophilic nature of the cyclopropane increases, allowing for reactions with 
electrophiles (Scheme 1-1, entry 2). The subsequent carbocation formed is also stabilized 
by the donating substituent. Lastly, in the case of cyclopropanes substituted with donor-
acceptor (DA) groups (Scheme 1-1, entry 3), a synergistic effect occurs due to the ‘push-
pull effect’ of both substituents. Polarization of the bond between the two groups leads to 
a 1,3 diploe (1-8), where each charge is stabilized by their respective group. While the 
position of the donor and acceptor groups can be geminal (on the same carbon), they do 
not contribute to the synergistic effect and only vicinally disubstituted DA cyclopropanes 
(on adjacent carbon atoms) will be discussed.  
Vicinally substituted donor-acceptor cyclopropanes display different modes of reactivity 
based on its reacting partner; of particular interest, nucleophiles can react to form acyclic 
products (Scheme 1-2, entry 1), or dipoles can react to form annulation products (Scheme 
1-2, entry 2).   
3 
 
 
Scheme 1-2 Formation of acyclic (1), or cyclic (2) products from cyclopropanes 
One of the earliest examples of cyclopropane reactivity comes from Bone and Perkin’s 
work on the nucleophilic ring opening of cyclopropanes with ethyl malonate in 1885.5  
There was a resurgence in the studies of cyclopropanes in the 1960’s and 1970’s with the 
work done by Stork6 and Danishefsky,7 but all of these examples focused on the 
reactivity of acceptor cyclopropanes. It was not until the 1980’s with the work of 
Wenkert8 and Reissig9 that studies on DA cyclopropanes began.  
1.2 Ring opening of DA cyclopropanes 
1.2.1 Ring opening of DA cyclopropanes with heteroatom 
nucleophiles 
Donor-acceptor cyclopropanes can react with various nucleophiles to undergo ring 
opening reactions that can be useful for accessing natural products/drug targets. For 
example, the synthesis of a dual serotonin/norepinephrine reuptake inhibitor (3R)-3-(1H-
indol-1-yl)-N-methyl-3-phenylpropan-1-amine (1-18) was highlighted during Lifchits and 
Charette’s methodology of amines opening DA cyclopropanes.10 During their 
optimization they found that AlCl3, SnCl4, and BF3•OEt2 gave the intramolecular 
rearranged product 1-17, whereby the nitro group opened the cyclopropane. It was then 
found that Ni(ClO4)2•6H2O gave the best yield of the acyclic product (1-16). Various 
anilines were used in the scope of the reaction, but due to the high basicity of aliphatic 
amines, complexation with Lewis acid occurred resulting in very sluggish reaction times. 
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Thus, only pyrrolidine and piperidine were shown to give useful yields, albeit with slow 
reaction times.  
 
Scheme 1-3 Charette group’s opening of cyclopropanes by amines 
The Charette group were then able to use their cyclopropane and react it with phenol to 
access (R)-atomoxetine (1-21, Strattera), which is used to treat anxiety and depression.11 
Electron rich and poor phenols were tolerated (59-84%), although low yields were 
obtained with m-chlorophenol (57%) and 1-naphthol (53%). When enantioenriched 
cyclopropanes were used, the ee of the product was preserved (90-95% ee). 
 
Scheme 1-4 Charette group’s opening of cyclopropanes by phenols 
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1.2.2 Ring opening of DA cyclopropanes with indoles 
An early example of donor-acceptor cyclopropanes being utilized with carbon 
nucleophiles to give acyclic products was developed by Harrington and Kerr in 1997.12 
Inspired by their work on alkylating indoles with Michael acceptors,13 they found that a 
Friedel-Crafts alkylation of indole 1-23 occurred with cyclopropane 1-22 to give the 
homo-Michael adduct 1-24 (Scheme 1-5). The reaction occurred under hyperbaric 
conditions (13 kbar), in dry acetonitrile, under Yb(OTf)3 catalysis; addition of small 
amounts of water resulted in no reaction, which contradicted literature precedence that 
water was a good co-solvent with acetonitrile at hyperbaric conditions,14 and that 
Yb(OTf)3 retained activity under aqueous conditions.
15 The reaction was tolerant of 
cyclopropanes substituted with H, Me, or Ph, and N-methyl or N-p-bromobenzyl indoles. 
 
Scheme 1-5 Kerr group’s opening of cyclopropanes by indoles 
The Kerr group later revisited the Friedel-Crafts alkylation of indoles with donor-
acceptor cyclopropanes at hyperbaric conditions when they showed that cyclopropanes 1-
25 (geminally disubstituted with one carboalkoxy, and one carbohydroxy group) could 
under go the same reaction with no catalyst (Scheme 1-6).16 Thermal conditions were 
unsuccessful in the transformation to the desired product, and it was also shown that both 
ester and acid were required for the transformation to occur. The optimization results 
suggest that hyperbaric conditions induce hydrogen bonding to activate the cyclopropane 
(1-26). Various 3 and 5-substituted indoles, along with aryl and heteroaryl substituted 
cyclopropanes were successful in the transformation, resulting in alkylated indoles (1-27) 
in 50-97%. 
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Scheme 1-6 Kerr group’s catalyst free opening of cyclopropanes by indoles 
In 2013, the Johnson group applied their previous studies on dynamic kinetic asymmetric 
transformations (DyKAT)17 for annulations of racemic donor-acceptor cyclopropanes18 to 
the Friedel-Crafts alkylation of indoles with cyclopropanes (Scheme 1-7).19 Through 
optimization studies, it was found that an electron deficient indole such as 1-28 was 
required as electron rich indoles would react with cyclopropanes before the cyclopropane 
epimerization process occurred. The scope of this reaction was excellent, and various 
racemic cyclopropanes, and indoles, were used with good yields (up to 96% yield) and 
high er (up to 97:3) to obtain alkylated indole 1-29.  
 
Scheme 1-7 Johnson group’s asymmetric opening of cyclopropanes by indoles 
While most groups focused on carbon based donor groups (on cyclopropanes) for the 
Friedel-Crafts alkylation of indoles, Waser’s group showed that aminocyclopropane 1-31 
was able to undergo this transformation by modifying the acceptor group.20 In order for 
this reaction to proceed, the typical dimethyl-1,1-cyclopropanedicarboxylate acceptor 
group had to be modified to a more activated bis(2,2,2-trifluoroethyl)cyclopropane-1,1-
dicarboxylate group (Scheme 1-8). Many cyclopropanes and indoles were used in the 
reaction and alkylated indole 1-33 was obtained in 49-94% yield; however, when indoles 
substituted at the 3 position were used, a C-3 to C-2 alkyl migration was observed. Waser 
7 
 
also showed that aminocyclopropanes could be opened with other aromatic compounds 
besides indoles, such as pyrroles and phenols.   
 
Scheme 1-8 Waser group’s opening of aminocyclopropanes by indoles 
A two-step cascade was developed by the Singh group in 2016, whereby indoles were 
formed in situ, and then underwent Friedel-Crafts alkylation with donor-acceptor 
cyclopropanes (Scheme 1-9).21 Aniline 1-34 was able to undergo alkyne 
activation/cyclization with AgSbF6, which was also able to catalyze the alkylation to form 
alkylated indole 1-35. This is unique to other thermal conditions whereby typical 
catalysts are Cu, Zn, Sc, In, Mg, or Yb based. Cyclopropanes substituted with aryl, 
heteroaryl, amino, and styrenyl groups could undergo the transformation.   
 
Scheme 1-9 Singh group’s two-step cascade - formation of indole and ring opening of 
cyclopropane  
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1.2.3 Ring opening of DA cyclopropanes with non-aromatic carbon 
nucleophiles 
As shown above, indoles are very effective at opening donor-acceptor cyclopropanes to 
result in acyclic products, but non-aromatic carbon nucleophiles are also capable in the 
acyclic opening of cyclopropanes. In 2003, Yu and Pagenkopf showed that glycal-
derived donor-acceptor cyclopropanes (1-36) could be opened with allyl silane 1-37, to 
allow a simple route to modified glycals (1-38) (Scheme 1-10).22 Using their procedure 
for the cycloproponation of glycals,23 a variety of modified glycals were made that could 
be ring opened with TiCl4 and allyl silane. It should be noted that if TiCl4 was added after 
the allyl silane, decomposition of the starting material was observed.  
 
Scheme 1-10 Pagenkopf group’s opening of cyclopropanes by allyl silane 
Silyl enol ethers 1-40 were used by the Tang group in 2009 to open donor-acceptor 
cyclopropanes (Scheme 1-11).24 During their Lewis acid screening, they found that 
Yb(OTf)3 favoured the cyclic product (1-41), while other triflates (Sc, In, Ga, Sn, Cu) 
favoured the acyclic product (1-42). It was then found that Cu(SbF6)2 gave the best 
selectivity and highest conversion towards the acyclic product, so it became the Lewis 
acid of choice. In an effort to gain further understanding of the mechanism, O-TMS and 
O-TBS silyl enol ethers were compared in the ring opening of cyclopropane 1-39 and it 
was found that the cyclic product became favoured with increased bulk around the silane. 
NMR experiments then confirmed that the cyclic product is actually formed first, and 
under prolonged stirring with Lewis acid, formation of the acyclic product occurred. The 
reaction worked well when aryl substituted cyclopropanes were used (64-92%), but were 
not very effective for styrenyl (49%), vinyl (28%), or 2-furanyl (15%).   
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Scheme 1-11 Tang group’s opening of cyclopropanes by silyl enol ethers 
One of the few examples that results in the direct alkylation/ring opening of donor 
acceptor cyclopropanes was highlighted by the Charette group in the formal synthesis of 
(±)-2-hydroxycalamenene (1-47) and (±)-xanthorrhizol (1-48).25 They were able to show 
that cyclopropane 1-43 could be opened with organocuprate 1-44, and then 
decarboxylated to give 1-45 in 65% yield over the two steps (Scheme 1-12). Compound 
1-45 was then taken to 1-46 to complete the formal synthesis. Organocuprates were also 
used by Corey to open a donor-acceptor cyclopropane towards the synthesis of the 
antidepressant Sertraline.26   
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Scheme 1-12 Charette group’s opening of cyclopropane with organocuprate towards the 
formal synthesis of (±)-2-hydroxycalamenene and (±)-xanthorrhizol 
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1.3 Ring opening of DA cyclopropanes with potassium 
organotrifluoroborates 
1.3.1 Introduction to potassium organotrifluoroborates 
Organoboron compounds have become popular reagents in carbon-carbon bond 
formation chemistry.27 Reactions include various coupling reactions (example: Suzuki 
reaction28), and conjugate additions. Originally these reactions have been done using 
boronic acids and boronate esters; however, these compounds have some limitations: they 
have low stability, high prices, and some reagents are highly sensitive towards air and 
moisture. To mitigate these issues, boronic acids and boronate esters have been replaced 
by potassium organotrifluoroborate salts (RBF3K). The crystalline salts are easily 
prepared from inexpensive starting materials, show greater nucleophilicity compared to 
boronic acids or boronate esters, and are air and moisture stable.29  While the 
aforementioned reactions contain a metal catalyst, it was not until 2002 with the work of 
Matteson and Kim that a metal free approach was undertaken. They were able to convert 
boronate ester 1-49 to the trifluoroborate salt 1-50, which then cyclized under SiCl4 
mediated conditions to give pyrrolidine 151 (Scheme 1-13).30 While many others 
explored the utility of RBF3K in non-metal-catalyzed reactions, only a select few are 
discussed below. 
 
Scheme 1-13 Matteson and Kim’s pyrrolidine synthesis by RBF3K 
1.3.2 Organotrifluoroborate salts as nucleophiles 
In 2008, the Stefani group wanted to find mild conditions for α-functionalization of N-
acyliminium ions, as these are important in the preparation of alkaloids and other 
biologically active nitrogen heterocycles.31 They were able to show that N-benzyl-3,4,5-
triacetoxy-2-pyrrolidinone (1-52) was able to undergo nucleophilic addition by 
organotrifluroborate 1-54 under Lewis acidic conditions to form pyrrolidinone 1-55 
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(Scheme 1-14).32 The reaction was unable to proceed without a Lewis acid, suggesting 
that the reaction proceeds via N-acyliminium ion intermediate 1-53 (Scheme 1-14). 
During their optimization of the reaction they found that four equivalents of Lewis acid, 
BF3•OEt2, was required to obtain good yields and increasing the Lewis acid loading did 
not give better yields. They also found that modifying the organotrifluoroborate counter 
ion, and changing the solvent from DCM to DCE had no effect on the reaction. They 
were able to show that aryl, heteroaryl, and alkynyl substituted trifluoroborate salts were 
effective nucleophiles towards pyrrolidinone 1-55. 
 
Scheme 1-14 Stefani group’s pyrrolidinone alkylation with organotrifluoroborate salts 
Mitchell and Bode, in 2009, found that organotrifluoroborate salts 1-54 react as 
nucleophiles with acetals 1-56 to access a variety of ethers (1-63, Scheme 1-15).33 The 
ability to circumvent the common way to synthesize ethers, typically a harsh process 
involving reaction of alkoxides with alkyl halides (Williamson ether synthesis), can 
minimize potential side reactions. They were effective in showing the synthesis of ethers 
from aryl, ally, alkynyl, and styrenyl organotrifluroborates reacting with various acetals. 
The reaction is proposed to proceed by the activated RBF2 nucleophile (1-57, which is 
also 11B NMR active)34,35 complexing with the acetal to form zwitterion 1-59, which 
collapses to oxocarbenium 1-60. Addition of the alkyl group to the oxocarbenium 
intermediate (1-61) would result in the desired ether (1-63) upon work up. 
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Scheme 1-15 Bode group’s synthesis of ethers from organotrifluoroborate salts 
In 2014, Taylor and Bolshan showed that they could access a variety of ynones (1-66) by 
the nucleophilic addition of alkynyl organotrifluoroborate salts (1-65) to acyl chlorides 
(1-64).36 Ynones were accessed from aryl or alkyl acyl chlorides reacting with aryl, or 
alkyl substituted alkynyl trifluoroborate salts in 39-99% yields (Scheme 1-16). Three 
mechanisms were proposed for the synthesis of the ynones. In pathway A, the BCl2 
nucleophile coordinates with the acyl chloride (1-68), activating the carbonyl for 
nucleophilic attack by the alkynl moiety. In pathway B, alkynyl transfer occurs to an 
oxocarbenium intermediate (1-71) which is formed by intramolecular chloride transfer of 
coordination complex 1-70. Lastly, a Friedel-Crafts alkylation type mechanism (1-72) 
can occur to give ynone, as shown in pathway C. It should be noted that pathway B and C 
are unlikely the route due to the highly unfavourable oxygen species proposed in the 
mechanism.  
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Scheme 1-16 Bolshan group’s synthesis of ynones from organotrifluoroborate salts 
Also in 2014, Roscales and Csáky found that trifluoroborate salts 1-54 could be used in 
the ring opening of epoxide 1-74 to form alcohol 1-75 (Scheme 1-17).37 Surprisingly, 
unlike the previous examples listed above, boron Lewis acids were not very effective in 
the transformation, and it was found that TFAA had the highest yields in acting as the 
fluoride acceptor to form the BF2 nucleophile, and promoting epoxide opening. Various 
epoxides reacted with aryl and alkenyl trifluoroborate salts to afford alcohol 1-75 in good 
yields (52-83%), and as single diastereomers. To explain the diastereoselectivity of the 
reaction, they proposed that the reaction proceeds similarly to a substitution nucleophilic 
internal (SNi) mechanism, whereby coordination of the BF2 nucleophile to the epoxide (1-
76) would allow for stereospecific addition of the R group to the polarized C-O bond.    
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Scheme 1-17 Csáky group’s ring opening of epoxides with trifluoroborate salts 
In 2015, Brady and Carreira, wanting to expand the work of oxetanes as useful synthetic 
intermediates,38 found that potassium organotrifluoroborates were effective in the 
nucleophilic ring opening of N,O-acetals (Scheme 1-18).39 Substituted N,O-acetals 
underwent addition reactions with alkynyl, allyl, allenyl, and vinyl potassium 
trifluoroborates in moderate yields.  
 
Scheme 1-18 Carreira group’s addition of trifluoroborate salts to oxetanyl N,O-acetals 
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1.3.3 Results and discussion 
1.3.3.1 Discovery of a novel nucleophilic ring opening of DA 
cyclopropanes by RBF3K 
With hopes of developing a new methodology for DA cyclopropanes, nucleophilic ring 
opening of cyclopropane 1-80a by potassium 2-phenyl-1-ethynyltrifluoroborate (1-81a) 
was pursued following similar conditions to the reports presented above. Gratifyingly, the 
initial test reaction proceeded cleanly (based on loss of starting material by TLC); 
however, upon further analysis (by 1H NMR spectroscopy) it was found that two 
inseparable compounds were isolated. It was speculated that acyclic 1-82a, and cyclic 1-
83 products were obtained (Scheme 1-19).  
 
Scheme 1-19 Assumed products of the reaction  
While the major product was initially assumed to be acyclic 1-82a, it soon became 
apparent that the 1H NMR spectral data did not support the structure; 20 protons were 
expected for the product, but only 19 were accounted for. Another puzzling piece of 
information was a single peak observed for both methoxy groups. Since the esters would 
be diastereotopic, it would be expected that the methoxy groups would not have the same 
chemical shift (though this phenomenon could be explained by coincidental chemical 
shifts, the result would be apparent when the structure was solved).   Efforts were then 
taken to find conditions that favoured one product over the mixture, in order to obtain full 
characterization data. The cyclic product was never isolated or fully characterized, since 
it was always obtained in relatively minor amounts, but evidence towards 1-83 was due 
to the presence of a signal in the 1H NMR spectrum as a doublet at 6.37 ppm (J = 2.3 
Hz).  
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1.3.3.2 Efforts towards obtaining a single product 
Taking into consideration the proposed mechanism of potassium trifluoroborates 
behaving as nucleophiles from the literature, varying equivalents of BF3•OEt2 and 
potassium trifluoroborate 1-81a were used in the optimization, as well as varying 
temperatures of the solvents DCM, or DCE. DCE was quickly favoured over DCM as the 
cyclopropane was consumed faster, all other variables equal. Despite many attempts, both 
products were always formed in an inconsistent ratio, with the alleged cyclized product 
always being the minor component. NMR experiments were also conducted to determine 
the ratio of products formed throughout the reaction, but were inconclusive as there was 
no obvious pattern to the results. It wasn’t until a new bottle of DCE was purchased that 
the cyclized product was no longer formed. With this insight, it was speculated that the 
reaction is fairly sensitive to water so an experiment was done to confirm this hypothesis. 
A reflux still for DCE (over calcium hydride) was assembled, and with dry DCE at hand, 
the same results were obtained as the new DCE bottle. Two water spike experiments 
were now done to confirm whether or not water was a factor (Scheme 1-20): one reaction 
involved using excess water (entry 1), while the other reaction used one equivalent of 
water (entry 2). When excess water was used in the reaction, only unreacted 
cyclopropane 1-80a was obtained. When one equivalent of water was added to the 
reaction, the same mixture of two compounds previously seen were formed (Scheme 
1-19), again in a relatively minor ratio for the cyclic product (<10%). Full 
characterization of the product, followed by optimization studies could now begin. 
 
Scheme 1-20 Water spike experiments 
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1.3.3.3 Characterization of unknown product 
To account for the missing proton, it was speculated that perhaps a fluorine was added to 
the molecule, which was then confirmed by 19F NMR spectrum, although we were 
slightly puzzled as to why there were two singlets (See Appendix I). An IR spectrum was 
also obtained to ensure that an alkyne was there, but there was no indication of a signal. 
The lack of alkyne signal could be interpreted in two ways: 1) the malonyl anion cyclized 
onto the alkyne to form a cyclic compound, or 2) since IR spectroscopy relies on changes 
in dipole moments, internal alkynes may not show a signal as they are pseudo 
symmetrical. Based on these results two structures (1-84 and 1-85) were proposed as 
shown in Scheme 1-21.  
 
Scheme 1-21 Revised structural assembly of the unknown compound 
Two dimensional NMR data were obtained (1H-1H gCOSY, 1H-13C gHSQC, 1H-13C 
gHMBCAD) in order to corroborate either structure, but the data did not provide enough 
evidence to either structure. Also, if indeed there was a fluorine attached to a carbon, we 
would have expected to see C-F coupling in the 13C NMR spectrum; however, the only 
C-F coupling found in the 13C NMR spectrum was for the carbonyl carbon which did not 
really support our revised structures. Due to these results, it was proposed that perhaps 
boron may also be involved in the product. An 11B NMR spectrum confirmed the 
presence of boron on the molecule; however, the structure still eluded us.  
At this point it was decided that single crystal x-ray diffraction spectroscopy data would 
be useful as the NMR spectroscopy data was too perplexing. After some time, suitable 
crystals were grown for an X-ray structure and a surprising structure was elucidated 
(Figure 1-1); the carbonyls of the ester coordinated to form an aromatic like malonyl-BF2 
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complex. The two singlets in the 19F NMR could now be rationalized by B-F splitting. 
Boron is composed of two NMR active isotopes in a 1:4 ratios (10B to 11B) and each of 
these isotopes were coupling with fluorine to give a signal. The isotope difference is 
shown in the integration and intensity of the signals in the 11B NMR spectrum (See 
Appendix I). Although a quartet would be expected for the 11B-19F coupling, diketone-
BF2 complexes exhibit similar spectral properties, due to the fast relaxation time of boron 
in this system.40 
 
Figure 1-1 Oak ridge thermal ellipsoid plot (ORTEP) representation of malonyl-BF2 
complex  
The malonyl-BF2 complex could be formed as shown in Scheme 1-22. 
Organotrifluoroborate 1-81 reacts with BF3•OEt2 to form the BF2 nucleophile. 
Coordination to one of the carbonyls by the BF2 can allow for nucleophilic addition of 
the alkynyl moiety (1-87). It should be noted that BF3•OEt2 could also be contributing to 
the activation of the cyclopropane. After alkynyl addition, enolization of the malonyl 
anion (1-86) can trap the BF2 to form malonyl-BF2 complex 1-86.  
 
Scheme 1-22 Proposed mechanism to access malonyl-BF2 complex 
20 
 
1.3.3.4 Optimization of BF2-complex 
A short optimization of the reaction was done after the characterization of the compound. 
Initially, a 1:4:8 cyclopropane 1-80a to trifluoroborate salt 1-81a to BF3•OEt2 at room 
temperature for 24 hours was used, but equivalents could be lowered to 1:2:4 without a 
loss in yield (85%). As the reaction did not always go to completion after 24 hours, 
instead the reaction could be heated to 60 °C for 12 hours for full conversion of the 
starting material, again without a loss in yield (Scheme 1-23). To determine if BF3•OEt2 
was required, typical Lewis acids involved in nucleophilic ring opening of cyclopropanes 
were used: neither Yb(OTf)3, Et2AlCl, or TiCl4, or removal of Lewis acid were successful 
in the transformation. While Yb(OTf)3 resulted in no reaction, Et2AlCl and TiCl4 resulted 
in decomposition of starting material. 
 
Scheme 1-23 Optimized conditions for formation of malonyl-BF2 complex 
It was then shown that the BF2 complex can be hydrolyzed efficiently with aqueous HCl 
in THF overnight to give the originally proposed malonate 1-82a (Scheme 1-24). 
 
Scheme 1-24 Acid hydrolysis of complex to form malonates 
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1.3.3.5 Synthesis of malonates   
Using the optimized conditions, the scope of organotrifluroborate salts were explored. 
Aryl (1-89), vinyl (1-90), and alkyl (1-91) trifluoroborate salts were used; however, none 
of these were able to open the cyclopropane (Scheme 1-25) and only decomposition of 
the starting material was recovered.  
 
Scheme 1-25 Trifluroborate salt scope to form malonyl-BF2 complex 
A substrate scope for cyclopropanes was then explored, each of them using potassium 2-
phenyl-1-ethynyltrifluoroborate as the RBF3K for the reaction. With isobutyl 
cyclopropane 1-94 or di-substituted cyclopropane 1-95 (Scheme 1-26, entry 1), again the 
desired product was not obtained and only decomposition of the starting material was 
recovered. When vinyl (1-98) or styrenyl (1-99) cyclopropane were used (Scheme 1-26, 
entry 2), ring opening of cyclopropane occurred; however, this was always found in an 
approximate 1:1 mixture with the SN2’ product. Efforts to favour one product over the 
other were unsuccessful.  
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Scheme 1-26 Cyclopropane scope to form malonyl-BF2 complex 
Based on the results discussed above, it was decided that the scope would involve 
potassium 2-phenyl-1-ethynyltrifluoroborate (1-81a) reacting with various aryl 
cyclopropanes (1-80), and dimethyl 2-phenylcyclopropane-1,1-dicarboxylate (1-80a) 
reacting with various alkynyl potassium trifluoroborate salts (1-81). The decision to use 
both of these compounds was due to their availability of starting material and ease of 
synthesis.  
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Table 1-1 Substrate scopes of aryl cyclopropanes with alkynyl trifluoroborate salts 
 
The scope of the reaction is displayed in Table 1-1. The reaction was tolerant of various 
aryl substituted cyclopropanes and malonates could be made with EDG (1-82c) or EWG 
(1-82e) at that position. Heteroaryl substituted cyclopropane worked, as in the case of 
thiophenyl (1-82i); however, the reaction did not work when a furanyl cyclopropane was 
used (1-82d). The decomposition of material from the furanyl cyclopropane could 
possibly be contributed to side reactions that may occur if the BF2 nucleophile, or Lewis 
acid, coordinated to the furanyl oxygen (although no analysis of the decomposition 
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products was done to confirm this). In terms of the alkynyl organotrifluoroborate salt, 
heteroaryl, aryl, and alkyl substituents were tolerated. When the RBF3K required to make 
malonate 1-82l was attempted, an inseparable mixture between product and 
decomposition was obtained. This may be contributed to the nucleophile being more 
reactive due to the EDG effects of the methoxy group, thus leading to more side 
reactions.  
1.3.3.6 Csákÿ’s ring opening of DA cyclopropanes by RBF3K 
In 2016, shortly after the results in Section 1.3 were finished and ready for publication, 
similar developments were published by Ortega and Csákÿ. They were able to open DA 
cyclopropanes by boronic acids or potassium organotrifluoroborates, under TFAA or 
BF3•OEt2 mediated conditions (Scheme 1-27).41  
 
Scheme 1-27 Csákÿ group’s ring opening of DA cyclopropanes by RBF3K or RB(OH)2 
Despite being very similar to the work discussed above, they never isolated the malonyl-
BF2 complex. Differences between the two procedures were: 1) they used their 
cyclopropane, RBF3K, and BF3•OEt2 in a 1:2:2 ratio (0.5 equivalents of TFAA was 
used), while the Lewis acid was always in excess in our studies; 2) their solvent was 
DCM, while we used DCE (DCE and DCM gave us the same results during optimization, 
but DCE was favoured due to faster reaction times); 3) they added their Lewis acid to a 
solution of RBF3K and cyclopropane, while we added the cyclopropane to a solution of 
Lewis acid and RBF3K; 4) and lastly, a basic work up was done prior to purification of 
their compounds while only an aqueous work up was done for the malonyl-BF2 complex 
(when a base wash was performed on the malonyl-BF2 complex, only slight 
decomplexation occurred). Despite these differences, they were able to open DA 
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cyclopropanes with alkynyl, styrenyl, vinyl, and allyl trifluoroborate salts in 49-81% 
yield (only alkynyl trifluoroborate salts were only compatible with the results discussed 
above).  
Ortega and Csákÿ’s results raise questions to the mechanism and reactivity of DA 
cyclopropanes towards RBF3K. It is apparent that the only real differences between the 
two procedures are equivalents of BF3•OEt2 and order of addition. As it is clear that 
excess BF3•OEt2 results in a malonyl-BF2 complex, perhaps there is more to the Lewis 
acid’s role than portrayed in Scheme 1-22, and further investigation would be required to 
determine where the BF2 source is coming from. The order of addition could explain why 
Ortega and Csákÿ were able to perform their reaction with alkenyl trifluoroborates, while 
we were unable to obtain the product. In our procedure, we forming the nucleophilic BF2 
species prior to cyclopropane addition. Since alkenyl trifluoroborates are more reactive 
than alkynyl trifluoroborates (due to less stabilization), it is possible that my nucleophile 
had decomposed before the cyclopropane was added. Changing the sequence of addition 
for my procedure could result in ring opening of cyclopropanes by alkenyl 
trifluoroborates to form malonyl-BF2 complexes.  
Lastly, although there is only one overlapping example (1-82c), there is a significant 
yield increase from our results to Ortega and Csákÿ (59-81%). Since there is a lower 
yield with our conditions, the Lewis acid could also be decomposing the cyclopropane, in 
addition to contributing to the malonyl-BF2 complex.  
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1.3.4 Conclusions 
A novel method to the acyclic opening of donor-acceptor cyclopropanes has been 
discovered using alkynyl trifluoroborate salts under BF3•OEt2 mediated conditions. 
Products were obtained as malonyl-BF2 complexes and then hydrolyzed with HCl to 
obtain substituted malonates in 36-75% yield in two steps. Unfortunately, just as the 
project came to an end, similar results were obtained by Ortega and Csákÿ. They were 
able to use organotrifluoroborate salts (alkynyl, alkenyl, allyl), but they were unable to 
access malonyl-BF2 complexes. A major factor to the difference in products could be 
because an excess amount of Lewis acid was used in our results, while Lewis acid was 
used in a 1:1 ratio with the organotrifluroborate salt in Ortega and Csákÿ’s results. While 
this could be contributing to the formation of the malonyl-BF2 complex, it could also be 
contributing to decomposition of the cyclopropane, and thus lower yields (as shown in 
the yield difference between 1-82c). Although there were no other overlapping products, 
an ~40% yield difference was found between product 1-82k and when Ortega and Csákÿ 
used the same trifluoroborate salt but used a different aryl cyclopropane (dimethyl 2-(4-
methoxyphenyl)cyclopropane-1,1-dicarboxylate), which could also be explained by the 
excess Lewis acid.   
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1.4 Annulation reactions with DA cyclopropanes 
1.4.1 Formation of carbocycles 
As shown in Scheme 1-2, cyclopropanes can undergo ring opening with nucleophiles to 
form acyclic products, or can form annulation products in the presence of a nucleophile 
and electrophile tethered together. This section will give a brief review towards 
annulation reactions with DA cyclopropanes. 
In 2009, Sapeta and Kerr – inspired by Trost and Chan’s work42 on [3+2] cycloadditions 
of Pd-trimethylenemethane (TMM) complexes with olefins – wanted to apply the concept 
to a formal [3+3] cycloaddition with cyclopropane 1-105 to form exo-
methylenecyclohexanes 1-107.43 Initially, they attempted using a TMM (1-106) precursor 
under Pd catalysis; however, this did not afford the desired [3+3] annulated product and 
the reaction needed to be slightly modified. It was then found that TiCl4 would react with 
1-108 and cyclopropane 1-105 to give ring open product 1-109. Despite trying numerous 
additives, the cyclization was unable to occur as a one-pot procedure. Instead, a two-step 
process was required, and NaH in DMF was successful in completing the formal 
annulation. The reaction was viable with the use of aryl, heteroaryl, spiro, and vinyl 
substituted cyclopropanes, and in total nine examples were made with a two step yield of 
40-92%.  
 
Scheme 1-28 Kerr group’s synthesis of cyclohexanes from cyclopropanes 
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In 2015 the Tang group showed that diene 1-110 can undergo an annulation with 
cyclopropane 1-111 to afford cycloheptanes 1-114 (Scheme 1-29).44 During their 
optimization they found that cyclopentane 1-113 was a competing product with their 
desired cycloheptane product. Increasing the bulk of the ester allowed for cycloheptane to 
be formed almost exclusively (adamantly esters were ideal, but benzyl esters could also 
be used). Through their optimization, they also found that 10 mol% ligand 1-112 and 
Cu(SbF6)2 were the best conditions to facilitate the transformation. The reaction was 
tolerant of aryl, heteroaryl, and styrenyl cyclopropanes (68-96% yield), although vinyl 
cyclopropane had a low 52% yield. In an effort to further understand the reaction 
mechanism, they monitored the reaction by 1H NMR spectroscopy and they found that 
cyclopentane 1-113 is actually formed first, and over time, the cyclopentane rearranges to 
the cycloheptane product (1-114). Thus, they concluded that cyclopentane is actually the 
kinetic product and cycloheptane is the thermodynamic product.  
 
Scheme 1-29 Tang group’s synthesis of cycloheptanes from cyclopropanes 
1.4.2 Formation of heterocycles 
Heterocycles are molecules of interest for organic chemists as they are found in many 
natural products/drug targets. Developing methods to allow ease of access to these class 
of molecules is an important undertaking. The Johnson group envisioned that they could 
access tetrahydrofuran 1-117 by the cycloaddition of donor-acceptor cyclopropane 1-105 
with aldehydes 1-115 (Scheme 1-30).45  Initial attempts to promote a cyclization with 
TiCl4, AlCl3, Mg(OTf)2, or La(OTf)3 resulted in decomposition or no reactivity. When 
Cu(OTf)2, Sc(OTf)3, or SnCl4 were used they were able to obtain tetrahydrofurans in 
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59:1, 3.1:1, and 31:1 diastereomeric ratios (cis:trans) respectively. It was then found that 
Sn(OTf)2 was able to give >100:1 cis:trans selectivity, and was therefore the catalyst of 
choice for their scope. The reaction was susceptible to electron-rich, electron-neutral, 
electron poor, heterocyclic, and α,β-unsaturated aldehydes (89-100% yield, >17:1 dr). To 
account for the cis selectivity in the reaction, Johnson proposed that the reaction proceeds 
through transition state 1-116, whereby after nucleophilic attack of the aldehyde to the 
cyclopropane, the substituents are placed pseudoequatorial to minimize unfavourable 
interactions.  
 
Scheme 1-30 Johnson group’s synthesis of tetrahydrofurans from cyclopropanes 
In a similar manner to Johnson’s works,45 Carson and Kerr showed that they can form 
pyrrolidine 1-121 by the three-component reaction of amine 1-118, aldehyde 1-119, and 
cyclopropane 1-105 (Scheme 1-31).46 They found that Yb(OTf)3 was the best Lewis acid, 
and it was imperative that the catalyst be added after the formation of the aldimine, since 
both amines10 and aldehydes45 have been shown to open cyclopropanes. For the scope, 
they showed that primary alkylamines and primary anilines were tolerated in the reaction; 
however, when modifying the aldehydes, only aryl and heteroaryl aldehydes were 
tolerated (aliphatic aldehydes gave poor results). The cis diastereomer was favoured in all 
cases, and is explained by intermediate 1-120, where the substituents would be placed 
pseudoequatorial to avoid steric interactions.  
 
Scheme 1-31 Kerr group’s synthesis of pyrrolidines from cyclopropanes 
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Following up on their 2014 publication of formal [2+3] formal addition with nitroarenes 
and cyclopropanes to afford isoxazolidines,47 Das, et al. found that the use of electron 
rich nitrosoarene 1-124 did not react to form isoxazolidine 1-122, but instead formed C-
8-brominated tetrahydroquinoline 1-125  (Scheme 1-32).48 While this reaction was able 
to proceed with aryl and alkenyl substituted cyclopropanes in yields ranging from 41-
63%, perhaps more interesting is the mechanism to obtain tetrahydroquinolines. When an 
enantioenriched cyclopropane was put through their reaction conditions, they found that 
the annulation occurred with retention at the stereogenic center (absolute configuration 
confirmed by X-ray analysis). To account for the stereochemistry they proposed the 
following mechanism. Cyclopropane 1-126 is activated by MgBr2 (1-127) which is then 
stereoselectively opened by a bromide anion, generating an enolate. The enolate then 
reacts with nitrosobenzene to form the six membered ring transition state (1-128), which 
then gives magnesiated hydroxylamine 1-129.49 Due to the presence of the methoxy 
group, N-O bond cleavage can occur (1-129) to form an iminoquinone-type species (1-
130), which is attacked by a bromide anion. Tautomerization (1-131) followed by 
stereoselective intramolecular Friedel-Crafts type alkylation (1-132) gives intermediate 1-
133. A final tautomerization results in tetrahydroquinoline 1-134.     
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Scheme 1-32 Studer group’s synthesis of tetrahydroquinolines 
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1.4.3 Formation of tetrahydro-1,2-oxazines 
Perhaps one of the more important discoveries of donor-acceptor cyclopropane reactivity 
comes from Young and Kerr in 2003. They were able to form tetrahydro-1,2-oxazines 
from the formal [3+3] cycloaddition of nitrones (1-135) and donor-acceptor 
cyclopropanes (Scheme 1-33).50 The reaction worked optimally using Yb(OTf)3, and 
nitrones bearing C-aryl, and N-aryl or N-alkyl. Cyclopropanes bearing phenyl, styrenyl, 
or vinyl substituents were also tolerated and yields of tetrahydro-1,2-oxazines were 
obtained between 50-96%. Shortly after their original publication, Young and Kerr 
expanded on the methodology when they showed that a three-component process can 
occur to access tetrahydro-1,2-oxazines.51 Aldehyde 1-119 and hydroxylamine 1-137 
reacted to form the nitrone in situ, prior to the addition of the cyclopropane. The 
procedure was favourable as nitrones did not need to be made in advance.  
 
Scheme 1-33 Kerr group’s synthesis of tetrahydro-1,2-oxazines 
While both methodologies gave a cis relationship between C-3 and C-6 of tetrahydro-1,2-
oxazine, they were uncertain of the mechanistic pathway. They speculated that it could 
occur through either a stepwise mechanism or concerted mechanism. It wasn’t until 2007 
that studies were undertaken to explore the mechanism.52 To this end, 2,3-disubstituted-
1,1-cyclopropanediester 1-138 was synthesized to undergo ring opening by nitrone 1-137. 
In a cycloaddition mechanism, the relationship between the two substituents on the 
cyclopropane would be preserved in the transition state (Scheme 1-34, 1-141). This 
would not be the case in a step-wise mechanism due to an inversion at C-5 when the 
malonyl anion undergoes Mannich-type ring closure (1-139). Since only product 1-140 
was obtained, and not 1-142, it was concluded that a step-wise mechanism had to be 
occurring.  
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Scheme 1-34 Mechanistic studies for the synthesis of tetrahydro-1,2-oxazines 
In 2005, the Sibi group showed how tetrahyrdo-1,2-oxazines could be synthesized 
enantioselectively by using Ni(ClO4)2 and ligand 1-144.
53 The methodology was 
successful in producing high ee (71-95%) tetrahydro,1-2,oxazines (1-145) when dimethyl 
cyclopropane-1,1-dicarboxylate (1-143) was utilized. Unfortunately, the methodology 
was not very useful for substituted cyclopropanes, as the diastereoselectivity was quite 
low. Despite poor diastereoselectivity, the ee’s for tetrahydro-1,2-oxazines derived from 
substituted cyclopropanes was still high.  
 
Scheme 1-35 Sibi group’s enantioselective synthesis of tetrahydro-1,2-oxazines from 
dimethyl cyclopropane-1,1-dicarboxylate  
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It wasn’t until 2007 that a protocol was developed to access tetrahydro-1,2-oxazines from 
substituted cyclopropanes and nitrones with high ee, and dr, by the Tang group.54 Their 
optimized conditions involved using trisoxazoline derived ligand 1-148, and Ni(ClO4)2. 
During their optimization they also found that the ester groups of the cyclopropane had 
an effect on ee: changing the methyl to ethyl esters raised the ee from 90 to 95%. The 
scope involved phenyl, styrenyl, and vinyl substituted cyclopropanes reacting with N-
methy, and C-aryl, C-heteroaryl, or C-styrenyl nitrones. When racemic dimethyl-2-
phenylcyclopropane-1,1-dicarbocylate was used in excess, it was discovered that the 
unreacted cyclopropane was enantioenriched (R in excess). These results prompted them 
to do kinetic resolution studies, and they found that under their conditions, various aryl 
substituted cyclopropanes were resolved with high ee. Due to this insight, they could 
form both enantiomers of tetrahydro-1,2-oxazine, based on the sequence of the reaction 
(Scheme 1-36). In the first pathway, racemic cyclopropane 1-146 is reacted under their 
normal conditions to obtain (+)-tetrahydro-1,2-oxazine 1-149. To obtain the enantiomer, 
excess racemic cyclopropane 1-146 is reacted with nitrone 1-147 such that unreacted R-
substituted cyclopropane 1-150 can be isolated as the undesired S-cyclopropane reacts to 
form tetrahydro-1,2-oxazine 1-149. Cyclopropane 1-150 can then be taken up under their 
standard conditions again to obtain (-)-tetrahydro-1,2-oxazine 1-151. 
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Scheme 1-36 Tang group’s enantio- and diastereoselective synthesis of tetrahydro-1,2-
oxazines from substituted cyclopropanes 
More recently, the Ioffe group developed a cyclic nitrone that reacts with donor-acceptor 
cyclopropanes to access a previously unknown heterobicycle (1-153, Scheme 1-37).55 
Using cyclic nitronate 1-152 with cyclopropane 1-105 and typical Yb(OTf)3 conditions 
allowed them to access a variety of bicycles in yields ranging from 61-92%.  
 
Scheme 1-37 Ioffe group’s synthesis of a new type of bicyclic nitrosoacetal from 
cyclopropanes 
36 
 
1.4.4 Functionalization of tetrahydro-1,2-oxazines 
1.4.4.1 Total synthesis of isatisine A  
Despite the elegance of the cycloaddition between nitrones and cyclopropanes, a major 
downfall of the methodology is its lack of regioselectivity when a 2,3-disubstituted 
cyclopropane is used.52 As a result, most syntheses of tetrahydro-1,2-oxazines lack 
functionality at the C5 position. Our group was inspired to tackle this issue after Avedis 
Karadeolian solved a similar problem during his total synthesis of isatisine A.56 A key 
step of his synthesis required accessing hydroxyl-tetrahydrofuran 1-156 (Scheme 1-38); 
however, attempts to convert tetrahydrofuran 1-154 to dihydrofuran 1-155 for further 
functionalization proved fruitless. After much deliberation it was found that a THF ring 
functionalized with a geminal allyl, methyl diester (1-157) would undergo a palladium(0) 
catalyzed dehydrogenative decarbonylation (dehydrocarbonylation) to form dihydrofuran 
1-158, which was dihydroxylated, and further manipulated to isatisine A (1-159). 
 
Scheme 1-38 Kerr group’s synthesis of isatisine A 
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1.4.4.2 Dehydrocarbonylation mechanism 
The dehydrocarbonylation reaction Avedis used in isatisine A was originally developed 
by Tsuji and Shimizu to produce α,β-unsaturated ketones (1-165) from allyl β-esters (1-
160). The proposed mechanism for the dehydrocarbonylation is shown in Scheme 1-39. 
Coordination of the metal to the allyl ester (1-161), followed by an oxidative insertion 
gives intermediate 1-162.  Dehydrocarbonylation of 1-162 occurs, which results in the 
palladium being coordinated to the enolate oxygen in 1-163. Tautomerization of the 
enolate, and migration of the palladium complex results in intermediate 1-164, which is 
then followed by a β-hydride elimination to produce the desired α,β-unsaturated ketone 
(1-165).  
 
Scheme 1-39 Tsuji and Shimizu’s synthesis of α,β-unsaturated ketones 
1.4.4.3 4,5-Dihydro-1,2-oxazines and synthesis of pyrroles 
With a method to install olefins, it was postulated that tetrahydro-1,2-oxazines can be 
modified to undergo the Tsuji reaction to give 3,4-dihydro-1,2-oxazines (1-168), which 
can then be manipulated to functionalize C5. We envisioned that C5 functionalization 
could then occur on 1-168 by the means of Diels-Alder chemistry (1-169), or by a 
coupling reaction (1-170, Scheme 1-40).   
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Scheme 1-40 Attempts to functionalize C5 from 3,4-dihydro,1-2,oxazine 
While the route to access 3,4-dihydro-1,2-oxazines was a success, functionalization at the 
C5 postion was not. In both Diels-Alder and Heck coupling attempts for C5 
functionalization, recovery of starting material was observed along with a minor 
undesired product (being more prominent as a by-product in the Heck reaction). Upon 
further investigation of the undesired product it was determined that it was a pyrrole (1-
174). The proposed mechanism of this transformation proceeds as shown in Scheme 
1-41. 
 
Scheme 1-41 Proposed mechanism to access pyrroles from 3,4-dihydro-1,2-oxazines 
Deprotonation of C6 in compound 1-171 would result in an enolate species (1-172), 
which then undergoes an E1cb mechanism resulting in an N-O bond cleavage (1-173). 
Acyl addition by the amide to form the hemiaminal could then undergo dehydration to 
form the pyrrole (1-174).  While the mechanism is not certain, similar transformations 
have been reported in the literature.57 With these insights into 3,4-dihydro-1,2-oxazine 
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reactivity, a methodology to access pyrroles from DA cyclopropanes was pursued. Prior 
to the results, the importance of pyrroles and previous syntheses will be discussed.  
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1.5 Synthesis of pyrroles from DA cyclopropanes 
1.5.1 Introduction to pyrroles 
Pyrrole was discovered in coal tar (and later bone oil) by Runge in 1834. It was named 
pyrrole after the Greek word for ‘red oil’ due to the colour that forms when its vapour 
acts on pine wood soaked with hydrochloric acid. Despite recognizing a new molecule, 
the structure was elucidated approximately 20 years later by Thomas Anderson. 
Anderson distilled over a ton of ivory oil to isolate a colourless oil with a boiling point of 
134-138 °C, which also had a “a hot pungent taste”. The first synthesis of pyrrole was in 
1860 when Schwanert heated ammonium mucate 1-175 (Scheme 1-42).58 
 
Scheme 1-42 Schwanert’s synthesis of pyrrole 
The pyrrole heterocycle is one of, if not the most, important heterocycle known. It is 
found in natural products from much of the world’s flora and fauna,59 and is present in 
many pharmaceutical drugs.60 The presence of pyrroles, as a tetramer, in two molecules 
necessary for most life on earth speaks of their importance: heme, found in blood and 
used to transport oxygen (Figure 1-2, 1-177); and chlorophyll, essential in photosynthesis 
of plants (Figure 1-2, 1-178).61 An important pyrrole containing pharmaceutical is 
atorvastatin (Lipitor) (Figure 1-2, 1-179). Atorvastatin belongs to a family of compounds 
called statins which are used as a lipid-lowering agent, and are used for the prevention of 
symptoms associated with cardiovascular disease. Developed in 1985, it went on to be 
one the highest selling drugs of all time.62  
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Figure 1-2 Structure of heme, chlorphyll a, and atorvastatin 
 
1.5.2 Various syntheses of pyrroles 
Due to the importance of pyrroles, there have been many methodologies developed to 
access them,63 and as such, only a select few examples will be highlighted in this section. 
1.5.2.1 Paal-Knorr pyrrole synthesis 
One of the earliest and most well known synthesis of pyrroles is the classic Paal-Knorr 
synthesis (Scheme 1-43). In 1884, Paal and Knorr independently found that 1,4-diketone 
1-180 can react with ammonia or primary amine 1-118 to access pyrrole 1-181 (Scheme 
1-43). The reaction has been greatly studied with many modifications discovered.64 The 
amine can be varied greatly, but generally a diketone is required as 1,4-dialdehydes or 
keto aldehydes are unstable. 
 
Scheme 1-43 General Paal-Knorr pyrrole synthesis 
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1.5.2.2 Hantzsch pyrrole synthesis 
A few years later, one of the earliest multi-component synthesis of pyrroles was 
developed by Arthur Hantzsch (Scheme 1-44).65 Addition of α-haloketone 1-184, β-keto 
ester 1-182 and ammonia, or a primary amine, give pyrrole 1-185. A key mechanistic 
feature of the reaction is the enamine intermediate (1-183) attacking the α-haloketone. As 
this has become another classic pyrrole synthesis, many modifications of this procedure 
have been developed. 
 
Scheme 1-44 General Hantzsch pyrrole synthesis 
One recent example of a Hantzsch type pyrrole synthesis comes from the Wu group. 
They were able to access polysubstituted pyrroles (1-188) in a one pot procedure from 
enamines (1-186) and α-bromo ketones (1-187); however, unlike the traditional 
mechanism, the pyrrole synthesis is initiated through a photoinduced electron transfer 
from Ir(ppy)3 (Scheme 1-45).
66 In their optimization, they were fortunate to obtain a 92% 
yield of pyrrole when a mixture of enamine, ketone, and Ir(ppy)3 in DMSO were 
irradiated with visible light; failure to include one of these components resulted in no 
pyrrole.  To confirm a radical process, TEMPO was placed into the reaction mixture and 
a significant drop in yield occurred (29%). With a relatively short optimization, they were 
then able to expand the scope of the methodology to access a variety of pyrroles. 
Unfortunately, only aryl substituents on the enamine and the α-bromo ketone were tested.  
Moderate yields were obtained for their pyrroles, but generally electron donating 
substituents offered greater yields than electron withdrawing, for example when R1 = p-
NO2-C6H4 there was a 57% yield of pyrrole, but when R
1 = p-OMe-C6H4 there was an 
84% yield. The proposed mechanism begins with the excitation of Ir(ppy)3 to Ir(ppy)3*, 
which then undergoes a single electron transfer oxidation by α-bromo ketone, to generate 
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Ir(ppy)3
+ and the reduced carbonyl. Reduced 1-189 then gets debrominated to give 
radical 1-190. Radical 1-190 reacts with the enamine to form intermediate 1-192, which 
then self catalyzes the reaction by reducing ketone 1-189. Cyclization of 1-193, followed 
by dehydration of 1-194 leads to the pyrrole 1-188.  
 
Scheme 1-45 Wu group’s light initiated Hantzsch synthesis of pyrroles  
1.5.2.3 Davies pyrrole synthesis 
Among the classics, modern ways have also been developed to access pyrroles. Inspired 
by the process developed by the Hashmi et al.67 to access furans from alkynyl epoxides, 
the Davies group set out to develop conditions to obtain pyrroles from a gold catalyzed, 
ring expansion of N-tosyl alkynyl aziridines (1-195) (Scheme 1-46).68 They found during 
their optimization that they could influence the pyrrole regioisomer by modifying the 
solvent, and the counter ion of the gold catalyst (PPh3AuCl). When AgOTs in DCE was 
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used, 2-5 substituted pyrrole 1-196 was formed exclusively. When AgOTf in 
dichloromethane was used, the 2-4 substituted pyrrole 1-197 was the major, or sole 
product. Lastly, when AgOTf in toluene was used it resulted in a mixture of 
regioisomers. The regioselectivity can be explained by intermediate 1-199 in the 
proposed mechanism. A basic counter ion, such as AgOTs, would facilitate in the 
elimination to form 2,5-disubstituted pyrroles (pathway A). The lack of a basic counter 
ion would require a Lewis basic solvent to facilitate in this role, as seen in the case with 
AgOTf, and toluene. Absence of either a basic counter ion or solvent would result in sole 
formation of the rearranged product (pathway B).  The effect of the counter ion on gold 
catalyst is not surprising to this case, as it has previously been reported in the literature.69 
 
Scheme 1-46 Davies group’s synthesis of pyrroles from alkynyl aziridines 
1.5.2.4 Glorius pyrrole synthesis 
In 2010, the Glorius group expanded on the work developed by Dr. Keith Fagnou’s 
indole synthesis,70 to access pyrroles by a allylic sp3 C-H activation, or vinylic sp2 C-H 
activation, of enamines and their subsequent coupling with alkynes (Scheme 1-47).71 The 
optimized conditions were found to be [Cp*RhCl2]2, AgSbF6, and Cu(OAc)2 in DCE; a 
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non-coordinating solvent, and choice of oxidant were important to the reaction (many Cu 
salts were not tolerable of the reaction conditions). The requirement for Cu(OAc)2 was 
confirmed whereby a reaction without copper gave a 2% yield (1H NMR yield), which 
then increased to 48% after addition of Cu(OAc)2 (
1H NMR yield). It was also found that 
SbF6 was the superior counter ion, and some anions, such as chloride anion, resulted in 
no reaction. The reaction scope was tolerable of various aryl internal alkynes with N-
acetyl enamine (R= CO2Me; R
1= H; R2= Ac) in 38-70% yields, and of various enamines 
with 1-phenyl-1-butyne, or diphenylacetylene. Since only one regioisomer was formed 
when R=CO2Me (1-206a), it was speculated that the reaction must be proceeded through 
intermediate 1-209 (whereby the rhodium coordinates with the carbonyl of the ester). 
This was confirmed when an enamine with R=CN was used. Since there is only one 
mode for coordination (as seen in intermediate 1-210), pyrrole 1-207a was formed 
exclusively.    
 
Scheme 1-47 Glorius group’s synthesis of pyrroles from C-H activation of enamines 
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1.5.3 Synthesis of pyrroles from DA cyclopropane  
In 2003, the Pagenkopf group showed that they can access pyrroles from donor-acceptor 
cyclopropanes. Their methodology consisted of the Lewis activated [3+2] cycloaddition 
between cyclopropane 1-211 and nitriles (1-212), followed by dehydration and 
tautomerization of intermediate 1-213 (Scheme 1-48).72 Alkyl, vinyl nitriles accessed 
pyrroles in good yields (77-91%), however aryl nitriles gave low yields (35-55%).  
 
Scheme 1-48 Pagenkopf group’s synthesis of pyrroles from cyclopropanes 
More recently, in 2014 the Zhang group showed that they can access pyrroles from 
donor-accepted cyclopropanes and anilines using an iron-mediated oxidation domino 
reaction (Scheme 1-49).73 Originally trying to access dihydropyrrole 1-220 from 
cyclopropane 1-215 and aniline 1-216, they thought that an iron catalyst would increase 
the rate of the reaction, but instead they discovered that they had isolated pyrrole 1-217. 
As seen in the proposed mechanism in Scheme 1-49, the iron catalyst facilitates in the 
ring opening of the cyclopropane by the aniline to form dihydropyrrole 1-220; however, 
subsequent single electron transfer oxidation of 1-220 by iron and oxygen, generate 
radical intermediate 1-221. The intermediate then becomes pyrrole 1-217 through radical 
dehydrogenation and deprotonation reactions. Radical trapping experiments were 
undertaken to confirm the conversion of 1-220 to 1-221 by single electron transfer (SET). 
Three radical scavengers were independently added to the reaction, and in each case the 
yield of pyrrole 1-217 decreased, while the yield of dihydropyrrole 1-220 increased. They 
were successful in forming various pyrroles from a variety of anilines and cyclopropanes 
in moderate yields. 
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Scheme 1-49 Zhang group’s synthesis of pyrroles from cyclopropanes 
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1.5.4 Results and discussion 
1.5.4.1 Synthesis of 1-allyl-1-methylcyclopropane-1,1-dicarboxylate 
In order to access pyrroles from DA cyclopropanes, via 4,5-dihydro-1,2-oxazines, various 
cyclopropanes containing an ally ester moiety first needed to be synthesized. A two-step 
procedure was undertaken to convert a methyl ester in cyclopropane 1-218 to an allyl 
ester (Scheme 1-50, 1-221). This involved monosaponification of an ester, followed by a 
substitution reaction with allyl bromide.  Using dimethylcyclopropane-1,1-dicarboxylate 
1-218 in sodium hydroxide and methanol allowed for monosaponification of the geminal 
ester trans to the substituent on the cyclopropane (1-219). Monosaponification of the 
trans ester occurs as it is the least hindered ester.74 Reacting the newly formed acid with 
allyl bromide through an SN2 or SN2’ mechanism afforded the required 1-allyl-1-
methylcyclopropane-1,1-dicarboxylate (1-221).  
 
Scheme 1-50 Synthesis of 1-allyl-1-methylcyclopropane-1,1-dicarboxylate 
Despite the stereoselective nature of the saponification reaction, the chirality will become 
inconsequential when tetrahydro-1,2-oxazine undergoes a Tsuji reaction, as this position 
becomes sp2 hybridized. The various cyclopropanes that underwent this transformation 
are shown in Figure 1-3. Pyrroles derived from cyclopropanes 1-221a and 1-221b were 
worked on by William Humenny, 1-221c and 1-221d by myself, and lastly 1-221e by 
Katarina Sapeta. 
49 
 
 
Figure 1-3 Library of 1-allyl-1methylcyclopropane-1,1-dicarboxylate  
1.5.4.2 Synthesis of tetrahydro-1,2-oxazine 
Each of the cyclopropanes in Figure 1 were reacted with various nitrones in order to 
obtain tetrahydro-1,2-oxazines (Table 1-2) following methods previously described in the 
literature.50,51 The nitrones utilized for the reaction were either developed in situ or 
isolated prior to use, and the decision to use one method versus the other was mostly 
decided by chemical availability.  
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Table 1-2 Synthesis of tetrahydro-1,2-oxazines 
 
The formation of tetrahydro-1,2-oxazine (1-223) proceeded smoothly and were obtained 
in very good yields (63-96%). While most of the reactions were carried out in DCM, or 
toluene, under catalytic Lewis acid conditions (10 mol % of Yb(OTf)3), compounds 1-
223f and 1-223g had to be carried out with 10 mol% of Sc(OTf)3; due to the slightly 
more Lewis acidity of the catalyst, it’s more effective in reactions containing weak donor 
groups. The relationship of the substituents on carbons 3 and 6 were assumed to be in a 
cis relationship due to literature precedence.52  
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1.5.4.3 Synthesis of 4,5-dihydro-1,2-oxazine 
With a process to develop tetrahydro-1,2-oxazine containing a geminal allyl, methyl 
ester, the dehydrocarbonylation procedure to form 4,5-dihydro-1,2-oxazine (1-226) was 
undertaken. Optimal reaction conditions determined by Avedis Karadolean were found to 
be heating 1-223 with 6 mol% Pd2(dba)3 in acetonitrile (Table 1-3).  
Table 1-3. Dehydrocarbonylation of tetrahydro-1,2-oxazines 
 
A limitation of this reaction is that only aniline derived nitrones are able to undergo this 
transformation, as N-alkyl or N-benzyl resulted in no reaction or partial conversion 
respectively (Scheme 1-51). Since N-alkyl and N-benzyl amines are more basic then 
aniline derived nitrones – because the lone pair in N-aryl nitrones are delocalized by the 
aromatic ring – catalyst poisoning can occur, thus limiting the reaction. Attempts to 
quaternerize the amine did not aid in the transformation.  
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Scheme 1-51. Limitations of dehydrocarbonylation 
1.5.4.4 Synthesis of pyrroles  
With 4,5-dihydro-1,2-oxazines at hand, we were now able to access pyrroles.  
Triethylamine was found to successfully convert 4,5-dihydro-1,2-oxazines to pyrroles at 
room temperature in 24 hours; however, the yields and time were improved when the 
reaction stirred for five minutes at room temperature with DBU (Table 1-4). Prolonged 
reaction times (greater than five minutes) resulted in the product decomposing. 
Table 1-4 Dehydration of 4,5-dihydro-1,2-oxazines 
 
As both dehydrocarbonylation and dehydration reactions occurred in acetonitrile, a one-
pot procedure was then explored to convert tetrahydro-1,2-oxazine (1-223) directly to 
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pyrrole (1-231). These efforts were successful and it was found that yields were similar, 
or vastly improved with the one pot procedure (Table 1-5).  
Table 1-5 Comparison between one-pot and two-pot procedure to pyrroles 
 
With a library of various 1-allyl-1methylcyclopropane-1,1-dicarboxylates (Figure 1-3) 
and an optimized route to pyrroles from tetrahydro-1,2-oxazines (Table 1-5), a substrate 
scope was explored (Table 1-6). Most pyrroles were formed in good yield using the 
optimized conditions but a few modifications needed to be done. Compound 1-231d 
required the use of NEt3 (and 24 hour reaction time), instead of five minutes with DBU, 
presumably because C6 proton was very acidic and lead to decomposition of starting 
material. Also, tetrahydro-1,2-oxazines 1-231f-i did not proceed under the optimized 
conditions, and it was required that the reactions be heated in order to proceed. The need 
for heat was presumably due to the decreased acidity of the proton on C6 due to lack of 
donor substituent on the cyclopropane. The synthesis of pyrroles is also tolerable of 
aniline derived nitrones with electron donating and withdrawing groups on the aniline 
(pyrrole 1-231m and 1-231n respectively), benzaldehyde derived nitrones with electron 
donating (pyrroles 1-231e, 1-231o) and withdrawing groups from benzaldehyde (pyrroles 
1-231d, 1-231l).  
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Table 1-6 One-pot procedure to pyrroles from tetrahydro-1,2-oxazines 
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1.5.4.5 Progress towards atorvastatin 
To highlight the utility of the pyrrole synthesis, progress towards the total synthesis of 
atorvastatin was undertaken by William Humenny (Scheme 1-52). Reacting nitrone 1-
233 with cyclopropane 1-232 gave tetrahydro-1,2-oxazine 1-234 but it should be noted 
that MgI2
75 was needed as the standard Yb(OTf)3 or Sc(OTf)3 would not work for this 
transformation. Pyrrole 1-235 was then accessed through the two-pot 
dehydrocarbonylation/dehydration in 70% yield over two steps. As atorvastatin contains 
a phenyl substituent at the two position of the pyrrole, bromination was carried out at this 
position in order to be a coupling partner later in the synthesis. Hydrolysis of the ester on 
1-235 was also formed to give compound 1-236 in 86% over two steps. Conversion of the 
acid to anilide 1-237 via the acyl chloride was obtained in variable yields (65-86%). 
Lastly, a Suzuki coupling with phenylboronic acid and pyrrole 1-237 gave pyrrole 1-238 
in a 75% yield. Pyrrole 1-238 could then be deprotected to access atorvastatin, however 
attempts with ceric ammonium nitrate were unsuccessful before William Humenny 
graduated.  
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Scheme 1-52 Progress towards atorvastatin 
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1.5.5 Conclusions 
Efforts were undertaken to functionalize the C5 position of tetrahydro-1,2-oxazines, via 
4,5-dihydro-1,2-oxazines. The 4,5-dihydro-1,2-oxazines were synthesized via a Tsuji 
dehydro/decarbonylation of an allyl ester on tetrahydro-1,2-oxazines. Attempts to add 
functionality on the olefin with Diels-Alder, or Heck coupling chemistry were 
unsuccessful; they formed pyrroles instead. Fifteen examples of tetrahydro-1,2-oxazines 
were converted to pyrroles in yields ranging from 48-95%. Although the method may be 
inferior to other pyrrole synthesis, it is nonetheless an interesting reaction that explores 
further manipulation of the easily prepared tetrahydro-1,2-oxazines heterocycle.   
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1.6 Summary and future work 
In summary, a new method to ring opening of DA cyclopropanes has been accessed, 
through the use of organotrifluoroborate salts. The methodology was only compatible 
with alkynyl trifluoroborate salts reacting with aryl substituted DA cyclopropanes. Each 
example was isolated as a malonyl-BF2 complex, which then went acid hydrolysis to 
access the desired malonate species. Examples were made in 36-75% yield over the two 
steps. Future work will look into the reactivity of the malonyl-BF2 complex and efforts 
will be undertaken to develop conditions that can undergo 5-endo-dig cyclization (1-240), 
or to react the complex with an electrophile (1-241). Near the completion of this project, 
similar work was published by Ortega and Csákÿ.41 
 
Scheme 1-53 Studying the reactivity of malonyl-BF2 complexes 
 
The work described in this chapter also expanded the Kerr group’s synthesis of 
tetrahydro-1,2-oxazines to access pyrroles. Modified cyclopropanes containing geminal 
allyl and methyl esters underwent an annulation reaction, with nitrones, to form 
tetrahydro-1,2-oxazines. These were then converted to pyrroles by a one-pot 
dehydrocarbonylation/dehydration procedure. Various pyrroles were accessed in 48-95% 
yield from the tetrahydro-1,2-oxazines. A limitation of this reaction is that only nitrones 
derived from anilines could be used for the reaction. Further exploration is required to 
find conditions compatible with N-alkyl nitrones, which would greatly open the utility of 
the methodology. The value of the methodology was then applied towards the total 
synthesis of atorvastatin by William Humenny.  
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1.7 Experimental 
1.7.1 Ring opening of DA cyclopropanes with RBF3K 
General considerations: 
All reactions were performed under an atmosphere of argon unless otherwise indicated. 
Dichloroethane was distilled over calcium hydride, boron trifluoride diethyl etherate was 
distilled over calcium hydride and diethyl ether under reduced pressure. All other 
reagents and solvents were used as purchased from Sigma Aldrich, Alfa Aesar, or VWR 
and used as received. Reaction progress was monitored by TLC (EM Science, silica gel 
60 F254), visualizing with UV light, and the plates developed with p-anisaldehyde. 
Column chromatography was performed using silica gel (230-400 mesh, Silicycle 
Chemical Division Inc). NMR experiments were performed on Varian Mercury 400, and 
Inova 400 MHz instruments with 13C operating frequency of 100 MHz, 11B operating 
frequency of 128 MHz, and 19F operating frequency of 376 MHz. Chemical shifts are 
reported in ppm relative to the residual solvent signal (CDCl3, referenced to residual 
CHCl3 at δ = 7.26 for 1H and δ = 77.0 for 13C). Coupling constants (J) are reported in Hz, 
and multiplicities of the signals are described using the following abbreviations: s = 
singlet, d = doublet, t = triplet, m = multiplet, app = apparent. High resolution mass 
spectra (HRMS) were obtained on a Thermo Scientific DFS™ Magnetic Sector Electron 
Ionization GC-HRMS. Infrared spectra were obtained as thin films on NaCl plates using 
a Bruker Vector 33 FT-IR instrument and are reported in frequency of absorption (cm-1). 
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General procedure and spectral data for dimethyl malonates: 
To a solution of organo trifluoroborate salt (2.5 equiv) in dry dichloroethane (0.5 mol/L), 
cooled to 0 °C, was added BF3•OEt2 (4.55 equiv) dropwise. The reaction stirred for 20 
minutes at 0 °C, at which point cyclopropane (1 equiv) in dichloroethane (0.8 mol/L) was 
added. The reaction stirred at 0 °C for 5 minutes, 5 minutes at room temperature, and 
then the reaction flask was placed in a 65 °C oil bath for 16 hours. After this time, water 
was added to the reaction flask, and the contents were extracted with dichloromethane. 
The combined organic layers were washed with brine, and dried with anhydrous MgSO4. 
Removal of the solvent in vacuo gave the crude malonyl-BF2 complex. The crude 
material was dissolved in tetrahydrofuran (0.1 mol/L) and to the reaction was added half 
the volume of a 20% HCl/H2O (v/v) solution, dropwise, at room temperature. The 
reaction stirred at room temperature for 12 hours. After this time, the contents were 
diluted with H2O, and then extracted with ethyl acetate. The combined organic layers 
were washed with aqueous sodium bicarbonate, brine, and then dried with anhydrous 
MgSO4. The malonates were then purified by flash column chromatography on silica gel 
(15% EtOAc/hexanes). 
dimethyl 2-(2,4-diphenylbut-3-yn-1-yl)malonyl-BF2 complex (1-
86a): Following the general procedure, to a chilled solution of 
potassium 2-phenyl-1-ethynyltrifluoroborate (208 mg, 1 mmol) in 
dry dichloroethane (2 mL), was added  BF3•OEt2 (225 µL, 1.82 
mmol). Dimethyl 2-phenylcyclopropane-1,1-dicarboxylate (94 mg, 
0.4 mmol) in dry dichloroethane (0.5 mL) was then added to the flask. The reaction was 
then diluted with water and the contents extracted with dichloromethane. The combined 
organic layers were washed with brine, dried with anhydrous MgSO4, and removal of the 
solvent in vacuo gave 1-86a. Normally these compounds are carried through crude, but 
can be purified for characterization by flash column chromatography on silica gel (15% 
EtOAc/hexanes); Rf = 0.56 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.45 - 
7.24 (m, 10 H), 3.88 (X of ABX, JAX=7.5 Hz, JBX=7.4 Hz, 1 H), 3.85 (s, 3 H), 2.74 (A of 
ABX, JAB=14.2 Hz, JAX=7.5 Hz, 1 H), 2.62 (B of ABX, JAB=14.2 Hz, JBX=7.4 Hz, 1 H); 
13C NMR (100 MHz, CDCl3) δ 173.6 (t, J(C-F)=2.3 Hz), 140.8, 131.5, 128.3, 128.3, 127.9, 
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127.6, 127.0, 123.4, 90.4, 83.6, 77.5, 55.5, 38.1, 30.6; 11B NMR (128 MHz, CDCl3) δ 
0.80 (s); 19F NMR (376 MHz, CDCl3) δ -142.8 (s), -142.9 (s); FT-IR (thin film, cm-1 ) 
νmax 2950, 1608, 1514, 1448, 1379, 1209, 1121, 1045, 913, 744; HRMS calc’d for 
C21H19BF2O4 [M+] 384.1344; found 384.1350. 
dimethyl 2-(2-(4-bromophenyl)-4-phenylbut-3-yn-1-
yl)malonyl-BF2 complex (1-86b): Following the general 
procedure, to a chilled solution of potassium 2-phenyl-1-
ethynyltrifluoroborate (208 mg, 1 mmol) in dry dichloroethane (2 
mL), was added  BF3•OEt2 (225 µL, 1.82 mmol). Dimethyl 2-
phenylcyclopropane-1,1-dicarboxylate (125 mg, 0.4 mmol) in dry dichloroethane (0.5 
mL) was then added to the flask. The reaction was then diluted with water and the 
contents extracted with dichloromethane. The combined organic layers were washed with 
brine, dried with anhydrous MgSO4, and removal of the solvent in vacuo gave the crude 
1-86b. Normally these compounds are carried through crude, but can be purified for 
characterization by flash column chromatography on silica gel (15% EtOAc/hexanes); Rf 
= 0.53 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 1H NMR (400 MHz, 
CHLOROFORM-d) δ ppm 7.47 (app d, J=8.6 Hz, 2 H), 7.42 - 7.40 (m, 2 H), 7.32 - 7.28 
(m, 3 H), 7.27 (app d, J=8.6 Hz, 2 H), 3.86 (s, 6 H), 3.89 - 3.85 (X of ABX, JAX=7.7 Hz, 
JBX=7.2 Hz, 1 H), 2.75 (A of ABX, JAB=14.3 Hz, JAX=7.7 Hz, 1 H), 2.62 (B of ABX, 
JAB=14.3 Hz, JBX=7.2 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 173.6 (t, J(C-F)=2.3 Hz), 
139.9, 131.5, 131.4, 129.4, 128.3, 128.1, 123.1, 120.8, 89.7, 83.9, 77.2, 55.5, 37.7, 30.5; 
11B NMR (128 MHz, CDCl3) δ 0.78 (s); 19F NMR (376 MHz, CDCl3) δ -142.8 (s), -
142.9 (s); FT-IR (thin film, cm-1 ) νmax 2950, 1609, 1516, 1448, 1380, 1208, 1123, 
1046, 912, 736; HRMS calc’d for C21H18BBrF2O4 [M+] 462.0450; found 462.0437. 
 
 
 
62 
 
dimethyl 2-(2,4-diphenylbut-3-yn-1-yl)malonate (1-82a): 
Following the general procedure, to a chilled solution of potassium 2-
phenyl-1-ethynyltrifluoroborate (208 mg, 1 mmol) in dry 
dichloroethane (2 mL), was added  BF3•OEt2 (225 µL, 1.82 mmol). 
Dimethyl 2-phenylcyclopropane-1,1-dicarboxylate (94 mg, 0.4 
mmol) in dry dichloroethane (0.5 mL) was then added to the reaction. Hydrolysis of the 
crude material in tetrahydrofuran (4 mL) by 20% HCl/H2O (v/v) (2 ml), and purification, 
afforded dimethyl malonate 1-82a (75%, 100 mg, 0.3 mmol) as a yellow oil; Rf = 0.72 
(30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.48 - 7.44 (m, 4 H), 7.36 (app t, 
J=7.6 Hz, 2 H), 7.33 - 7.27 (m, 4 H), 3.97 (app dd, J=9.8, 5.9 Hz, 1 H), 3.79 - 3.74 (m, 1 
H), 3.77 (s, 3 H), 3.71 (s, 3 H), 2.53 - 2.34 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 
169.5, 169.4, 140.5, 131.7, 128.7, 128.2, 128.0, 127.5, 127.2, 123.2, 89.3, 84.6, 52.6, 
52.6, 49.9, 37.2, 36.3; FT-IR (thin film, cm-1 ) νmax 3029, 2952, 1751, 1736, 1490, 
1436, 1226, 1152, 1030, 758, 693; HRMS calc’d for C21H20O4 [M+] 336.1362; found 
336.1358. 
dimethyl 2-(2-(4-bromophenyl)-4-phenylbut-3-yn-1-
yl)malonate (1-82b): Following the general procedure, to a 
chilled solution of potassium 2-phenyl-1-ethynyltrifluoroborate 
(208 mg, 1 mmol) in dry dichloroethane (2 mL), was added  
BF3•OEt2 (225 µL, 1.82 mmol). Dimethyl 2-(4-
bromophenyl)cyclopropane-1,1-dicarboxylate (125 mg, 0.4 mmol) in dry dichloroethane 
(0.5 mL) was then added to the reaction. Hydrolysis of the crude material in 
tetrahydrofuran (4 mL) by 20% HCl/H2O (v/v) (2 ml), and purification, afforded 
dimethyl malonate 1-82b (70%, 116 mg, 0.28 mmol) as an orange oil; Rf = 0.50 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.48 (app d, 2 H), 7.45 - 7.43 (m, 2 H), 
7.34 - 7.30 (m, 5 H), 3.93 (app dd, J=9.6, 5.7 Hz, 1 H), 3.76 (s, 3 H), 3.73 (app dd, J=8.8, 
5.7 Hz, 1 H), 3.70 (s, 3 H), 2.48 - 2.29 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 169.4, 
169.3, 139.6, 131.7, 131.7, 129.2, 128.3, 128.2, 122.9, 121.1, 88.6, 84.9, 52.7, 52.7, 49.7, 
37.0, 35.8; FT-IR (thin film, cm-1 ) νmax 3055, 2952, 2845, 1735, 1488, 1436, 1155, 
1012, 913, 826, 758, 692; HRMS calc’d for C21H19BrO4 [M+] 414.0467; found 
414.0476. 
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dimethyl 2-(2-(4-methoxyphenyl)-4-phenylbut-3-yn-1-
yl)malonate (1-82c): Following the general procedure, to a 
chilled solution of potassium 2-phenyl-1-ethynyltrifluoroborate 
(208 mg, 1 mmol) in dry dichloroethane (2 mL), was added  
BF3•OEt2 (225 µL, 1.82 mmol). Dimethyl 2-(4-
methoxyphenyl)cyclopropane-1,1-dicarboxylate (106 mg, 0.4 mmol) in dry 
dichloroethane (0.5 mL) was then added to the reaction. Hydrolysis of the crude material 
in tetrahydrofuran (4 mL) by 20% HCl/H2O (v/v) (2 ml), and purification, afforded 
dimethyl malonate 1-82c (59%, 87 mg, 0.24 mmol) as an orange oil; Rf = 0.43 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.48 - 7.43 (m, 2 H), 7.36 (app d, J=8.6 
Hz, 2 H), 7.32 - 7.28 (m, 3 H), 6.89 (app d, J=8.6 Hz, 2 H), 3.91 (app dd, J=9.4, 6.3 Hz, 1 
H), 3.81 (s, 3 H), 3.76 (s, 3 H), 3.76-3.73 (m, 1 H), 3.71 (s, 3 H), 2.49 - 2.32 (m, 2 H); 
13C NMR (100 MHz, CDCl3) δ 169.5, 169.4, 158.7, 132.6, 131.6, 128.5, 128.2, 128.0, 
123.2, 114.0, 89.7, 84.3, 55.3, 52.6, 52.6, 49.8, 37.3, 35.5; FT-IR (thin film, cm-1 ) νmax 
3032, 2953, 2837, 1735, 1609, 1512, 1437, 1035, 832, 759, 696, 563; HRMS calc’d for 
C22H22O5 [M+] 366.1467; found 366.1453. 
dimethyl 2-(2-(4-cyanophenyl)-4-phenylbut-3-yn-1-
yl)malonate (1-82e): Following the general procedure, to a 
chilled solution of potassium 2-phenyl-1-ethynyltrifluoroborate 
(208 mg, 1 mmol) in dry dichloroethane (2 mL), was added  
BF3•OEt2 (225 µL, 1.82 mmol). Dimethyl 2-(4-
cyanophenyl)cyclopropane-1,1-dicarboxylate (104 mg, 0.4 mmol) in dry dichloroethane 
(0.5 mL) was then added to the reaction. Hydrolysis of the crude material in 
tetrahydrofuran (4 mL) by 20% HCl/H2O (v/v) (2 ml), and purification, afforded 
dimethyl malonate 1-82e (65%, 93 mg, 0.26 mmol) as an orange oil; Rf = 0.36 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.67 - 7.63 (m, 2 H), 7.60 - 7.55 (m, 2 
H), 7.46 - 7.43 (m, 2 H), 7.35 - 7.30 (m, 3 H), 4.04 (app dd, J=10.0, 5.3 Hz, 1 H), 3.79 - 
3.76 (m, 1 H), 3.78 (s, 3 H), 3.70 (s, 3 H), 2.27 - 2.51 (m, 2 H); 13C NMR (100 MHz, 
CDCl3) δ 169.2, 169.1, 146.0, 132.5, 131.7, 128.5, 128.5, 128.3, 128.3, 122.5, 118.6, 
111.2, 87.5, 85.7, 52.8, 52.8, 49.7, 36.8, 36.4; FT-IR (thin film, cm-1 ) νmax 3002, 2954, 
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2229, 1735, 1608,1437, 1154, 913, 837, 759, 693, 572 ; HRMS calc’d for C22H19NO4 
[M+] 361.1314; found 361.1311. 
dimethyl 2-(4-phenyl-2-(o-tolyl)but-3-yn-1-yl)malonate (1-82f): 
Following the general procedure, to a chilled solution of potassium 2-
phenyl-1-ethynyltrifluoroborate (208 mg, 1 mmol) in dry 
dichloroethane (2 mL), was added  BF3•OEt2 (225 µL, 1.82 mmol). 
Dimethyl 2-(o-tolyl)cyclopropane-1,1-dicarboxylate (99 mg, 0.4 
mmol) in dry dichloroethane (0.5 mL) was then added to the reaction. Hydrolysis of the 
crude material in tetrahydrofuran (4 mL) by 20% HCl/H2O (v/v) (2 ml), and purification, 
afforded dimethyl malonate 1-82f (70%, 97 mg, 0.28 mmol) as a yellow oil; Rf = 0.5 
(30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.63 (app d, J=7.4 Hz, 1 H), 7.49 
- 7.44 (m, 2 H), 7.34 - 7.29 (m, 3 H), 7.26 - 7.17 (m, 3 H), 4.18 (app dd, J=10.6, 4.7 Hz, 1 
H), 3.91 (app dd, J=10.0, 4.9 Hz, 1 H), 3.81 (s, 3 H), 3.71 (s, 3 H), 2.43 (s, 3 H), 2.48 - 
2.22 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 169.5, 169.4, 138.8, 135.1, 131.6, 130.6, 
128.2, 128.0, 127.5, 127.1, 126.4, 123.2, 89.7, 84.1, 52.6, 50.0, 35.7, 33.0, 19.0; FT-IR 
(thin film, cm-1 ) νmax 3021, 2953, 1752, 1736, 1490, 1436, 1284, 1154, 914, 745, 692; 
HRMS calc’d for C22H22O4 [M+] 350.1518; found 350.1503. 
dimethyl 2-(2-(3-nitrophenyl)-4-phenylbut-3-yn-1-yl)malonate (1-
82g): Following the general procedure, to a chilled solution of 
potassium 2-phenyl-1-ethynyltrifluoroborate (208 mg, 1 mmol) in dry 
dichloroethane (2 mL), was added  BF3•OEt2 (225 µL, 1.82 mmol). 
Dimethyl 2-(3-nitrophenyl)cyclopropane-1,1-dicarboxylate (112 mg, 
0.4 mmol) in dry dichloroethane (0.5 mL) was then added to the reaction. Hydrolysis of 
the crude material in tetrahydrofuran (4 mL) by 20% HCl/H2O (v/v) (2 ml), and 
purification, afforded dimethyl malonate 1-82g (64%, 97 mg, 0.25 mmol) as an orange 
oil; Rf = 0.39 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 8.35 (app t, J=2.0 
Hz, 1 H), 8.15 (app dt, J=8.2, 1.0 Hz, 1 H), 7.80 (app d, J=7.8 Hz, 1 H), 7.54 (app t, 
J=8.0 Hz, 1 H), 7.49 - 7.43 (m, 2 H), 7.38 - 7.29 (m, 3 H), 4.11 (app dd, J=10.2, 5.1 Hz, 1 
H), 3.81 - 3.77 (m, 1 H), 3.79 (s, 3 H), 3.71 (s, 3 H), 2.55 - 2.32 (m, 2 H); 13C NMR (100 
MHz, CDCl3) δ 169.2, 169.1, 148.5, 142.8, 133.7, 131.7, 129.6, 128.5, 128.3, 122.5, 
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122.5, 122.4, 87.5, 85.8, 52.8, 52.8, 49.7, 36.9, 36.0; FT-IR (thin film, cm-1 ) νmax 
3067, 2953, 2874, 1751, 1532, 1490, 912, 759, 692, 414; HRMS calc’d for C21H19NO6 
[M+] 381.1212; found 381.1210. 
dimethyl 2-(4-phenyl-2-(thiophen-2-yl)but-3-yn-1-yl)malonate (1-
82h): Following the general procedure, to a chilled solution of 
potassium 2-phenyl-1-ethynyltrifluoroborate (208 mg, 1 mmol) in dry 
dichloroethane (2 mL), was added  BF3•OEt2 (225 µL, 1.82 mmol). 
Dimethyl 2-(thiophen-2-yl)cyclopropane-1,1-dicarboxylate (96 mg, 0.4 mmol) in dry 
dichloroethane (0.5 mL) was then added to the reaction. Hydrolysis of the crude material 
in tetrahydrofuran (4 mL) by 20% HCl/H2O (v/v) (2 ml), and purification, afforded 
dimethyl malonate 1-82h (58%, 80 mg, 0.23 mmol) as an orange oil; Rf = 0.5 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.48 - 7.42 (m, 1 H), 7.35 - 7.29 (m, 3 
H), 7.22 (app dd, J=5.1, 1.2 Hz, 1 H), 7.05 (app d, J=3.5 Hz, 1 H), 6.96 (app dd, J=5.1, 
3.5 Hz, 1 H), 4.26 (app dd, J=9.0, 5.9 Hz, 1 H), 3.79 - 3.75 (m, 1 H), 3.76 (s, 3 H), 3.72 
(s, 3 H), 2.62 - 2.43 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 169.4, 169.3, 143.9, 131.7, 
128.2, 126.7, 124.9, 124.4, 122.8, 88.7, 84.2, 52.7, 52.7, 49.6, 37.1, 31.6; FT-IR (thin 
film, cm-1 ) νmax; 3105, 2952, 2848, 1735, 1598, 1490, 1436, 1156, 1039, 850, 758, 
692; HRMS calc’d for C19H18O4S [M+] 342.0926; found 342.0920. 
dimethyl 2-(2-phenyl-4-(thiophen-2-yl)but-3-yn-1-yl)malonate (1-
82i): Following the general procedure, to a chilled solution of 
potassium 2-thiophenyl-1-ethynyltrifluoroborate (214 mg, 1 mmol) in 
dry dichloroethane (2 mL), was added  BF3•OEt2 (225 µL, 1.82 
mmol). Dimethyl 2-phenylcyclopropane-1,1-dicarboxylate (94mg, 0.4 mmol) in dry 
dichloroethane (0.5 mL) was then added to the reaction. Hydrolysis of the crude material 
in tetrahydrofuran (4 mL) by 20% HCl/H2O (v/v) (2 ml), and purification, afforded 
dimethyl malonate 1-82i (48%, 66 mg, 0.19 mmol) as an orange oil; Rf = 0.46 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.41 - 7.36 (m, 2 H), 7.35 - 7.28 (m, 2 
H), 7.27 - 7.21 (m, 1 H), 7.20 - 7.14 (m, 2 H), 6.93 (app dd, J=5.1, 3.9 Hz, 1 H), 3.95 
(app dd, J=9.4, 5.9 Hz, 1 H), 3.73 (s, 3 H), 3.68 (s, 3 H), 3.67 (app dd, J=8.6, 6.2 Hz, 1 
H), 2.48 - 2.32 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 169.4, 169.3, 140.1, 131.7, 
66 
 
128.7, 127.5, 127.3, 126.8, 126.6, 123.1, 93.3, 77.6, 52.6, 49.8, 49.8, 36.9, 36.6; FT-IR 
(thin film, cm-1 ) νmax 2952, 1750, 1734, 1493, 1435, 1152, 913, 743, 700, 553; HRMS 
calc’d for C19H18O4S [M+] 342.0926; found 342.0936. 
dimethyl 2-(2-phenyl-4-(o-tolyl)but-3-yn-1-yl)malonate (1-82j): 
Following the general procedure, to a chilled solution of potassium 2-
methylphenyltrifluoroborate (222 mg, 1 mmol) in dry dichloroethane 
(2 mL), was added  BF3•OEt2 (225 µL, 1.82 mmol). Dimethyl 2-
phenylcyclopropane-1,1-dicarboxylate (94mg, 0.4 mmol) in dry 
dichloroethane (0.5 mL) was then added to the reaction. Hydrolysis of the crude material 
in tetrahydrofuran (4 mL) by 20% HCl/H2O (v/v) (2 ml), and purification, afforded 
dimethyl malonate 1-82j (49%, 69 mg, 0.24 mmol) as a yellow oil; Rf = 0.49 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.51 - 7.42 (m, 3 H), 7.37 (app t, J=7.6 
Hz, 2 H), 7.32 - 7.25 (m, 1 H), 7.24 - 7.20 (m, 2 H), 7.18 - 7.12 (m, 1 H), 4.03 (app dd, 
J=9.8, 5.9 Hz, 1 H), 3.83 (dd, J=9.0, 5.5 Hz, 1 H), 3.78 (s, 3 H), 3.71 (s, 3 H), 2.56 - 2.35 
(m, 1 H), 2.47 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 169.5, 169.4, 140.6, 140.0, 132.0, 
129.3, 128.6, 128.0, 127.4, 127.1, 125.4, 122.9, 93.2, 83.5, 52.6, 49.9, 37.4, 36.5, 20.8; 
FT-IR (thin film, cm-1 ) νmax 3061, 2952, 2849, 1752, 1736, 1600, 1493, 1453, 1154, 
760, 700, 562; HRMS calc’d for C22H22O4 [M+] 350.1518; found 350.1512. 
dimethyl 2-(2-phenyloct-3-yn-1-yl)malonate (1-82k): Following 
the general procedure, to a chilled solution of potassium 2-butyl-1-
ethynyltrifluoroborate (188 mg, 1 mmol) in dry dichloroethane (2 
mL), was added  BF3•OEt2 (225 µL, 1.82 mmol). Dimethyl 2-
phenylcyclopropane-1,1-dicarboxylate (94mg, 0.4 mmol) in dry dichloroethane (0.5 mL) 
was then added to the reaction. Hydrolysis of the crude material in tetrahydrofuran (4 
mL) by 20% HCl/H2O (v/v) (2 ml), and purification, afforded dimethyl malonate 1-82k 
(36%, 46 mg, 0.15 mmol) as a yellow oil; Rf = 0.63 (30% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3) δ 7.40 - 7.29 (m, 4 H), 7.26 - 7.20 (m, 1 H), 3.77 - 3.68 (m, 2 H), 3.76 
(s, 3 H), 3.70 (s, 3 H), 2.40 - 2.15 (m, 2 H), 2.23 (dt, J=7.0, 2.3 Hz, 2 H), 1.56 - 1.37 (m, 
4 H), 0.92 (t, J=7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 169.6, 169.5, 141.3, 128.5, 
127.4, 126.9, 84.8, 79.6, 52.5, 49.9, 37.5, 35.8, 31.0, 21.9, 18.5, 13.6; FT-IR (thin film, 
67 
 
cm-1 ) νmax 2955, 2872, 1753, 1737, 1494, 1434, 1252, 1154, 1042, 913, 744, 700; 
HRMS calc’d for C19H24O4 [M+] 316.1675; found 316.1662. 
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1.7.2 Synthesis of pyrroles from DA cyclopropanes 
General considerations: 
All reactions were performed under an atmosphere of Ar unless otherwise indicated.  
Toluene, acetonitrile, N,N-dimethylformamide (DMF), and dichloromethane were dried 
and deoxygenated by passing the nitrogen purged solvents through activated alumina 
columns. All other reagents and solvents were used as purchased from Sigma Aldrich, 
Alfa Aesar, Caledon, Strem or VWR and used as received.  Reaction progress was 
monitored by TLC (EM Science, silica gel 60 F254), visualizing with UV light, and the 
plates developed with p-anisaldehyde, vanillin, or basic potassium permanganate stains.  
Column chromatography was performed using silica gel (230-400 mesh, Silicycle 
Chemical Division Inc).   
NMR experiments were performed on Varian Mercury 400, Inova 400 and Inova 600 
MHz instruments with 13C operating frequencies of 100, 100 and 125 MHz respectively.  
Chemical shifts are reported in ppm relative to the residual solvent signal (CDCl3, 
referenced to residual CHCl3 at δ = 7.26 for 1H and δ = 77.0 for 13C).  Coupling constants 
(J) are reported in Hz, and multiplicities of the signals are described using the following 
abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad.  
High resolution mass spectra (HRMS) were obtained on a Finnigan MAT 8200 or 8400 
mass spectrometer at an ionizing voltage of 70 eV.  Melting points were determined 
using a Gallenkamp melting point apparatus and are uncorrected.  Infrared spectra were 
obtained as thin films on NaCl plates using a Bruker Vector 33 FT-IR instrument and are 
reported in frequency of absorption (cm-1). 
As this was a collaborative effort, only compounds I synthesized are included in the 
experimental. 
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General procedure and spectral data for 1-allyl-1-methylcyclopropane-1,1-
dicarboxylate (1-221): 
 
To a 1.7 M solution of NaOH (1.2 equiv) in an equal volume of MeOH was added the 
desired dimethylcyclopropane-1,1-dicarboxylate (1-218). Upon complete saponification 
of one ester based on TLC analysis the reaction was acidified to pH 4 with 4 M HCl and 
the cyclopropane was extracted with Et2O. Removal of solvent under reduced pressure 
afforded the cyclopropane ester acid (1-219). The ester acid was then dissolved in DMF 
and cooled to 0 °C. At this point 1.1 equiv of K2CO3 was added in and the solution was 
stirred for 30 minutes. After which time allyl bromide was added dropwise and the 
reaction mixture continued to stir until the ester acid was consumed based on TLC 
analysis. From here H2O was added to the reaction flask and the organics were extracted 
with Et2O and the 1-allyl-1-methylcyclopropane-1,1-dicarboxylate (1-221) were purified 
by flash column chromatography (EtOAc/hexanes 1:10). 
 (1R*,2S*)-1-allyl 1-methyl 2-phenylcyclopropane-1,1dicarboxylate 
(1-221a) : yellow oil; Rf = 0.50  (30% EtOAc/hexanes); 1H NMR (600 
MHz, CDCl3) δ 7.28−7.19 (m, 5H), 5.98-5.88 (m, 1H), 5.35 (dd, J = 
17.2, 1.6 Hz, 1H), 5.25 (dd, J = 10.6, 1.2 Hz, 1H), 4.69 (m, 2H), 3.37 (s, 3H), 3.25 (app t, 
J = 8.6 Hz, 1H), 2.21 (dd, J = 7.8, 5.1 Hz, 1H), 1.76 (dd, J = 9.4, 5.1 Hz, 1H); 13C NMR 
(400 MHz, CDCl3) δ 169.4, 166.9, 134.5, 131.6, 128.4, 128.1, 127.4, 118.2, 110.8, 66.1, 
52.1, 42.1, 37.3, 32.5, 19.1; FT-IR (thin film, cm-1) νmax 2951, 1728 , 1500, 1437, 1382, 
1333, 1274, 1217, 1180, 1130, 984, 933, 793, 750, 698, 453, 418; HRMS calc’d for 
C15H16O4 [M+] 260.1049, found 260.1042.   
 (1R*,2S*)-1-allyl 1-methyl 2-(furan-2-yl)cyclopropane-1,1 
dicarboxylate (1-221c): colourless oil; Rf
 = 0.51 (30% EtOAc/hexanes);   
1H NMR (400 MHz, CDCl3) δ 5.89-5.79 (m, 1H), 5.42-5.07 (m, 5H), 
4.64-4.51 (m, 2H), 3.68 (s, 3H), 2.54 (app q, J = 8.2 Hz, 1 H), 1.68 (dd, J = 7.6, 4.9 Hz, 
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1H), 1.53 (dd, J = 9.0, 4.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 170.0, 167.6, 132.8, 
131.5, 118.5, 118.0, 65.9, 52.4, 35.7, 31.2, 20.4; FT-IR (thin film, cm-1) νmax 3452, 3088, 
2992, 2954, 1732, 1639, 1438, 1389, 1332, 1227, 1208, 1134, 960, 922, 787, 747, 710, 
669, 556; HRMS calc’d for C11H14O4 [M+] 210.0892, found 210.0892. 
 (1R*,2S*)-1-allyl 1-methyl 2-(furan-2-yl)cyclopropane-1,1-
dicarboxylate (1-221d): yellow oil; Rf = 0.40 (30% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ 6.28 (app dd, J = 3.1, 2.0 Hz, 1H), 6.12 
(app d, J = 3.5 Hz, 1H), 5.95-5.86 (m, 1H), 5.36-5.31 (m, 1H), 5.27-5.23 (m, 1H), 4.72-
4.60 (m, 2H), 3.55 (s, 3H), 3.11 (dd, J = 9.2, 8.0 Hz, 1 H), 2.09 (dd, J = 7.9, 5.1 Hz, 1H), 
1.79 (dd, J = 9.8, 5.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 168.6, 166.7, 149.4, 142.1, 
131.3, 118.1, 110.3, 107.4, 66.0, 52.3, 36.4, 25.2, 18.6; FT-IR (thin film, cm-1) νmax 
3453, 3121, 2995, 2952, 2887, 1731, 1649, 1600, 1505, 1438, 1367, 1332, 1275, 1208, 
1130, 1099, 1010, 943, 884, 741, 599, 416; HRMS calc’d for C13H14O5 [M+] 250.0841, 
found 250.0839. 
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Experimental procedure and spectral data for preparation of tetrahydro-1,2-
oxazines (1-223): 
General method A – two-component coupling 
To a solution of 1-allyl-1-methylcyclopropane-1,1-dicarboxylate 1-221 (1.0 equiv), 
Yb(OTf)3 (10 mol%) in either CH2Cl2 or toluene (5−10 mL) was added in one portion the 
desired nitrone 1-222 (1.3 equiv).  The reaction was stirred at the temperature indicated, 
for the time indicated, under an atmosphere of argon.  On completion, the reaction 
mixture was filtered through celite, pre-adsorbed onto silica gel, and purified by column 
chromatograpy (silica gel, EtOAc/hexanes).   
General method B – three-component coupling 
Hydroxylamine 1-224 (1.3 equiv), aldehyde 1-225 (1.4 equiv) and Yb(OTf)3 (10 mol%) 
were stirred under an atmosphere of argon at ambient temperature in the presence of 4 Å 
molecular sieves in either toluene or CH2Cl2 (5−10 mL) for 0.5 h.  Once the nitrone was 
formed in situ, 1-allyl-1-methylcyclopropane-1,1-dicarboxylate 1-221 (1.0 equiv), 
dissolved in 1−2 mL of the appropriate solvent, was added to the reaction mixture in one 
portion. The reaction was stirred at the temperature indicated, for the time indicated, 
under an atmosphere of argon.  On completion, the reaction mixture was filtered through 
celite, pre-adsorbed onto silica gel, and purified by column chromatograpy (silica gel, 
EtOAc/hexanes). 
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4-allyl 4-methyl 2,3,6-triphenyl-1,2-oxazine-4,4-dicarboxylate (1-
223a): Following general method B, phenylhydroxylamine (55 mg, 
0.50 mmol), benzaldehyde (57 mg, 0.54 mmol), cyclopropane 1-
221a (100 mg, 0.38 mmol), and Yb(OTf)3 (24 mg, 0.038 mmol) 
were stirred in toluene (5 mL) for 20 h; affording 1-223a, after filtration and purification 
(column chromatography, EtOAc/hexanes 1:20) as a pale yellow viscous oil (91 %, 160 
mg, 0.35 mmol, 1.7:1 diastereomeric mixture at C4); Rf = 0.47 (30% EtOAc/hexanes);
 1H 
NMR (400 MHz, CDCl3) Diastereomer A: δ 5.69-5.57 (m, 1H) 5.18 (app dd, J = 10.6, 
1.2 Hz, 1H), 5.16-5.13 (m, 1H), 3.93 (s, 3H); Diastereomer B: δ 6.04-5.93 (m, 1H), 5.41 
(app dd, J = 17.2, 1.2 Hz, 1H), 5.30 (app dd, J = 10.2, 1.2 Hz, 1H), 3.48 (s, 3H); 
Diastereomeric Mixture: δ 7.62−7.54 (m, 7H), 7.47 (t, J = 7.0 Hz, 3H), 7.42−7.37 (m, 
2H), 7.22−7.16 (m, 6H), 7.15−7.08 (m, 6H), 6.84−6.79 (m, 2H), 5.81 (s, 2H), 5.05 (app 
dt, J = 12.1, 2.7 Hz, 2H), 4.84 (app dt, J = 5.9, 1.2 Hz, 1H), 4.39-4.28 (m, 2H), 2.94−2.77 
(m, 4H); 13C NMR (100 MHz, CDCl3) Diastereomeric Mixture: δ 170.0, 169.1, 168.1, 
167.4, 148.5, 139.4, 135.0, 134.8, 131.4, 131.0, 130.6, 130.3, 128.6, 128.5, 128.4, 128.2, 
128.1, 128.0, 127.9 (x2), 127.3, 126.4, 126.3 78.8, 66.7, 66.2, 65.8, 59.5, 53.4, 52.5, 37.3, 
32.4, 31.7, 31.6, 19.0; FT-IR (thin film, cm-1) νmax 3030, 2952, 1732, 1599, 1942, 1453, 
1228, 1064, 988, 944, 911, 810, 734, 700, 650, 600; HRMS calc’d for C28H27NO5 [M+] 
457.1889, found 457.1886. 
4-allyl 4-methyl 6-(furan-2-yl)-2,3-diphenylmorpholine-4,4-
dicarboxylate (1-223j): Following general method A, requisite (150 
mg, 0.75 mmol), cyclopropane 1-221d (160 mg, 0.63 mmol), and 
Yb(OTf)3 (40 mg, 0.063 mmol) stirred in room temperature dichloromethane (10 mL) for 
20 hours, gave, after filtration and purification (column chromatography, EtOAc/hexanes 
1:20) 1-223j as a white viscous oil (88%, 250 mg, 0.55 mmol, 1:1 diastereomeric mixture 
at C4); Rf = 0.56 (30%, EtOAc/hexanes); 1H NMR (600 MHz, CDCl3) Diastereomer A: 
δ 6.60 (d, J = 2.9 Hz, 2H), 6.02-5.96 (m, 1H), 5.41 (d, J = 17.0 Hz, 1H), 4.88-4.80 (m, 
2H), 3.90 (s, 3H); Diastereomer B: δ 6.47 (s, 2H), 5.71-5.65 (m, 1H), 5.30 (d, J = 10.5 
Hz, 1H), 4.45-4.30 (m, 2H), 3.50 (s, 3H); Diastereomeric Mixture: δ 7.64 (d, J = 7.0 Hz, 
4H), 7.55 (s, 2H), 7.23-7.11 (m, 15H), 6.85 (t, J = 7.3 Hz, 2H), 5.81 (s, 2H), 5.23-5.15 
(m, 4H), 3.2 (apt dt, J = 13.5, 6.4 Hz, 2H), 2.81 (app d, J = 14.6 Hz, 2H); 13C NMR (100 
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MHz, CDCl3) Diastereomeric Mixture: δ 169.7, 168.8, 167.9, 167.2, 151.7, 148.3, 143.0, 
134.7, 134.5, 131.3, 130.9, 130.6, 130.4, 128.3, 128.0, 127.8 (x2), 121.6, 118.7, 118.5, 
115.9, 110.3, 108.9, 72.2 (x2), 66.7, 66.2, 66.1, 59.1 (x2), 53.3, 52.4, 28.2; FT-IR (thin 
film, cm-1) νmax 2952, 1740, 1597, 1492, 1452, 1232, 1197, 1151, 1069, 1013, 921, 820, 
750, 701, 599; HRMS calc’d for C26H25NO6 [M+] 447.1682; found 447.1678. 
4-allyl 4-methyl 2,3-diphenyl-6-vinylmorpholine-4,4-dicarboxylate 
(1-223k): Following general method A, requisite nitrone (360 mg, 1.8 
mmol), cyclopropane 1-221c (330 mg, 1.5 mmol), and Yb(OTf)3 (90 
mg, 0.15 mmol) stirred in room temperature dichloromethane (10 mL) 
for 20 hours, gave, after filtration and purification (column chromatography, 
EtOAc/hexanes 1:20) 1-223k as a pale yellow viscous oil (83%, 510 mg, 1.2 mmol, 1:1 
diastereomeric mixture at C4); Rf = 0.40 (30%, EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3) Diastereomer A: δ 5.95 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.54-5.52 (m, 1H), 3.47 
(s, 3H): Diastereomer B: δ 5.63 (ddt, J = 17.2, 10.5, 6 Hz, 1H), 5.50-5.48 (m, 1H), 3.89 
(s, 3H): Diastereomeric Mixture: δ 7.53-7.50 (m, 4H), 7.19-7.12 (m, 10H), 7.08-7.06 (m, 
4H), 6.84-6.79 (m, 2H), 6.08 (ddd, J = 17.4, 10.8, 5.5 Hz, 2H), 5.70 (s, 2H), 5.41-5.34 
(m, 3H), 5.28 (dq, J = 10.6, 1.2 Hz, 1H), 5.20-5.14 (m, 2H), 4.84-4.75 (m, 2H), 4.54-4.48 
(m, 2H), 4.40-4.22 (m, 3H), 2.61-2.59 (m, 3H); 13C NMR (100 MHz, CDCl3) 
Diastereomeric Mixture: δ 170.0, 169.1, 168.2, 167.5, 148.6 (x 2), 135.9, 134.9, 134.8, 
131.5, 131.1, 130.6, 130.4, 128.5, 128.0, 127.9 (x 2), 121.6 (x 2), 118.8, 118.7, 117.3, 
115.9 (x 2), 77.1, 66.7, 66.3, 66.0 (x 2), 59.1 (x 2), 53.4, 52.5, 41.8, 30.4 (x 2); FT-IR 
(thin film, cm-1) νmax  3092, 3061, 3028, 2988, 2952, 1740, 1648, 1598, 1493, 1453, 1435, 
1229, 1198, 1153, 1085, 1031, 990, 916, 810, 755, 734, 701, 662, 597, 549; HRMS 
calc’d for C24H25NO5 [M+] 407.1733; found 407.1731. 
4-allyl 4-methyl 3-(4-cyanophenyl)-2-phenyl-6-
vinylmorpholine-4,4-dicarboxylate (1-223l): Following general 
method A, requisite nitrone (260 mg, 1.2 mmol), cyclopropane 1-
221c (200 mg, 0.97 mmol), and Yb(OTf)3 (60 mg, 0.097 mmol) 
stirred in room temperature dichloromethane (10 mL) for 20 h, gave, after filtration and 
purification (column chromatography, EtOAc/hexanes 1:20) 1-223l as a pale yellow 
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viscous oil (63%, 260 mg, 0.61 mmol, 1.75:1 diastereomeric mixture at C4); Rf = 0.34 
(30%, EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) Diastereomer A: δ 5.95 (ddt, J = 
17.0, 11.0, 5.7 Hz, 1H), 5.53-5.52 (m, 1H), 3.9 (s, 3H): Diastereomer B: δ 5.63 (ddt, J = 
17.4, 10.1, 5.8 Hz, 1H), 5.49-5.48 (m, 1H), 3.50 (s, 3H): Diastereomeric Mixture:  δ 7.65-
7.62 (m, 4H), 7.483-7.45 (m, 3H), 7.18-7.14 (m, 3H), 7.03 (d, J = 8.2 Hz, 3H), 6.85 (t, J 
= 7.2 Hz, 2H), 6.05 (ddd, J = 17.4, 10.9, 5.3 Hz, 1H), 5.73 (s, 2H), 5.40-5.16 (m, 5H), 
4.85-4.76 (m, 1H), 4.55-4.51 (m, 2H), 4.42-4.27 (m, 2H), 2.67-2.63 (m, 2H), 2.53-2.45 
(m, 2H); 13C NMR (100 MHz, CDCl3) Diastereomeric Mixture: δ 169.4, 168.5, 167.9, 
167.1, 148.1, 140.4, 140.3, 135.4, 131.6, 131.5, 131.4, 131.2, 131.1, 130.6, 128.7, 122.3, 
119.3, 119.2, 118.4, 117.7, 115.8, 112.0, 77.1, 67.0, 66.5, 65.9, 58.8, 58.7, 30.4, ; FT-IR 
(thin film, cm-1) νmax  2953, 2229, 1740, 1708, 1648, 1597, 1493, 1436, 1254, 1227, 1201, 
1152, 1074, 991, 941, 831, 758, 693, 605, 548, 500; HRMS calc’d for C25H24N2O5 [M+] 
432.1685; found 432.1684. 
4-allyl 4-methyl 6-(furan-2-yl)-2-(4-methoxyphenyl)-3-
phenylmorpholine-4,4-dicarboxylate (1-223m): Following 
general method A, requisite nitrone (850 mg, 1.2 mmol), 
cyclopropane 1-221d (180 mg, 0.71 mmol), and Yb(OTf)3 (44 
mg, 0.071 mmol) stirred in room temperature dichloromethane (10 mL) for 20 h, gave, 
after filtration and purification (column chromatography, EtOAc/hexanes 1:20) 1-223m 
as a colourless viscous oil (90%, 300 mg, 0.64 mmol, 1:1 diastereomeric mixture at C4); 
Rf = 0.28 (30%, EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) Diastereomer A: δ 6.64 
(dd, J = 9.0, 1.2 Hz, 4H), 5.25 (dq, J = 10.3, 1.2 Hz, 1 H) 3.88 (s, 3H): Diastereomer B: δ 
6.93 (app d, J = 9.0 Hz, 4H), 5.36 (dq, J = 17.2, 1.6 Hz, 1H), 3.51 (s, 3H): Diastereomeric 
Mixture: δ 7.56-7.52 (m, 4H), 7.49-7.48 (m, 2H), 7.17-7.15 (m, 6H), 6.52 (d, J = 3.1 Hz, 
2H), 6.41 (dd, J = 3.1, 2.0 Hz, 2H), 5.99-5.89 (m, 1H), 5.65-5.55 (m, 3H), 5.17-5.06 (m, 
5H), 4.85-4.73 (m, 3H), 4.38-4.20 (m, 3H), 3.11 (ddd, J = 14.4, 12.5, 3.9 Hz, 2H), 2.71 
(dd, J = 14.5, 2.7 Hz, 2H); 13C NMR (100 MHz, CDCl3) Diastereomeric Mixture: δ 
170.0, 169.1, 168.1, 167.4, 155.1, 152.1, 143.0, 142.2 (x 2), 134.9, 134.7, 131.5, 131.1, 
130.9, 130.7, 128.1, 127.9 (x 2), 118.9, 118.7, 118.4, 113.7, 110.3, 108.9, 72.3, 72.2, 
67.5, 67.4, 66.8, 66.3, 59.4, 59.3, 55.3, 53.4, 52.6, 29.7, 28.2; FT-IR (thin film, cm-1) 
νmax  2298, 2953, 2836, 1740, 1648, 1611, 1508, 1453, 1363, 1245, 1199, 1177, 1151, 
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1034, 1013, 985, 945, 917, 828, 787, 735, 702, 648, 599, 557; HRMS calc’d for 
C27H27NO7 [M+] 477.1788; found 477.1776. 
4-allyl 4-methyl 6-(furan-2-yl)-2-(4 
(methoxycarbonyl)phenyl)-3-phenylmorpholine-4,4-
dicarboxylate (1-223n): Following general method A, 
requisite nitrone (190 mg, 0.75 mmol), cyclopropane 1-221d 
(160 mg, 0.63 mmol), and Yb(OTf)3 (40 mg, 0.063 mmol) stirred in room temperature 
dichloromethane (10 mL) for 20 h, gave, after filtration and purification (column 
chromatography, EtOAc/hexanes 1:20) 1-223n as a white viscous oil (91%, 290 mg, 0.57 
mmol, 1.5:1diastereomeric mixture at C4); Rf = 0.28 (30%, EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3) Diastereomer A: δ 5.71-5.61 (m,1H), 3.88 (s, 3H); Diastereomer B: δ 
3.51 (s, 3H); Diastereomeric Mixture: δ 7.83 (app d, J = 8.6 Hz, 4H), 7.60-7.54 (m, 6H), 
7.21-7.19 (m, 5H), 7.09 (dd, J = 8.8, 1.8 Hz, 4H), 6.60 (app d, J = 3.5 Hz, 2H), 6.47 (dd, 
J = 3.3, 1.8 Hz, 2H), 5.98 (m, 3H),  5.36 (dd, J =17.2, 1.6 Hz, 1H), 5.27 (dd, J = 10.6, 0.8 
Hz), 5.22-5.17 (m. 2H), 5.07 (dt, J = 12.7, 2.9, 2.7 Hz, 2H), 4.85-4.73 (m, 2H), 4.45-4.27 
(m, 3H), 3.81 (s, 6H), 3.21-3.13 (m, 2H), 2.76 (dd, J = 14.5, 2.0 Hz, 2H); 13C NMR (100 
MHz, CDCl3) Diastereomeric Mixture: δ169.6, 168.8, 167.7, 167.0, 166.8, 151.8, 151.2, 
143.3, 134.4, 134.3, 131.2, 130.9, 130.5, 130.4, 130.2, 128.4, 128.1 (x2), 122.6, 119.1, 
118.9, 114.3, 114.3, 110.4, 109.3, 72.5, 72.5, 66.9, 68.5, 64.7 (x2), 58.9 (x2), 53.5, 52.7, 
51.6, 41.8, 28.3; FT-IR (thin film, cm-1) νmax 2952, 1741, 1717, 1605, 1508, 1435, 1363, 
1282, 1253, 1178, 1152, 1113, 1090, 1067, 946, 914, 885, 776, 736, 702, 618, 599, 550; 
HRMS calc’d for C28H27NO8 [M+] 505.1737; found 505.1732. 
4-allyl 4-methyl 3-(4-methoxyphenyl)-2-phenyl-6-
vinylmorpholine-4,4-dicarboxylate (1-223o): Following 
general method A, requisite nitrone (220 mg, 0.98 mmol), 
cyclopropane 1-221c (150 mg, 0.82 mmol), and Yb(OTf)3 (50 
mg, 0.082 mmol) stirred in room temperature dichloromethane (10 mL) for 20 h, gave, 
after filtration and purification (column chromatography, EtOAc/hexanes 1:20) 1-223o as 
a colourless viscous oil (80%, 290 mg, 0.66 mmol, 1:1 diastereomeric mixture at C4); Rf 
= 0.37 (30%, EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) Diastereomer A:  δ 5.53 (dt, 
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J = 3.03, 1.42 Hz, 1H), 3.88 (s, 3H): Diastereomer B: δ 5.50 (dt, J = 3.03, 1.42 Hz, 1H), 
3.49 (s, 3H): Diastereomeric Mixture: δ 7.46-7.44 (m, 4H), 7.18-7.14 (m, 4H), 7.09 (s, 
2H), 7.07 (d, J = 0.4 Hz, 2H), 6.82 (td, J = 7.2, 1.2 Hz, 2H), 6.71-6.68 (m, 4H), 6.00 
(ddd, J = 17.4, 10.9, 5.3, 2H), 6.00-5.90 (m, 1H), 5.73-5.63 (m, 3H), 5.40-5.34 (m, 3H), 
5.28 (dd, J = 10.6, 1.2 Hz, 1H), 5.22-5.16 (m, 2H), 4.84-4.75 (m, 2H), 4.55-4.49 (m, 2H), 
4.44-4.25 (m, 3H), 3.69 (s, 6H), 2.61-2.59 (m, 3H); 13C NMR (100 MHz, CDCl3) 
Diastereomeric Mixture: δ 170.0, 169.1, 168.2, 167.5, 159.1 (x 2), 148.6 (x 2), 136.0, 
131.8, 131.6, 131.5, 131.1, 128.4, 126.8, 126.7, 121.6, 121.5, 118.7, 118.6, 117.2, 115.9 
(x 2), 113.2 (x 2), 77.1, 66.7, 66.2, 65.5, 59.1, 54.9 (x 2), 53.3, 52.5, 41.7, 30.4, 30.3, 
29.7; FT-IR (thin film, cm-1) νmax  2996, 2953, 2837, 1741, 1648, 1600, 1512, 1491, 
1453, 1254, 1200 ,1181, 1154, 1116, 1075, 1033, 991, 936, 840, 753, 730, 693, 613, 538; 
HRMS calc’d for C25H27NO6 [M+] 437.1838; found 437.1836. 
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Experimental procedure and spectral data for dihydro-1,2-oxazines (1-226) 
To a solution of tetrahydro-1,2-oxazine (1-223, 1 mmol) in CH3CN (3−5 mL) was added 
Pd2(dba)3 (6 mol%). The solution was placed under Ar and brought to reflux (80 °C) for 
three hours. At this time, the reaction was cooled to RT and filtered through celite. The 
extract was absorbed onto silca and the solvent was removed by reduced pressure. Pure 
product was obtained by flash column chromatography on silica gel (eluent: EtOAc in 
hexanes). 
methyl 2,3,6-triphenyl-3,6-dihydro-2H-1,2-oxazine-4-carboxylate 
(1-226a): Following the general procedure, tetrahydro-1,2-oxazine 1-
223a (190 mg, 0.74 mmol) and Pd2(dba)3 (40 mg, 0.044 mmol) were 
brought to reflux in CH3CN (5 mL) for 3 h. Filtration and 
purification (silica gel column chromatography, EtOAc/hexanes 1:20) provided dihydro-
1,2-oxazine 1-226 (66%, 100 mg, 0.28 mmol) as a white powder; Rf = 0.43 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.56−7.51 (m, 2H), 7.50−7.40 (m, 3H), 
7.37−7.30 (m, 3H), 7.23−7.16 (m, 5H), 7.04 (d, J = 7.8 Hz, 2H), 6.91 (dd, J = 7.0 Hz, 
1H), 5.75 (s, 1H), 5.58 (s, 1H), 3.72 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 175.3 165.2, 
148.0, 139.7, 136.7, 136.5, 131.1, 129.5, 128.9, 128.9, 128.6, 127.9, 127.7, 122.3, 117.0, 
78.6, 62.9, 52.0; FT-IR (thin film, cm-1) νmax 3061, 3031, 2951, 2846, 2360,  1719, 1598, 
1493, 1453, 1436, 1245, 1078, 1029, 909, 735, 696, 667, 627, 696; HRMS calc’d for 
C24H21NO3 [M+] 371.1521, found 371.1519. 
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Experimental procedure and spectral data for preparation of pyrroles (1-231) 
General method A: To a solution of dihydro-1,2-oxazine 1-226 (1 equiv) in CH3CN 
(3−5 mL) was added DBU (3 equiv) and stirred under Ar at the indicated temperature for 
the indicated time. Upon completion (TLC analysis), the solution was filtered through 
celite and the solvent was removed under reduced pressure. Purification of the residue by 
column chromatography (silica gel, EtOAc/hexanes 1:20) gave the desired pyrroles (1-
231). 
General method B – one-pot procedure: To a solution of tetrahydro-1,2-oxazine (1-
223, 1 equiv) in CH3CN (3−5 mL) was added Pd2(dba)3 (6 mol %). The solution was 
placed under Ar and brought to reflux (80 °C) for 3 h. At this time, the reaction was 
cooled to 40 °C and either NEt3 or DBU (3 equiv) was added in one portion, and the 
reaction was stirred further for the time indicated. Upon completion (TLC analysis), the 
solution was filtered through celite and the solvent was removed under reduced pressure. 
Purification of the residue by column chromatography (silica gel, EtOAc/hexanes 1:20) 
gave the desired pyrroles (1-231). 
Note: for compounds that co-elute with dba, the following work-up procedure was used: 
the reaction residue was dissolved in MeOH (3 mL) and NaBH4 (1.2 equiv/ mmol dba) 
was slowly added. After dba reduction (as based on TLC analysis), the mixture  the 
organics were collected via extraction with Et2O. The extract was absorbed onto silca and 
the solvent was removed by reduced pressure. Purification was then effected by the above 
methods. 
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methyl 1,2,5-triphenyl-1H-pyrrole-3-carboxylate (1-231a): 
Following general method A, dihydro-1,2-oxazine 1-226a (38 mg, 0.10 
mmol) and DBU (45 μL, 0.30 mmol) in CH3CN (4 mL, 25 °C, 5 min) 
gave 1-231a (79%, 28 mg, 0.079 mmol).  Following general method B 
(one-pot procedure), tetrahydro-1,2-oxazine 1-223a (57 mg, 0.12 
mmol), Pd2(dba)3 (7 mg, .0072 mmol) in CH3CN (5 mL), followed by DBU (54 μL, 0.36 
mmol) at room temperature (5 min) gave 1-231a (76%, 28 mg, 0.080 mmol) as a white 
powder; Rf = 0.45 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.25−7.12 (m, 
11H), 7.11−7.07 (m, 2H), 6.95 (s, 1H), 6.94−6.91 (m, 2H), 3.73 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 165.1, 139.9, 137.8, 134.7, 132.1, 131.4, 131.2, 128.8, 128.6, 128.5, 
128.0, 127.8, 127.6, 127.2, 126.8, 113.8, 110.8, 51.0; FT-IR (thin film, cm-1) νmax 3061, 
2948, 2251, 1714, 1599, 1559, 1496, 1474, 1439, 1404, 1274, 1223, 1183, 1113, 912, 
777, 760, 731, 696, 542; HRMS calc’d for C24H19NO2 [M+] 353.1416, found 353.1424. 
methyl 5-(furan-2-yl)-1,2-diphenyl-1H-pyrrole-3-carboxylate (1-
231j): Following general method B, tetrahydro-1,2-oxazine 1-223j 
(110 mg, 0.23 mmol), Pd2(dba)3 (13 mg, 0.014 mmol) in CH3CN (5 
mL, 3 h), followed by DBU (110 μL, 0.70 mmol) at RT (5 minutes) 
gave 1-231j (60%, 50 mg, 0.14 mmol); white powder; Rf = 0.45 (30% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ 7.31-7.27 (m, 4H), 7.22-7.18 (m, 5H), 7.23-7.10 (m, 3H), 
6.19 (dd, J = 5.6, 2.0 Hz, 1H), 5.30 (d, J = 3.2 Hz, 1H), 3.72 (s, 3H)  ; 13C NMR (100 
MHz, CDCl3) δ 164.9, 146.5, 141.29, 137.8, 131.1, 130.9, 129.0, 128.8, 128.5, 127.9, 
127.3, 126.3, 110.8, 110.0, 109.6, 106.0, 51.0, 41.8; FT-IR (thin film, cm-1) 1701, 1496, 
1437, 1238, 1210, 1134, 1034, 913, 744, 700, 668; HRMS for C22H17NO3 [M+] calc’d 
343.1208; found 343.1206. 
methyl 1,2-diphenyl-5-vinyl-1H-pyrrole-3-carboxylate (1-231k): 
Following general method B, tetrahydro-1,2-oxazine 1-223k (150 mg, 
0.36 mmol), Pd2(dba)3 (20 mg, 0.021 mmol) in CH3CN (5 mL, 3 h), 
followed by DBU (160 μL, 1.1 mmol) at RT (5 minutes) gave 1-231k 
(61%, 66 mg, 0.22 mmol); white powder; Rf = 0.45 (30% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3) δ 7.28-7.25 (m, 3H), 7.18-7.13 (m, 5H), 7.04 (dd, J = 6.6, 3.6 Hz, 
80 
 
2H), 7.01 (s, 1H), 6.18 (dd, J = 17.6, 11.2 Hz, 1H), 5.53 (dd, J = 17.6, 1.2 Hz, 1H), 5.00 
(dd, J = 11.2, 1.2 Hz, 1H), 3.69 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 165.0, 139.4, 
137.1, 133.2, 131.2, 131.0, 128.8, 128.1, 127.8, 127.3, 125.7, 113.7, 113.0, 110.0, 107.7, 
50.97; FT-IR (thin film, cm-1) 3060, 2924, 1713, 1673, 1652, 1621, 1596, 1557, 1497, 
1477, 1425, 1338, 1245, 1218, 1188, 1113, 991, 778, 764, 697; HRMS for C20H17NO2 
[M+] calc’d 303.1259; found 303.1252. 
methyl 2-(4-cyanophenyl)-1-phenyl-5-vinyl-1H-pyrrole-3-
carboxylate (1-231l): Following general method B, tetrahydro-1,2-
oxazine 1-223l (110 mg, 0.24 mmol), Pd2(dba)3 (13 mg, 0.015 
mmol) in CH3CN (5 mL, 3 h), followed by DBU (110 μL, 0.11 
mmol) at RT (5 minutes) gave 1-231l (58%, 47 mg, 0.73 mmol); yellow powder; Rf = 
0.33 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.40-7.18 (m, 7H), 6.96 (s, 
1H), 6.12 (dd, J = 17.4, 10.8 Hz, 1H), 5.51 (d, J = 17.6 Hz, 1H), 5.00 (d. J = 11.2 Hz, 
1H), 3.66 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 164.6, 136.6, 136.5, 135.9, 134.3, 
131.7, 131.0, 129.1, 128.6, 125.2, 118.6, 114.6, 114.1, 111.3, 108.1, 51.11, 41.8; FT-IR 
(thin film, cm-1) 2922, 2228, 1715, 1495, 1436, 1249, 1220, 1115, 1029, 913.2, 850, 743, 
700, 668; HRMS for C21H16N2O2 [M+] calc’d 328.1212; found 328.1209. 
methyl 5-(furan-2-yl)-1-(4-methoxyphenyl)-2-phenyl-1H-pyrrole-3- 
carboxylate (1-231m): Following general method B, tetrahydro-1,2-
oxazine 1-223m (100 mg, 0.21 mmol), Pd2(dba)3 (11 mg, 0.013 mmol) 
in CH3CN (5 mL, 80 °C, 3 h), followed by DBU (94 μL, 0.63 mmol) at 
room temperature (5 min) gave 1-231m (61%, 50 mg, 0.13 mmol) as a 
white powder; Rf = 0.29 (30% EtOAc/hexanes); 1H NMR (600 MHz, CDCl3) δ 7.30 (d, 
J = 1.2 Hz, 1H), 7.22-7.18 (m, 5H), 7.09 (s, 1H), 7.03 (app d, J = 8.8 Hz, 2H), 6.78 (app 
d, J = 9.4 Hz, 2H), 6.20 (app q, J = 1.8, 1H), 5.29 (d, J = 3.5 Hz, 1H) 3.78 (s, 3H), 3.71 (s, 
3H); 13C NMR (100 MHz, CDCl3) δ 165.0, 159.3, 146.6, 141.2, 140.6, 131.1, 131.0, 
129.9, 127.8, 127.3, 126.6, 113.9, 113.7, 109.2, 105.8, 52.3, 50.0; FT-IR (thin film, cm-1 
) 1716, 1514, 1489, 1437, 1382, 1234, 1189, 1109, 1030, 913, 840, 748, 699; HRMS for 
C23H19NO4 [M+] calc’d 373.1314; found 373.1315. 
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methyl 5-(furan-2-yl)-1-(4-(methoxycarbonyl)phenyl)-2-phenyl-
1H-pyrrole-3-carboxylate (1-231n): Following general method B, 
tetrahydro-1,2-oxazine 1-223n (93 mg, 0.18 mmol), Pd2(dba)3 (10 mg, 
0.011 mmol) in CH3CN (5 mL, 3 h), followed by DBU (80 μL, 0.55 
mmol) at RT (5 minutes) gave 1-231n (71%, 48 mg, 0.13 mmol); 
white powder; Rf = 0.45 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J 
= 8.8 Hz, 2H), 7.28 (d, J = 2.4 Hz, 1H), 7.22-7.15 (m, 7H), 7.10 (s, 1H), 6.21 (dd, J = 3, 2 
Hz, 1H), 5.50 (d, J = 3.6 Hz, 1H), 3.90 (s, 3H), 3.72 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 166.1, 164.7, 146.0, 141.9, 141.7, 140.1, 131.1, 130.5, 130.1, 130.0, 128.9, 
128.2, 127.5, 126.0, 110.9, 110.5, 110.0, 106.8, 52.3, 51.1, 41.8, ; FT-IR (thin film, cm-1) 
1716, 1514, 1489, 1436, 1382, 1234, 1189, 1109, 1030, 913, 840, 743, 699; HRMS for 
C24H19NO5 [M+] calc’d 401.1263; found 401.1253. 
methyl 2-(4-methoxyphenyl)-1-phenyl-5-vinyl-1H-pyrrole-3-
carboxylate (1-231o): Following general method B, tetrahydro-
1,2-oxazine 1-223o (86 mg, 0.20 mmol), Pd2(dba)3 (11 mg, 0.012 
mmol) in CH3CN (5 mL, 3 h), followed by DBU (90 μL, 0.59 
mmol) at RT (5 minutes) gave 1-231o (70%, 46 mg, 0.14 mmol); white powder; Rf = 
0.39 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.31-7.28 (m, 3H), 7.09-7.04 
(m, 4H),  7.00 (s, 1H), 6.72 (d, J = 8.4 Hz, 2H), 6.19 (dd, J = 17.4, 11.2 Hz, 1H), 5.52 
(dd, J = 17.2, 1.2 Hz, 1H), 5.00 (dd, J = 11.4, 0.8 Hz, 1H), 3.74 (s, 3H), 3.72 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 165.1, 159.0, 137.3, 133.0, 132.2, 128.9, 128.8, 128.1, 125.8, 
112.9, 112.8, 107.7, 55.1, 51.0, 41.9; FT-IR (thin film, cm-1) 2924, 2853, 1714, 1611, 
1597, 1558, 1487, 1440, 1290, 1249, 1217, 1178, 1114, 1036, 944, 906, 839, 776, 699, 
517; HRMS for C21H19NO3 [M+] calc’d 333.1365; found 333.1361. 
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Chapter 2 - Diels-Alder Approach Towards Fargesine and 
Fumimycin 
2 Chapter introduction 
Chapter two describes the formal synthesis of the indole containing natural product 
fargesine, and efforts towards the total synthesis of benzofuranone containing natural 
product fumimycin. Both of these syntheses are dependent on the Diels-Alder reaction of 
quinoid species, and as such are presented together in this chapter. A general description 
of Diels-Alder chemistry and its application in total synthesis preludes the chapter, 
followed by an introduction to indoles, and lastly the introduction and results for each 
natural product. The work on the formal synthesis of fargesine was developed in 
collaboration with Sharon Michalak, while efforts towards the total synthesis of 
fumimycin was independent.  
2.1 Diels-Alder reaction  
2.1.1 Overview  
With the ability to form two new carbon-carbon bonds, the potential to set four 
contiguous stereocenters in one step, and with predictive regioselectivity, the Diels-Alder 
reaction is one of the most powerful reactions to chemists.1 The reaction involves a 
[4π+2π] cycloaddition between a diene, and an olefin (dienophile). Although the 
cycloaddition had been previously reported by Wieland,2 Albrecht,3 and Euler,4 they had 
incorrectly assigned their products. It was not until 1928 that Otto Diels and his student 
Kurt Alder were able to successfully elucidate the products between 1,4-benzoquinone 
and cyclopentadiene (Scheme 2-1).5 Through their subsequent studies on the mechanism, 
they were awarded the Nobel Prize in Chemistry in 1950 “for their discovery and 
development of the diene synthesis”.6 
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Scheme 2-1 Diels and Alder’s reaction [4π+2π] cycloaddition 
The mechanism is often explained with Frontier Molecular Orbital theory (FMO theory).7 
According to FMO theory, the full orbitals of one reactant must have the same symmetry, 
and similar energy level, with the empty orbitals of another reactant in order for the 
reaction to proceed. In the Diels-Alder reaction, the highest occupied molecular orbital 
(HOMO) of the diene, and the lowest unoccupied molecular orbital (LUMO) of the 
dienophile interact as they are symmetrical and relatively close in energy (Figure 2-1, 
Standard Diels-Alder). The reaction can be made more favourable by decreasing the 
energy gap between the HOMO and the LUMO. For example, addition of electron 
donating groups to the diene increases the energy of the system, while electron 
withdrawing groups on the dienophile decrease the energy of the system, thus minimizing 
the energy gap (Figure 2-1, Diels-Alder with EDG/EWG).8  
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Figure 2-1 FMO representation of the Diels-Alder reaction  
As FMO theory involves full orbitals of the diene interacting with the empty orbitals of 
the dienophile, regioselectivity can be predicted simply by resonance to find the most 
electron rich sites of the diene, and the most electron deficient site of the dienophile. 
These will react through a cyclic transition state to form the product (Scheme 2-2).   
 
Scheme 2-2  Regioselectivity of the Diels-Alder reaction 
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For substituted dienes or dienophiles, the relative stereochemistry of the olefins in either 
reacting partner will be maintained in the cycloadduct. For example, cis olefins in the 
dienophile will result in substituents on the cycloadduct with a cis relationship (Scheme 
2-3, entry 1), similarly trans olefins in the dienophile will give trans substituents in the 
product (Scheme 2-3, entry 2). For dienes composed of olefins with different 
stereoisomers (cis and trans), the substituents on the cycloadduct will have a trans 
relationship (Scheme 2-3, entry 3), and dienes composed of olefins with the same 
stereoisomers will result in products containing substituents with a cis relationship 
(Scheme 2-3, entry 4).8  
 
Scheme 2-3 Stereospecificity of the Diels-Alder reaction 
As can be seen in Scheme 2-4, a simple Diels-Alder reaction can result in two possible 
products with differing stereoselectivity which are titled endo or exo products. The two 
outcomes for the reaction are due to the relative stabilities in the transition states for 
either product. The endo product involves secondary orbital interactions in the transition 
state, while the exo product does not contain these interactions. Since secondary orbital 
interactions allow for a more stable transition state, the endo product is the kinetic 
product, and is usually the favoured product unless steric interactions prohibit forming an 
endo transition state.8 
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Scheme 2-4 Endo and exo transition states of the Diels-Alder reaction 
Due to the great insight of the Diels-Alder mechanism, it provides chemists with an 
invaluable tool in total synthesis. The earliest example of the reaction being used in a 
total synthesis was by the Stork group on their synthesis of cantharidin in 1951 (Scheme 
2-5).9 
 
Scheme 2-5 Stork group’s synthesis of cantharidin 
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2.1.2 Hyperbaric Diels-Alder 
As the Diels-Alder reaction has been around for over 100 years, many conditions have 
been developed for it. Simply heating the diene and dienophile can be enough for the 
reaction to proceed and catalytic systems have also been developed to form adducts 
enantioselectively. However, another method to facilitate the reaction is through the use 
of hyperbaric conditions. A reaction will proceed if the reactants are in close proximity 
(omitting other factors such as temperature, solvent, etc); therefore, hyperbaric conditions 
promote reactions by forcing strong intermolecular interactions.10 The effect of pressure 
on a reaction was described by Evans and Polanyi using transition-state theory.11 In 
transition-state theory, molecules interact to form an unstable intermediate (transition 
state), which then can form a stable product. The derived formula of their work is (∂ln 
k/∂P)T = - ΔV‡/RT; where k is the rate of a reaction, P is the pressure, R is the gas 
constant, T is temperature, and ΔV‡  is the difference in ‘volume of activation’. The 
volume of activation is the difference between the volume of the transition state species, 
and the volume of the reactant molecules. It can be seen from the formula that if ΔV‡ is 
negative, then the rate will increase with pressure. Generally speaking, reactions that are 
bond forming result in a negative volume of activation, and reactions that are bond 
breaking result in a positive volume of activation. Thus, the Diels-Alder reaction is 
favourable under hyperbaric conditions.   In order for the rate to significantly change, 
several hundred bars of pressure must be applied to the reaction, and approximately 700 
bar is required to increase the reaction rate by a factor of two or four.12 The hyperbaric 
Diels-Alder will be further discussed later in this chapter (Section 2.6, Progress towards 
the total synthesis of fumimycin). 
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2.1.3 Diels-Alder reaction in natural product synthesis  
The use of the Diels-Alder reaction in total synthesis grew substantially after Stork’s 
synthesis of cantharidin and many classic targets were accessed this way including Gates’ 
morphine synthesis,13 and Woodward’s steroid syntheses.14 Several variations of the 
Diels-Alder reaction have been extensively studied and widely used in the synthesis of 
natural products and pharmaceuticals, and due to vast amount of information on the topic, 
only a few recent examples that showcase the transformation of simple starting material 
to complex natural products will be discussed below.  
In memory of Aaron C. Kinsman, the total synthesis of (+)-haplindole Q will be 
discussed. In 2003, Kinsman and Kerr were able to access the four contiguous 
stereocenters required for (+)-hapalindole Q through a Diels-Alder reaction between 
achiral indole 2-25 and cyclohexadiene 2-26 (Scheme 2-6).15 Stereoselective control in 
the reaction was brought about with MacMillan’s chiral organocatalyst (2-27). 
MacMillian’s chiral amine catalyst reacts with α,β-unsaturated aldehydes to form an 
iminium ion which effectively lowers the LUMO of the dienophile, due to the amplified 
electron withdrawing effect of the iminium ion.16 Since the catalyst is chiral, it allows for 
a highly enantioselective Diel-Alder reaction to occur. As shown in the transition state 2-
28, the top face of the molecule is blocked, thus favouring only one enantiomer. 
Although the Diels-Alder cycloadduct was formed in a low 35% yield, they were able to 
obtain the product with high endo selectivity (70%) and a high ee of 93%. Further 
manipulations were done to complete the total synthesis of (+)-haplindole Q in a total 12 
steps from indole 2-25 in a 1.7% overall yield. 
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Scheme 2-6 Kinsman and Kerr’s synthesis of (+)-hapalindole Q 
In 2007 the Jullian group isolated the sesterterpenoid bolivianine (2-37) from 
Hedyosmum angustifolium (Chloranthaceae).17 Jullian hypothesized that bolivianine is 
synthesized within the organism from: 1) allylic oxidation of onoseriolide (2-31, Scheme 
2-7), 2) nucleophilic attack to geranylpyrophosphate (2-32, GPP), and lastly 3) an 
annulation and hetero-Diels-Alder to form the remaining rings.  
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Scheme 2-7 Jullian’s proposed biosynthesis of bolivianine 
Inspired by the proposed biogenesis of bolivianine by Jullian, the Liu group thought they 
could synthesize onoseriolide, and then access bolivianine from a Diels-
Alder/intramolecular hetero-Diels-Alder cascade between oxidized onoseriolide and GPP 
related terpene, β-E-ocimene (2-38).18 As seen in Scheme 2-8, entry 1, oxidized 
onoseriolide and terpene 2-38 were heated to 150 °C in toluene (sealed tube), and 
remarkably they were able to access bolivianine in a 52% yield. Through their Diels-
Alder/intramolecular hetero-Diels-Alder cascade they were able to generate three new 
rings, four C-C bonds, and five sterogenic centers with excellent selectivity. To 
determine if the hetero-Diels-Alder reaction initiates the cascade, the Liu group attempted 
a Diels-Alder between 2-33 and dienophile 2-39 (Scheme 2-8, entry 2). Despite many 
attempts, the reaction did not work suggesting that the hetero-Diels-Alder reaction only 
occurs once the proper orientation is set from the initial Diels-Alder reaction. They were 
able to show that this was indeed the case as a hetero-Diels-Alder occurred at room 
temperature for compound 2-40 (Scheme 2-8, entry 3), which was already in the proper 
orientation. Based on their findings they can explain the high selectivity of their Diels-
Alder cascade due to: 1) diene 2-38 will react with dienophile 2-33 from the least 
96 
 
hindered face to form endo product 2-36, and as a result 2) the orientation of the 
dienophile for the hetero-Diels-Alder is aligned to react at the a-face of the diene, 
yielding bolivianine.  
 
Scheme 2-8 Liu group’s total synthesis of bolivianine (1), and mechanism investigations 
(2 and 3)  
One of the most famous natural product targets known is the anti-cancer drug paclitaxel 
(Taxol, 2-42, Figure 2-2).19 Taxol comes from a family of terpenes called taxanes, which 
contain at least 350 members with varying oxidation states, including 
decinnamoyltaxinine E (2-43), taxabaccatin III (2-44), taxusin (2-45), taxadienone (2-46). 
A parent molecule of the taxanes is taxadiene (2-47); this minimally oxidized natural 
product has functional group handles for further oxidation. 
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Figure 2-2 Examples of taxanes 
Taxadiene is produced in extremely small quantities in nature (less than 1 mg from 750 
kg of tree bark from T. brevifolia),20 thus developing a method to access it would allow 
the synthesis of various taxanes and derivatives for further pharmaceutical testing. In 
2012, the Baran group completed a gram-scale synthesis of the taxadiene, with a Diels-
Alder reaction detrimental to their synthetic route (Scheme 2-9).21 Starting from known 
diene 2-48 and ketone 2-49, they were able to access intermediate 2-50 in three steps. An 
intramolecular Diels-Alder reaction formed compound 2-51 with a 47% yield of the 
desired diastereomer. Compound 2-51 was then converted to taxadienone (2-46) in two 
steps, which could then be converted to taxadiene (2-47) in three more steps. More 
recently, the Baran group was able to highlight the utility of their taxadienone synthesis 
in the first total synthesis of decinnamoyltaxinine E (18 steps from 2-46) and 
taxabaccatin III (19 steps from 2-46).22 Although the key Diels-Alder step in Baran’s 
synthesis looks fairly simple, Williams23 had accessed (±)-taxadiene with a Diels-Alder 
reaction; however, his synthesis had 26 steps, while Baran’s synthesis had 10 steps. The 
difference in the amount of synthetic steps goes to show how powerful the Diels-Alder 
can be given the right substrates.    
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Scheme 2-9 Baran group’s synthesis of taxadienone and taxadiene 
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2.2 Introduction to indoles and their syntheses  
2.2.1 Introduction to indoles 
Indole is an aromatic heterocycle consisting of a benzene ring fused to a pyrrole ring. It 
was first isolated from the treatment of indigo with oleum, hence how the name was 
derived. In 1866, Adolf von Baeyer synthesized indole by the zinc reduction of 
oxindole,24 but it was not until 1869 that he was able to correctly elucidate the structure.25 
The indole moiety is one of the largest classes of heterocycles, with indole containing 
compounds found in many natural products, and pharmaceuticals,26 and a few examples 
are shown below in Figure 2-3.  
 
Figure 2-3 Various indole containing natural products, and pharmaceuticals  
One of the more important indole containing natural products known is tryptophan (2-
52), which is an essential amino acid for humans. Tryptophan is also a precursor to 
serotonin (2-53; a neurotransmitter known to be associated with feelings of happiness), 
and melatonin (2-54; involved with the circadian rhythms). Commonly used today for 
recreation, the Aztecs used psilocybin mushrooms in ceremonies, which contained 
psychedelics psilocybin (2-55) and psilocin (2-56).  In ancient India, the flower 
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Rauwolfia serpentine was a common medicine for stomach pains, fever, and vomiting, 
and also contained reserpine (2-57), which is more commonly used today to treat high 
blood pressure.27  More recently, an important indole containing pharmaceutical is 
Tadalafil (2-58, Cialis), which is a PDE5 inhibitor. As of 2013, Tadalafil (Cialis) was the 
51st top selling drug in the US,28 and is expected to keep rising.     
2.2.2 Syntheses of indoles 
Given the importance of indoles, there have been a vast amount of research dedicated to 
their synthesis. A few researchers who worked in the field include Leimgruber-Batcho,29 
Fischer,30 Bartoli,31 Bischler-Möhlau,32 Fukuyama,33 Gassman,34 Larock,35 Madelung,36 
Nenitzescu,37 Reissert,38 and Plieninger.39 Due to amount of work dedicated to this field, 
only a small subset will be discussed.  
2.2.2.1 Fischer indole synthesis 
One of the most well-known indole synthesis was developed in 1883 by Fischer and 
Jourdan. As seen in Scheme 2-10, they reacted pyruvic acid 1-methylphenylhydrazone 
(2-61, derived from ketone 2-59 and phenylhydrazine 2-60) with HCl and isolated 1-
methylindole-2-carboxylic acid (2-62).40 The reaction is tolerant of many protic or Lewis 
acids, although Lewis acids generally allow for cooler reaction temperatures. For the 
indolization of unsymmetrical ketones with phenylhydrazines, when a strong acid is used 
indolization usually occurs at the least substituted α-carbon, and at the more substituted 
α-carbon under weakly acidic conditions.41 The mechanism of the reaction, originally 
proposed by Robinson in 1924,42 first involves protonation of imine 2-63, which its self is 
made from a condensation between a ketone and phenylhydrazine. Tautomerization of 2-
63 to form ene-hydrazine 2-65, followed by a [3,3]-sigmatropic rearrangement results in 
di-imine 2-66. Another tautomerization occurs to form enamine 2-67, which immediately 
cyclizes to aminal 2-68. Indole 2-69 is finally produced by the elimination of ammonia.  
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Scheme 2-10 Fischer indole synthesis 
2.2.2.2 Bartoli indole synthesis 
Many naturally occurring indoles, and therapeutics, possess substitution at C7; however, 
synthesis of these indoles can be troublesome.  In 1989, the Bartoli group developed an 
efficient protocol to access C7-substituted indoles through the reaction of substituted 
nitro groups with substituted vinyl Grignard reagents (Scheme 2-11).31 The first step of 
the mechanism involves a reduction of the nitro group in 2-70, by a Grignard reagent, to 
form nitroso 2-75. Confirmation of the initial reduction was done by obtaining 2-74 as a 
by-product, and also because indoles could be formed straight from nitrosoarene 2-75. 
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Scheme 2-11 Bartoli indole synthesis 
Another Grignard addition, this time to nitrosoarene 2-75, gives intermediate 2-76 which 
then undergoes a [3,3] sigmatropic rearrangement to give imine 2-77. A third Grignard 
reagent is used to deprotonate 2-77, which results in re-aromatization of the six 
membered ring to give 2-79, and by product 2-78. Aniline 2-79 then undergoes a 
cyclization reaction, and subsequent dehydration to give indole 2-72. If X=Br then a 
plethora of modifications at the C7 of the indole can occur via various coupling reactions. 
A few more benefits of the Bartoli indole synthesis include: 1) nitroarenes are 
commercially available, or can be easily synthesized;43 2) the reaction is usually very fast 
and can easily be scaled up; and lastly, 3) nitro and nitrosoarenes are more reactive than 
many functional groups towards Grignard reagents, thus alleviated the necessity for 
protecting groups.44  
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2.2.2.3 Larock indole synthesis 
In 1991, Larock developed an indolization sequence from the Pd-catalyzed coupling of 2-
iodoanilines (2-81) and disubstituted alkynes (2-82, Scheme 2-12).45 The reaction is 
tolerant to many different substituents on the aniline, or the alkyne, and the coupling is 
also fairly regioselective – with larger substituents located at the 2-position of the 
indole.46 The rationale for the regioselectivity could be explained by sterics in 
intermediate 2-85, whereby larger functional groups would avoid the arene.  
 
Scheme 2-12 Larock indole synthesis  
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The proposed mechanism is highlighted in Scheme 2-12. To begin the synthesis, the 
Pd(II) source is reduced to Pd(0), which then undergoes an oxidative addition with 
aniline 2-84. The alkyne then undergoes a ligand exchange with the palladium complex 
to form 2-85, followed by a syn-insertion to the arylpalladium bond (2-86). The amine 
then displaces the halide to form the six-membered, heteroatom-containing palladacycle 
2-87, which then undergoes a reductive elimination to regenerate the Pd(0) species, and 
to form indole 2-83.  
In 2013, the Jia group modified the Larock indole synthesis to access 3,4-fused tricyclic 
indole 2-90 from an intramolecular Larock indole synthesis of aniline 2-88 (Scheme 
2-13).47 Various atoms in the tether (Y= C, N, or O) could be utilized, and many different 
sized rings (6, 9, 10, 11, 18) were synthesized.  
 
Scheme 2-13 Jia group’s intramolecular Larock indole synthesis 
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2.2.2.4 Huang indole synthesis 
More recently, in 2013, the Huang group found that they could access indoles through a 
triazene-directed (2-91) C-H annulation with alkyne 2-92 (Scheme 2-14).48 During their 
optimization they found that [{RhCp*Cl2}2] and methanol were required, as other 
catalysts or solvents did not form the indole. Also necessary was a stoichiometric amount 
of copper oxidant, and catalytic amounts of a non-coordinating silver counter ion. 
Triazenyl arenes substituted with alkyl, EWG, and halides were able to undergo the 
indolization sequence, however arenes with EDG resulted in decomposition. Alkynes had 
either aryl or alkyl substituents, while terminal alkynes could not be used as they lead to 
dimerization. The proposed mechanism is seen below in Scheme 2-14. After the 
formation of the active Rh3+ acetate species, a directed C-H bond insertion occurs (2-94). 
Insertion of the alkyne results in seven-membered metallacycle 2-95, which can rearrange 
to the more stable six-membered metallacycle (2-96, Pathway A). Solvolysis of the 
triazene by methanol (2-96), followed by reductive elimination of 2-98 results in indole 
2-93. Alternatively, after the formation of the seven-membered metallacycle 2-95, N=N 
insertion to the Rh-C bond forms intermediate 2-99 (Pathway B). Reduction of the Rh 
catalyst, results in an intermediate similar to 2-96, which also undergoes solvolysis to 
access indole 2-93. 
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Scheme 2-14 Huang group’s synthesis of indoles through triazene directed C-H 
annulation 
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2.2.2.5 Plieninger indolization sequence 
In 1956, the Plieninger group were able to convert dihydronaphthalenamine 2-100 to 
indole 2-103 through an ozonolytic cleavage/dehydration procedure (Scheme 2-15).49 
 
Scheme 2-15 Plieninger’s indole synthesis 
Despite the relative simplicity of the reaction, the indolization sequence did not build 
much traction within the synthetic community, likely because the indoles were obtained 
in low yields and dihydronaphthalenamines were not easily accessible at the time. A 
Birch reduction of 2-aminonaphthalene 2-104 was commonly employed to access 
dihydronaphthalenamines (Scheme 2-16); however, many functional groups are not 
tolerated by the reducing conditions. Nevertheless, the protocol was used in a total 
synthesis by Plieninger, 20 years later, to access (±)-chanoclavine I.50  
 
Scheme 2-16 Accessing dihydronapthalenamine via Birch reduction 
In the synthesis of (±)-chanoclavine I (Scheme 2-17, 2-111), the dihydronapthalenamine 
was not accessed through a Birch reaction, but instead from a Diels-Alder reaction 
between diene 2-106 and maleic anyhydride (2-107). After some further manipulations 
Plieninger had requisite dihydronapthalenamine 2-109, which underwent the Plieninger 
indolization sequence. After a few more synthetic steps, he was able to complete the total 
synthesis of (±)-chanoclavine I. 
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Scheme 2-17 Plieninger group’s total synthesis of (±)-chanoclavine I 
The indolization sequence was also used by Maehr and Smallheer nine years later in their 
total synthesis of (±)-rivularin D1 (2-116a) and (±)-rivularin D3 (2-116b) (Scheme 
2-18).51 A Birch reduction of aminonaphthalene hydrochloride 2-112, followed by 
bromination by pyridinium tribromide (2-113), and lastly tosylation of the amine gave 
access to dihydronaphthalenamine 2-114. Submitting 2-114 to the Plieninger indolization 
sequence afforded indole 2-115 in a 32% yield over two steps. The indole then underwent 
a Fischer indole synthesis to install the other indole moiety, followed by some final 
manipulations to form (±)-rivularin D1 and (±)-rivularin D3.  
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Scheme 2-18 Maehr and Smallheer’s total synthesis of (±)-rivularin D1 and D3  
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2.3 Diels-Alder/Plieninger indolization sequence 
2.3.1 Accesing dihydronaphthalenamines 
The Kerr group recognized that the Plieninger indolization sequence can be a useful tool 
to natural product synthesis, and set out to improve the protocol. Inspired by the work of 
Moore52 (Scheme 2-19, entry 1) and Coutts53 (Scheme 2-19, entry 2) on the Diels-Alder 
of quinone imines (2-117) and quinone imine ketals (2-120) respectively, the Kerr group 
realized they could use these Diels-Alder adducts and convert them to 
dihydronaphthalenamines by acid promoted aromatization. 
 
Scheme 2-19 Moore (1), and Coutts (2) Diels-Alder of imine quinoid species 
Originally, the Kerr group used hyperbaric conditions to access their Diels-Alder adducts; 
however, one of the main issues with this protocol was limited scalability.54 It was then 
found that quinone imine ketal 2-117 and diene 2-123 in toluene at 140 °C (sealed tube) 
can effectively form Diels-Alder adduct 2-124 (Scheme 2-20, entry 1).55  These adducts 
were then efficiently converted to dihydronaphthalenamine 2-125 with the use of 
catalytic HCl in THF.54b The scope of the reaction is excellent and various quinone imine 
ketals and dienes were converted to dihydronaphthalenamine in high yields (85-99%). 
One downfall of this protocol is that R1,R4-disubstituted dienes are not tolerant of the 
Diels Alder reaction. Steric interactions can occur between the substituent of the diene 
and the ketal of the dienophile, preventing a cycoaddtion; however, a corollary of the 
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steric effect means that dienes that are R1 substituted will be regioselective in the Diels-
Alder reaction. The Kerr group later showed that they could also form 
dihydronaphthalenamines from the Diels-Alder reaction of N-arylsulfonyl quinone imine 
(2-120) and various dienes (Scheme 2-20, entry 2).56 These dienophiles were found to be 
more reactive than quinone imine ketals, and the cycloaddition could effectively proceed 
at room temperature.      
 
Scheme 2-20 Kerr group’s Diels-Alder approach to dihydronaphthalenamines 
2.3.2 Accessing indoles 
With a protocol developed to efficiently access dihydronaphthalenamines, efforts were 
then taken to develop better conditions for the indolization sequence, as these often gave 
poor yields under the standard Plieninger indolization sequence. The Kerr group was 
inspired to tackle this issue after work done in Pearson et al. in 1991. In an effort to make 
4-(2-N,N-dialkylaminoethyl)indole (2-128) dopamine agonists, Persons et al. used a 
modified Plieininger indolization sequence to access indole 2-103 from the oxidative 
cleavage of 2-100 by OsO4 and NaIO4, in a 24% yield (Scheme 2-21).
57  
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Scheme 2-21 Persons group’s synthesis of dopamine agonists 
Although the yield was poor, the Kerr group decided to use these conditions as a starting 
point to optimize the indolization sequence. Johnson Lemieux oxidation58 resulted in 
extensive decomposition, and ultimately it was found that a two-step procedure required 
in order for the indolization to be effective (Scheme 2-22). The protocol involved 
dihydroxylation of the olefin in 2-125 by NMO and catalytic OsO4, followed by oxidative 
cleavage by silica-supported NaIO4 to give hemiaminal 2-129.  
 
Scheme 2-22 Kerr group’s modified Plieninger indolization sequence 
Silica-supported NaIO4 was used as diol 2-128 had poor solubility in aqueous solvents 
normally used for oxidative cleavage allowing the use of organic solvents such as THF or 
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DCM.59 Also, purification of the crude material was made extremely easy as only a 
filtration was required to remove the NaIO4/SiO2. The indole could then be accessed by 
an acid promoted dehydration of hemiaminal 2-129 with HCl, PTSA, or H2SO4. With a 
revised Plieininger indolization sequence at hand, the Kerr group was able to access 
many indole containing natural products (Scheme 2-23).60  
 
Scheme 2-23 Kerr group Diels-Alder/Plieninger indolization sequence 
114 
 
2.3.3 Project goal 
While the Kerr group provided an efficient route to indoles and utilized the procedure for 
the total synthesis of indole containing natural products, it was thought that the 
methodology can be expanded to access benzylamine containing indoles such as: PD 
102807 (2-143), which is a selective antagonist for an acetylcholine (a neurotransmitter) 
receptor;61 fargesine (2-144), a natural product;62 and umifenovir (2-145), a therapeutic 
for influenza (Figure 2-4).63 
 
Figure 2-4 Benzylamine containg indoles 
As a benzylic aldehyde is normally present in indoles synthesized via the Diels-
Alder/Plieninger indolization sequence, a loss of one carbon was required. We envisioned 
that oxidation of aldehyde 2-146 to acid 2-147, followed by a Curtius rearrangement 
(Scheme 2-24) would be an effective procedure to access the molecules in Figure 2-4. 
We were particularly interested in fargesine, and the following section will discuss its 
formal synthesis. 
 
Scheme 2-24 Two-step procedure to access benzylamine containing indoles 
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2.4 Formal synthesis of fargesine 
2.4.1 Introduction to fargesine 
In 2006, the Zhu group isolated three novel alkaloids from the plant Evodia fargesii 
(Figure 2-5); fargesine (2-144), plectocomine 12-methyl-5-O-β-D-glucopyranoside N-
oxide (2-149), and bufotenine 12-5-O-β-D-glucopyranoside N-oxide (2-150).62 The fruit 
of the plant is used as folk medicine in the Jiangxi province of China to relieve cough 
after measles, and for abdominal pains.   
 
Figure 2-5 Isolation of three alkaloids from Evodia fargesii 
To date there has only been one synthesis of fargesine by the Jia group, which utilized 
their 3,4-fused tricyclic Larock indole synthesis.47 The total synthesis can be seen in 
Scheme 2-25. To begin the synthesis, a reductive amination between known aldehyde 2-
15164 and amine 2-152 was undertaken to afford secondary amine 2-153. A Boc 
protection on the phenol and amine proceeded nicely with a 90% yield to give 2-154. 
Reduction of the nitro group with Zn in acetic acid afforded the precursor for the 
intramolecular Larock indolization in a 60% yield (2-155). Gratifyingly, they were able 
to perform their intramolecular Larock indolization in a quantitative yield to obtain indole 
2-156. To finish the total synthesis, TFA was used to deprotect the TES group and the N-
Boc in a 66% yield to access compound 2-157. Reductive amination of 2-157 with 
formaldehyde (81% yield), followed by m-CPBA oxidation of the amine afforded N-
oxide 2-159 in 70% yield. The total synthesis of fargesine was completed by the 
deprotection of the O-Boc in sodium methoxide. 
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Scheme 2-25 Jia group’s total synthesis of fargesine 
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2.4.2 Results and discussion 
2.4.2.1 Retrosynthesis  
To access fargesine (2-144), we proposed (Scheme 2-26) that the last two steps would 
come about similarly to the literature synthesis: N-oxidation, and deprotection of the 5-
hydroxy indole. Methylamine indole 2-165 would come from the reduction of methyl 
carbamate, and detosylation of 3,4-fused indole 2-164. Fused indole 2-164 would be 
obtained through the cyclization between methyl carbamate and a leaving group in indole 
2-163. Oxidation of aldehyde indole 2-162 followed by a Curtius rearrangement would 
give carbamate indole 2-163. Lastly, indole 2-162 would be developed using the Kerr 
group’s Diels Alder/Plieninger indolization sequence of quinone imine ketal 2-160 and 
diene 2-161. 
 
Scheme 2-26 Retrosynthetic pathway for fargesine. 
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2.4.2.2 Formal synthesis of fargesine  
A model study was undertaken by Sharon Michalak with readily available indole 2-
166,54b in order to validate our key oxidation/Curtius rearrangement steps required for 
fargesine (Scheme 2-27). Gratifyingly, oxidation of the aldehyde by a Pinnick 
oxidation,65 resulted in an 80% yield of acid indole 2-167. A Curtius rearrangement was 
then attempted on the acid following a literature protocol,66 however the desired product 
(2-168) was not obtained. Despite being unsuccessful on the first attempt of the 
rearrangement, it was decided that no further exploration of the reaction would happen as 
it would be more efficient to optimize the rearrangement on the requisite substrate for 
fargesine.   
 
Scheme 2-27 Model study for the oxidation/Curtius rearrangement protocol 
To commence the synthesis of fargesine, Sharon synthesized quinone imine ketal 2-
16054a and diene 2-161a67 using literature procedures. She then heated the reactants to 
140 °C in toluene for 24 hours, with catalytic amounts of BHT, to undergo the Diels-
Alder reaction per the protocol developed by Kerr.55 While these reaction conditions 
sometimes resulted in partial aromatization to form dihydronaphthalenamine 2-170, 
reheating the Diels-Alder adduct in toluene at 160 °C for 12 hours was an effective 
method for full aromatization. Thus, 2-164 was obtained in an 80% yield over the two 
steps (Scheme 2-28). With dihydronaphthalenamine 2-170 at hand, the modified 
Plieninger indolization sequence could begin. Dihydroxylation of the olefin proceeded 
cleanly (based on a crude 1H NMR spectrum), and did not require further purification. 
Oxidative cleavage of diol 2-171 with NaIO4/SiO2 formed the dialdehyde species which 
immediately cyclized in situ to give hemiaminal 2-172 in a 91% yield over two steps. 
Despite the crude 1H NMR of hemiaminal 2-172 appearing to be clean, it required 
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purification by flash column chromatography in order for the acid mediated dehydration 
to proceed effectively. Camphor sulfonic acid was used for this transformation as it 
provided higher yields than other acids previously used in the modified Plieninger 
indolization sequence. Indole 2-162a was then obtained in 96% yield if isolated, but most 
of the time was used crude.  
 
Scheme 2-28 Diels Alder, Plieninger indolization sequence 
With the modified Plieninger indolization sequence complete, it was now time to attempt 
the key reactions to the synthesis. Using the Pinnick oxidation conditions from the model 
study, aldehyde indole 2-162a was able to be fully converted to acid 2-173 (based on 
TLC analysis), but low yields were obtained during purification of the acid by flash 
column chromatography. Despite many eluents being used for the purification, it was 
found that the crude acid was best purified by crystallization in DCM and hexanes. Thus, 
acid indole 2-167 was obtained in a 70% yield from hemiaminal 2-172 (Scheme 2-29). 
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Scheme 2-29 Pinnick oxidation to access acid for the required Curtius rearrangement 
With the requisite acid at hand, the Curtius rearrangement could now be attempted. 
Efforts towards optimizing the Curtius rearrangement by Sharon are shown below in 
Table 2-1.  
Table 2-1 Initial attempts at the Curtius rearrangement  
 
Entry ROH Time (h) Temperature (°C) Solvent Yield (%) 
1 MeOH 17 110 toluene 18 
2 MeOH 24 110 toluene 28 
3 MeOH 48 110 toluene 30 
4 MeOH 24 80 toluene 43 
5 EtOH 22 80 toluene 19 
6 MeOH 36 80 benzene 23 
7 --- 57 60 methanol 45 
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Each of the examples shown in Table 2-1 involved a one-pot procedure containing acid 
indole 2-173 in a solvent, along with triethylamine, diphenylphosphoryl azide (DPPA), 
and an alcohol.  Unlike the model study, the initial attempt at the Curtius rearrangement 
of 2-173 resulted in a low 18% yield of the product (Table 2-1, entry 1). Attempts to 
increase the yield involved modifying the temperature and reaction time (entry 2-5). It 
was found that doing the reaction in toluene at lower temperatures, with methanol as the 
alcohol, resulted in an increased yield of 43% (entry 4). As entry 4 provided the highest 
yield, a solvent screening was then undertaken. When the reaction was performed in 
benzene, a lower yield was obtained (entry 6); however, when the reaction was done with 
methanol as the solvent,68 a 45% yield (entry 7) was obtained.  
With Sharon’s contributions to the synthesis complete, it was found that the Curtius 
rearrangement required that the isocyanate be formed in situ, followed by subsequent 
addition of methanol to form the carbamate. Due to the purification (by flash column 
chromatography) of the Curtius product being somewhat tedious, the process could be 
simplified by conversion of 2-163b to 2-163c since there was a major change in retention 
factor. Thus, deprotection of the TBS group in 2-163b occurred effortlessly in TBAF at 
room temperature overnight to give deprotected alcohol indole 2-163c in a 66% yield 
over the two steps (Scheme 2-30). Attempts to form the cyclic carbamate under 
Mitsunobu69 conditions were unfruitful; the reaction showed miniscule amounts of the 
desired product and excessive decomposition. It was decided that mesylation of the 
alcohol, followed by substitution with the carbamate could afford the desired 3,4-fused 
tricyclic indole. Mesylation of the primary alcohol with methanesulfonyl chloride at 0 °C 
formed indole 2-163d in an 83% yield.   
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Scheme 2-30 Synthesis of the cyclic precursor 
Efforts to form 3,4-fused tricyclic indole 2-164 with tBuOK, K2CO3, or just thermal 
conditions did not yield the desired product. Eventually it was found that sodium hydride 
in DMF (for three hours) could promote cyclization of 2-163d to indole 2-164 (Scheme 
2-31); however, a minor amount of detosylated indole 2-174 was also formed. Longer 
reaction times (16 hours) did not result in full detosylation so another deprotection 
method was explored. Indole 2-164 was added to tetrabutyl ammonium fluoride (TBAF) 
and heated to 130 °C in the microwave for 20 minutes, which gave detosylated indole 2-
174, and a minor amount of unreacted indole.70 Resubmitting the crude material to the 
reaction conditions allowed for full detosylation, but since it was already known that 
tosyl indole was hydride labile, it was decided to carry the crude material forward to the 
reduction of the carbamate. Thus, the crude mixture of detosylated indole 2-174 was 
added to a solution of LAH in THF and stirred at room temperature. Surprisingly, these 
conditions only resulted in full detosylation of the indole (no reduction of the carbamate 
occurred) but reduction was possible when the THF was heated to 60 °C. Therefore, 
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methyl amine indole 2-165 could be quickly accessed over three steps from indole 2-
163d by: 1) cyclization with NaH 2) submitting the crude material from step 1 to 
detosylation conditions with TBAF, and finally 3) submitting the crude material from 
step 2 to reducing conditions, which afford methyl amine indole 2-165 with an overall 
75% yield. Attempts to go directly from 2-164 to 2-165 with LAH resulted in a mixture 
between 2-165, and tosylated 2-165. Since an optimized route to form 2-165 was already 
developed, efforts towards a one-pot procedure were abandoned. 
 
Scheme 2-31 Synthesis of N-reduced methoxy fargesine 2-159 
With methyl amine indole 2-157 at hand, only two more steps were required to access 
fargesine: oxidation of the amine, and subsequent deprotection of the methoxy goup. 
Despite many attempts to oxidize the amine with m-CPBA, following Jia’s procedure,47 
only decomposition was obtained (Scheme 2-32, entry 1). Modifying the procedure to 
shorter reaction times, slow addition of the indole, or cooler temperatures also resulted in 
decomposition, and no other oxidants were attempted. As the only difference between 
Jia’s indole and our indole at this stage was the protecting group on the 5-hydroxy indole 
(Jia protected the alcohol with a Boc group), it was speculated that the amine in indole 2-
165 was not as delocalized and was therefore more reactive, leading to decomposition. 
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To circumvent the oxidation issues, it was decided to deprotect the methoxy group prior 
to N-oxidation. Attempts at methoxy deprotection with typical BBr3 conditions (3, 9.5, or 
47 equivalents with temperatures ranging from -78 °C to RT) resulted in decomposition. 
An attempt at methoxy deprotection using thiophenol and K2CO3 also lead to 
decomposition (Scheme 2-32, entry 2).71  
 
Scheme 2-32 Attempts to oxidize or deprotect indole 2-165 towards fargesine 
As it was becoming apparent that the route above would not be viable, it was decided to 
attempt the methoxy deprotection at an earlier stage of the synthesis. When indole acid 2-
173 (Scheme 2-33, entry 1) was reacted with BBr3, decomposition was obtained; 
however, when cyclic indole 2-164 was taken up in DCM and BBr3 (3 equivalents, at -78 
C to RT) 5-hydroxyindole 2-178 was accessed (Scheme 2-33, entry 2). After liquid-liquid 
extraction (EtOAc/H2O), the crude yield of this reaction was very good (97% yield on 
200 mg scale, and 86% yield on 345 mg scale); however, when the material was purified 
by flash column chromatography, approximately 50% of the mass was lost.  It was also 
found that if the crude material, or purified material, was left alone for a short period of 
time, the material would begin to become insoluble in many solvents. As the crude and 
purified 1H NMR spectra looked the same, it was concluded that the material 
decomposed and had to be quickly used for the next step.   
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Scheme 2-33 Earlier stage methoxy deprotection by BBr3 
Recalling that that tosyl indole is hydride labile (Scheme 2-31, 2-163d to 2-165), crude 
indole 2-178 was then taken up in THF and LAH at 60 °C in hopes of detosylating, and 
reducing the carbamate in a one-pot procedure. Gratifyingly, the one-pot procedure 
worked and methyl amine indole 2-176 was obtained in a 77% yield. As time and 
material were running low at this stage, only one amine oxidation was attempted to 
complete the synthesis of fargesine; however, only decomposition was obtained (Scheme 
2-34, entry 1). It was then decided to Boc protect the alcohol as this would then converge 
with Jia’s total synthesis of fargesine. The Boc protection was successfully performed in 
DMF, as the indole was fairly insoluble in other solvents, to obtain Jia’s indole 
intermediate (2-158) in a 41% yield, thus completing the formal synthesis of fargesine 
(Scheme 2-34, entry 2).   
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Scheme 2-34 Completing Jia’s intermediate for a formal synthesis of fargesine 
 
2.4.3 Conclusions 
Efforts towards the total synthesis of fargesine were undertaken utilizing a Diels-Alder, 
Plieninger indolization sequence. Despite advancing to a late stage intermediate that only 
required an oxidation and methoxy ether deprotection, the route was not viable in the 
sysnthesis of fargesine and an alternative route was carried out that converged with Jia’s 
synthesis of fargesine. Although the Jia group synthesis of fargesine is shorter (14 versus 
6 steps - from literature compounds) to obtain the same intermediate, many steps in our 
synthesis can be done on multi-gram scale, and only four purifications by flash column 
chromatography are required (most reactions are carried forward crude).  
127 
 
2.5 Accessing oxygen analogues of indole: benzofuran, 
and derivatives 
2.5.1 Introduction to benzofuran and derivatives 
Despite indoles having a vast amount of research dedicated towards their synthesis, the 
oxygen analogue benzofuran (Figure 2-6, 2-179) does not.72 Nevertheless, it is still an 
important molecule for chemists as benzofurans and its derivatives exhibit many 
biological activity including antifungal,73 antitubercular,74 anticonvulsant,75 anticancer,76 
analgesic,77 antidiabetic,78 and anti-Alzheimer's properties.79 Benzofurans are also 
utilized in polymer chemistry80 and the dye industry.81 
 
Figure 2-6 Depiction of benzofuran (2-179), and benzofuranone (2-180) 
A derivative of benzofuran is the benzofuranone (Figure 2-6, 2-180), which is simply a 
lactone of dihydrobenzofuran. Some examples include: rhuscholide A (Figure 2-7, 2-
181), which shows anti-HIV properties;82 fumimycin (2-182), which has bacterial peptide 
deformylase inhibitor properties;83 abiesinol E (2-183), which shows antitumor-initiating 
effects;84 and lastly, ferrubietolide (2-184), which is used as a pesticide.85 
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Figure 2-7 Benzofuranone containing natural products  
2.5.2 Accessing benzofuranones 
In 2010, the Yu group developed a two-step C-H activation/C-O bond formation 
procedure to convert alcohol 2-185 to 2,3-dihydrobenzofurans 2-188 (Scheme 2-35).86 A 
key step to the procedure involves oxidation of the Pd(II) palladacycle 2-186 to Pd(IV) 2-
187 by a ‘bystanding oxidant’ to facilitate reductive elimination.87 Through careful 
selection of oxidant, a higher energy metallic species forms to make the reductive 
elimination favourable, while minimizing potential side reactions. 
 
Scheme 2-35 Yu group’s synthesis of 2,3-dihydrobenzofurans 
129 
 
In 2013, the Yu group further developed their protocol to include the synthesis of 
benzofuranones from phenylacetic acid 2-189 (Scheme 2-36).88 During their optimization 
for synthesizing benzofuranones, they found that PhI(OAc)2 was the best oxidant to 
promote lactonization, but the highest yield obtained was only 42%. Despite various 
additives and ligands tested, they were unable to obtain benzofuranones in higher yields. 
They then tried N-protected amino acids as ligands since the Yu group had previously 
shown they can promote C-H activation.89 When N-acetylated glycine was used as a 
ligand, they were able to obtain various benzofuranones (2-191a) in moderate to 
excellent yields (56-94%); although the substrate scope was somewhat limited because 
R1=R2=Me if there was substitution on the phenyl ring. The enantioselective synthesis of 
benzofuranones was then explored through the desymmetrization90 process of diaryl 
acetic acid 2-189b. Isoleucine (N-Boc protected) gave the best results in the 
desymmetrization process, obtaining benzofuranone 2-191b in moderate yields and high 
ee (89-96%)  
 
Scheme 2-36 Yu group’s synthesis of benzofuranones 
Recently, benzofuranones with 3-hydroxy, 3-trifluromethyl substitution have been shown 
to exhibit great biological activity and are being explored as potential therapeutics.91 For 
example, racemic bis(1,1-dimethylethyl)-3-hydroxy3(trifluoromethyl)-2(3H)benzo- 
furanone  (BHFF) has potential to treat nervous system disorders, and furthermore, it has 
been shown that (-)-BHFF is more robust than racemic or (+)-BHFF in animal studies.92 
The Tang group set out to access these therapeutically interesting class of benzofuranones 
through a catalytic and asymmetric tandem Friedel-Crafts/lactonization between phenol 
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2-192 and trifluoropyruvate 2-193 (Scheme 2-37).93  While the tandem Friedel-
Crafts/lactonization sequence has been known since 1980, reaction conditions typically 
require strong organic acids as solvents, high temperatures, stoichiometric amounts of 
Lewis Acid, and were never performed enantioselectively.94 The Tang group were able to 
achieve their goal through the use of chiral BOX/Cu(II) system, developed by 
Jørgensen.95 Specifically, the Tang group found that BOX derived ligand 2-194 was able 
to access benzofuranone 2-196 with the best yields and ee (80-94%). They were also able 
to synthesize (-)-BHFF (2-196a) in a 62% yield, and >99% ee (after recrystallization). 
Mechanistic studies confirmed that the phenol was important for the regioselectivity of 
the Friedel-Crafts reaction, as C4 alkylation was more prominent when methyl ethers 
were utilized.        
 
Scheme 2-37 Tang group’s synthesis of benzofuranones and (-)-BHFF (2-196a)  
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2.5.3 Project goal 
Since the Kerr group had previously shown that they were able to convert 
dihydronaphthalenamines to indoles (Scheme 2-23), it was speculated that we would be 
able to convert the oxygen equivalent – dihydronaphthalenol (2-200) – into benzofuran 
and derivatives (2-201 or 2-202, Scheme 2-38). The dihydronaphthalenol would come 
from the Diels-Alder between quinone ketal 2-197 and diene 2-198. Efforts to develop a 
methodology and its application towards the total synthesis of fumimycin (2-182) are 
discussed below. 
 
Scheme 2-38 Proposed route towards benzofurans (2-201) or benzofuranones (2-202) 
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2.5.4 Diels-Alder reaction of quinone ketals 
The use of quinone ketals as dienophiles had previously been shown to proceed thermally 
by Farina and co-workers (Scheme 2-39), but not without many limitations: only reactive 
dienes could be used, extreme temperatures were required, long reaction times were 
necessary, and poor yields were obtained for the products.96 For example, when isoprene 
was reacted with p-benzoquinone ketal in benzene at 140 °C for 160 hours, only a 32% 
yield of the Diels Alder adduct was obtained. 
 
Scheme 2-39 Farina group’s Diels-Alder of quinone ketals 
The Kerr group suspected that hyperbaric conditions could improve Farina’s work, and 
would also serve as an expansion of Kerr’s hyperbaric Diels-Alder of quinone imine 
ketals.54a They were able to effectively promote the cycloaddition of various dienes with 
quinone ketal 2-203, in moderate yields and a 72 hour average reaction time (Scheme 
2-40).97 As noted in Section 2.3.1, dienes with R1 and R4 substitution were unable to react 
due to steric interactions with the acetal.  The Diels-Alder adducts were aromatized to 
their corresponding dihydronaphthalenol 2-206 in moderate yields ranging from 37-94%, 
with PTSA in dry toluene. With the use of hyperbaric conditions, the Kerr group had 
successfully overcome the limitations of the Diels-Alder reactions of quinone ketals. 
 
Scheme 2-40 Kerr group’s hyperbaric Diels-Alder of quinone ketals 
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2.6 Progress towards the total synthesis of fumimycin 
2.6.1 Introduction to fumimycin and previous synthesis 
Fumimycin was isolated from the fermentation broth of Aspergillus fumisynnematus 
F746, a fungus collected from a Korean soil sample by Kim and co-workers in 2007.83 
Fumimycin displays high inhibition of peptide deformylase (PDF),98 which is an enzyme 
involved in the removal of formyl groups at the N-terminus of bacterial proteins and 
essential for prokaryotic growth.99 As this process is not important for mammalian cells, 
PDF inhibitors represent a class of antibacterial agents which may have very little side 
effects in humans. To date, there has only been one total synthesis of fumimycin, and this 
was done by Gross and Bräse in 2010. They were able to access (±)-fumimycin in 18 
steps (16 step longest linear sequence) in a 2.2% overall yield.  
To begin the synthesis of fumimycin, vanillin was allylated and then converted to phenol 
2-209 by a Dakin oxidation using H2O2/B(OH)3/H2SO4.
100 Friedel-Crafts acylation with 
ethyl 2-chloro-2-oxoacetate afforded 2-210 in an 82% yield. TBS protection of the 
phenol, followed by a condensation reaction with hydroxylamine gave oxime 2-211 (91% 
yields over two steps), which was then converted to ketimine 2-214 with 
chlorodiphenylphospine. The mechanism for this transformation occurs as follows: 1) 
nucleophilic attack of the oxygen in oxime 2-211 to the phosphine gives intermediate 2-
212; 2) thermally induced homolytic N-O bond cleavage occurs to give the two radical 
species shown in intermediate 2-213; and lastly, 3) recombination of the radicals forms 
ketimine 2-214.101 The decision to form ketimine 2-214 served two purposes: 1) due to 
the EWG effects of acyl group, it would promote Grignard addition to the imine, and 2) it 
would provide a mild protecting group for the amine after Grignard addition to ketimine 
2-214. The aforementioned Grignard addition into the amine gave compound 2-215 in 
65%. TBS ether was then deprotected by heating the compound to 120 °C in DMF, which 
also promoted formation of the benzofuranone core, and continued heating in DMF 
resulted in a Claisen rearrangement to give benzofuranone 2-216. Isomerization of the 
terminal olefin under rhodium catalysis102 occurred in near quantitative yield with 10:1 
selectivity towards the desired trans isomer. From here, Gross and Bräse decided a 
protecting group change on the alcohol was in order as deprotection of the methoxy later 
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on was unsuccessful. After many attempts, it was found that BI3 allowed for isolation of 
diol 2-218 in a 90% yield.103  
 
Scheme 2-41 Gross and Bräse’s total synthesis of fumimycin  
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Mono-protection of diol 2-218 with TIPSOTf afforded 2-219 in an 83% yield. 
Deprotection of the amine and subsequent acylation with 2-221 gave benzofuranone 2-
222 in a 24% yield over two steps. Fumimycin (2-182) was then accessed by TBAF 
deprotection of the TIPS ether, and TFA promoted cleavage of the t-butyl ester.  
 
Scheme 2-42 Completing Gross and Bräse’s total synthesis of fumimycin 
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2.6.2 Results and discussion 
2.6.2.1 Retrosynthesis 
As shown in the retrosynthesis below, we planned to complete our synthesis of 
fumimycin by converging with Gross and Bräse’s synthesis by accessing intermediate 2-
220. The amine in Gross’s intermediate would come from a similar protocol to fargesine, 
which involved an oxidation of benzofuranone aldehyde 2-228 to an acid followed by a 
Curtius rearrangement, and subsequent hydrolysis of the isocyanate. The other half of 
Gross’s intermediate would arise from a deprotection of the acetal and subsequent mono-
protection of the diol with TIPS. The olefin in compound 2-228 could be accessed from a 
Grignard addition to the least hindered carbonyl of 2-227 followed by a dehydration 
reaction. Benzofuranone dialdehyde 2-227 would come about from an oxidative cleavage 
of the olefin in benzofuranone 2-226, which would have come from the oxidative 
lactonization of 2-225. Lastly, dihydronaphthalenol 2-225 would have come about 
through the Kerr group’s Diels-Alder between diene 2-224 and dienophile 2-223.   
 
Scheme 2-43 Retrosynthesis of fumimycin  
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2.6.2.2 Forward synthesis 
To begin our studies, a Diels-Alder reaction between known diene 2-224a104 or 2-
224b,105 and quinone ketal 2-223106  were attempted to access dihydronaphthalenol 2-
225.  However, attempts at forming the Diels-Alder adduct under hyperbaric conditions 
(13 kbar at RT or 30 °C), thermal conditions (toluene heated to reflux), or Lewis acid 
catalysis (TiCl2(OiPr)2 with BINOL,
107 or with BF3•OEt2) resulted in no product (Scheme 
2-44).  
 
Scheme 2-44 Initial Diels-Alder attempts 
It was thought that perhaps the dienophile could be made more reactive by using a 1,4-
benzoquinone 2-229 as the reacting partner. These have a stronger electron withdrawing 
effect on the dienophile, lowering the energy level of the LUMO, and thus making them 
more suitable for Diels-Alder chemistry. When similar Diels-Alder conditions from 
above were done on 1,4-benzoquinone 2-229 and diene 2-224, again no product was 
obtained (Scheme 2-45), and it is clear that the diene is too sterically encumbered to 
react. Due to these results a revised retro synthesis had to be arranged.  
 
Scheme 2-45 Utilizing 1,4-benzoquinone 2-223 to access dihydronaphthalenol 2-224 
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2.6.2.3 Revised retrosynthesis 
It was thought that Kerr’s Diels-Alder/Plieninger indolization sequence could be 
modified as a methodology to access benzofurans, or benzofuranones (Scheme 2-46). 
 
Scheme 2-46 Divergent methodology towards benzofurans and benzofuranones 
The modification of the indolization protocol relies on utilizing quinone ketal 2-231 
instead of quinone imine ketal for the Diels-Alder reaction. Under the standard Plieninger 
indolization sequence one would obtain a hemiacetal, and then a dehydration would 
allow for an indole; however, due to this route being the oxygen analogue, we would 
access hemiacetal 2-235, which can then get oxidized to benzofuranone 2-236, or 
dehydrated to form benzofuran 2-237. 
The revised retrosynthetic plan is shown below in Scheme 2-47. Again, fumimycin would 
be derived from Gross’s intermediate; however, a new approach would be required to 
access the amine. A stereoselective amination protocol of benzofuranones would install 
Boc-protected hydrazine alpha to the carbonyl (2-241).108 Due to the stereoselective 
control of this reaction, it would allow for the synthesis of naturally occurring fumimycin 
(2-182a). The required amine in Gross’s intermediate can then be accessed by reduction 
of the Boc-protected hydrazine.109 The olefin in benzofuranone 2-240 would come from a 
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Grignard addition/dehydration procedure from the aldehyde in 2-239. Lastly, the 
modified Diels Alder/Plieninger sequence of piperylene and quinone ketal 2-223 can 
access benzofuranone 2-239.    
 
Scheme 2-47 Modified retrosynthesis towards natural (-)-fumimycin  
 
2.6.2.4 Model study I -  towards modified Diels-Alder, Plieninger 
protocol  
A model study was attempted to determine conditions for the modified Diels-Alder/ 
Plieninger protocol using quinone imine ketal 2-242 (Scheme 2-48). To this end, 
piperylene and quinone imine ketal were reacted under hyperbaric conditions (13 kbar) 
for 12 hours to afford 2-243. Aromatization of the crude adduct could then be performed 
with PTSA in toluene to obtain 2-244 in a 76% yield over the two steps. Attempts to 
promote the cycloaddition under thermal conditions (toluene heated to 140 °C in a sealed 
tube, with BHT, for 18 hours), resulted in an approximate ratio of 3:2 between product 
and unreacted starting material, and it was decided to continue to use hyperbaric 
conditions.  At this stage, we protected phenol 2-244 as a TBS ether to avoid 
complications that may arise from the phenol in subsequent steps; thus, TBS ether 2-245 
was formed in a 58% yield.  TBS protected phenol was then dihydroxylated with OsO4 
and NMO to give diol 2-245 in a 93% yield, and was used crude to obtain dial 2-241 in a 
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79% yield. Despite the yields in the pathway being moderate, the route became 
problematic as there was difficulty in removing the TBS group. Attempts with HCl, HF, 
and TBAF were unsuccessful as they did not promote deprotection but rather 
decomposed the material (based on crude 1H NMR).   
 
Scheme 2-48 Model study I - towards the modified Diels-Alder/Plieninger protocol 
towards benzofuranones 
2.6.2.5 Model study II - towards modified Diels-Alder, Plieninger 
protocol  
As the deprotection of TBS ether was proving to be difficult, an alternative protecting 
group was used. We decided that isolation of dihydronaphthalenol 2-244 was 
unnecessary, and a protected phenol can easily be accessed by a one-pot 
aromatization/alcohol protection to afford dihydronaphthalenyl acetate 2-249. To this 
end, crude Diels-Alder adduct was taken up in acetic anhydride and a catalytic amount of 
sulfuric acid was added to give dihydronaphthalenyl acetate 2-249 in an 86% yield over 
two steps. Dihydroxylation of dihydronaphthalenyl acetate afforded diol 2-250 in a 
quantitative yield, which then underwent oxidative cleave to give dialdehyde species 2-
251 in a 74% yield.  
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Scheme 2-49 Model study II - towards the modified Diels-Alder/Plieninger protocol 
towards benzofuranones 
Unfortunately, deprotection of the acetate was unsuccessful at this stage, and it was 
decided to remove the acetyl group at an earlier stage. Deprotection of the acetyl group in 
diol 2-50 went smoothly and did not require further purification to give triol 2-253. The 
crude triol was then submitted to oxidative cleavage conditions with NaIO4, which 
immediately cyzclized in situ to hemiacetal 2-248 in a 98% yield. The cleavage did not 
with the previously used NaIO4/SiO2/CH2Cl2 conditions as the triol was not soluble in 
dichloromethane. 
As shown above, it became apparent that the phenol did not need to be protected for the 
oxidative cleavage, so we set out to determine if protection of dihydronaphthalenol 2-238 
was required at all. To this end, dihydronaphthalenol 2-244 was submitted to 
dihydroxylation conditions and triol 2-247 was obtained in a 93% crude yield. Since the 
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overall yield to access the triol was higher via the acetylation route, it became the 
preferred route to access hemiacetal 2-248.  
 
Scheme 2-50 Accessing triol 2-247 without a protecting group 
With hemiacetal 2-254 at hand, attempts to oxidize the alcohol with IBX or Fetizon’s 
reagent110 (Ag2CO3/celite) were unsuccessful. Attempts to dehydrate the alcohol with 
KHSO4, PTSA, and H3PO4 were also unsuccessful. Despite being unable to access a 
benzofuran, or benzofuranone, we were not discouraged as this was only a model study, 
and hoped that we would be able perform the oxidation on the requisite hemiacetal for 
fumimycin. 
2.6.2.6 Progress towards the total synthesis of fumimycin 
Efforts towards the total synthesis of fumimycin followed conditions optimized in the 
model study. To begin, a Diels-Alder reaction between quinone ketal 2-223, and 
piperylene was performed, which then underwent aromatization/alcohol protection to 
give 2-255 in 61% yield over two steps (Scheme 2-51). Dihydroxylation of the 
dihydronaphthalenyl acetate gave diol 2-256 in 89% yield, and subsequent deprotection 
of the acetate afforded triol 2-257 in a 69% yield. Unfortunately, when periodate 
cleavage was attempted on triol 2-57, a substantial amount of decomposition was 
obtained and only a minor amount of product could be seen in the crude 1H NMR 
spectrum.  
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Scheme 2-51 Attempts to access benzofuranone core for fumimycin 
An alternative route was required, and despite failing in the model study, it was decided 
to keep the phenol protected for the periodate cleavage. Di-aldehyde species 2-259 was 
formed in a quantitative yield, however once again this route was unsuccessful as 
deprotection conditions were decomposing the molecule. Efforts were then attempted to 
reduce the aldehyde with NaBH4, or oxidize the aldehydes via Pinnick or PDC oxidation, 
but to no avail.  
One last approach towards fumimycin was attempted. A Diels-Alder reaction was 
performed between quinone ketal 2-223 and 2-238 to give 2-260 in an 83% yield, but 
instead of aromatizing the Diels-Alder adduct, it was decided to attempt the 
dihydroxylation on this intermediate. Dihydroxylation with OsO4 and NMO afforded diol 
2-261 in an 88% yield; dihydroxylation only occurred on the olefin derived from 
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piperylene as it is not as delocalized as the other olefin. From diol 2-261 periodate 
cleavage gave dial 2-262 in a quantitative yield. Efforts to promote cyclization under 
protic acids or BF3•OEt2 gave decomposition; however, preliminary studies to promote 
the cyclization under Yb(OTf)3 mediated conditions appear to have formed hemiacetal 2-
263, (based on crude 1H NMR of a test reaction). Unfortunately, no other trials could be 
done on this intermediate, and we were unsuccessful in forming the benzofuranone core 
to fumimycin. Nevertheless, future work is needed to optimize the cyclization, and 
further investigation is required to oxidize 2-263 to a benzofuranone. With optimized 
conditions to access benzofuranone, very few synthetic steps are required to access 
fumimycin.   
 
Scheme 2-52 Attempt at accessing benzofuranone core for fumimycin   
2.6.3 Conclusions 
Multiple attempts were taken to modify the Diels-Alder, Plieninger indolization 
sequence, in an effort to access benzofuranones; however, none were successful.  The 
probable reason to the demise of the route is oxidation of the phenol in late stage 
intermediates. A final route was devised that avoided phenol synthesis; however, more 
work is required to determine if the route is a viable method to access benzofuranones. 
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2.7 Summary and future work 
In summary, this chapter showed the trials and tribulations involved in research dedicated 
to the total synthesis of natural products. The first section of this chapter showed the 
successful formal synthesis of fargesine. The indole in fargesine was accessed using the 
Kerr group’s Diels-Alder/Plieninger indolization sequence. A two-step procedure was 
then carried out to convert the benzylic aldehyde to a benzylamine, as required in 
fargesine. As can be seen during the formal synthesis of fargesine, similar synthetic 
strategies are not always viable, and alternative routes must be explored (as seen in 
attempts reproduce Jia’s N-oxidation conditions in intermediate 2-165). 
The second half of the chapter discussed attempts towards fumimycin. Fumimycin was 
going to be accessed through a modified Diels-Alder/Plieninger indolization sequence 
however many attempts to form a benzofuranone failed. A potentially viable route has 
been found through compound 2-262. Lewis acid promoted cyclization could afford 
hemiacetal 2-263 which can then undergo a reduction to form benzofuran 2-264, or 
benzofuranone 2-265. This intermediate is also useful as a Paal-Knorr type procedure 
could also potentially be utilized to access indole 2-266. 
 
Scheme 2-53 Future work to access benzofurans, benzofuranones, or indoles  
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2.8 Experimental  
2.8.1 Formal synthesis of fargesine 
General considerations: 
All reactions were performed under an atmosphere of Ar unless otherwise indicated.  
Toluene, acetonitrile, N,N-dimethylformamide (DMF), and dichloromethane were dried 
and deoxygenated by passing the nitrogen purged solvents through activated alumina 
columns. All other reagents and solvents were used as purchased from Sigma Aldrich, 
Alfa Aesar, Caledon, Strem or VWR and used as received.  Reaction progress was 
monitored by TLC (EM Science, silica gel 60 F254), visualizing with UV light, and the 
plates developed with p-anisaldehyde stain.  Column chromatography was performed 
using silica gel (230-400 mesh, Silicycle Chemical Division Inc).   
NMR experiments were performed on Varian Mercury 400, Inova 400 MHz instruments 
with 13C operating frequencies of 100 MHz.  Chemical shifts are reported in ppm relative 
to the residual solvent signal (CDCl3, referenced to residual CHCl3 at δ = 7.26 for 1H and 
δ = 77.0 for 13C).  Coupling constants (J) are reported in Hz, and multiplicities of the 
signals are described using the following abbreviations: s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet, br = broad.  High resolution mass spectra (HRMS) 
were obtained on a Thermo Scientific DFS™ Magnetic Sector GC-HRMS.  Melting 
points were determined using a Gallenkamp melting point apparatus and are uncorrected.  
Infrared spectra were obtained as thin films on NaCl plates using a Bruker Vector 33 FT-
IR instrument and are reported in frequency of absorption (cm-1). 
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N-(8-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4,4-dimethoxy-4a,5,8,8a 
-tetra-hydronaphthalen-1(4H)-ylidene)-4-methylbenzenesulfonami- 
de (2-169): N-(4,4-dimethoxycyclohexa-2,5-dien-1-ylidene)-4-methyl -
benzenesulfonamide (2-160) (6.14 g, 20 mmol), tert-butyl(hexa-3,5-
dien-1-yloxy)dimethylsilane (2-161a) (12.74g, 60 mmol), toluene (20 mL, 1 mol/L), and 
butylated hydroxytoluene (< 10 mg) were placed into a glass pressure tube, and then the 
tube placed into a 140 °C oil bath. The reaction stirred for 24 hours, and the solvent 
removed in vacuo. The product was purified by trituration with cold hexanes, and 
isolated by filtration. Diels-Alder adduct 2-169 was then obtained (85%, 8.84 g, 17 
mmol) as a white solid (melting point: 97-98 °C); Rf = 0.56 (30% EtOAc/hexanes); 1H 
NMR (400 MHz, CDCl3) δ  7.76 (app d, J=8.6 Hz, 2 H), 7.30 - 7.22 (m, 3 H), 6.41 (app 
dd, J=10.6, 2.3 Hz, 1 H), 5.46 (s, 2 H), 3.56 (t, J=6.3 Hz, 2 H), 3.35 (t, J=3.7 Hz, 1 H), 
3.30 (s, 3 H), 3.25 (s, 3 H), 2.70 - 2.61 (m, 1 H), 2.55 - 2.46 (m, 1 H), 2.41 (s, 3 H), 2.09 - 
2.00 (m, 1 H), 1.95 - 1.83 (m, 2 H), 1.80 - 1.70 (m, 1 H), 0.85 (s, 9 H), -0.02 (s, 3 H), -
0.02 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.0, 143.2, 142.1, 138.7, 130.4, 129.3, 
126.8, 124.8, 123.7, 99.0, 61.6, 49.6, 47.6, 44.8, 44.8, 36.8, 35.4, 25.9, 24.3, 21.6, 18.2, -
5.4, -5.4; FT-IR (thin film, cm-1) νmax 3024, 2953, 2928, 2855, 1588, 1471, 1319, 1254, 
1156, 1091, 1053, 829, 777, 681, 561; HRMS calc’d for C27H41NO5SSi [M+] 519.2475; 
found 519.2492. 
 
N-(8-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4-methoxy-5,8-dihydro-
naphthalen-1-yl)-4-methylbenzenesulfonamide (2-170): Diels-Alder 
adduct 2-169 (8.84 g, 17 mmol) in toluene (20 mL, 0.85 mol/L), and 
butylated hydroxytoluene (<10 mg) were placed into a glass pressure 
tube, and then the tube was placed into a 160 °C oil bath. The reaction stirred for 24 
hours, and then the solvent removed in vacuo. The product was purified by trituration 
with cold hexanes, and isolated by filtration. Dihydronaphthalenamine 2-170 was 
obtained (94%, 7.79 g, 15.98 mmol) as a beige solid (melting point: 126-127); Rf = 0.58 
(30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 8.18 (s, 1 H), 7.42 - 7.35 (m, 3 H), 
7.11 (app d, J=8.2 Hz, 2 H), 6.75 (app d, J=8.6 Hz, 1 H), 5.80 (m, 1 H), 5.49 (ddd, J=9.5, 
6.0, 3.3 Hz, 1 H), 3.82 (s, 3 H), 3.58 (dt, J=11.3, 3.9 Hz, 1 H), 3.44 (dd, J=20.3, 5.9 Hz, 1 
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H), 3.21 (td, J=11.3, 2.3 Hz, 1 H), 2.88 - 2.75 (m, 2 H), 2.35 (s, 3 H), 1.63 - 1.51 (m, 1 
H), 1.15 - 1.04 (m, 1 H), 0.96 (s, 9 H), 0.20 (s, 3 H), 0.18 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 155.0, 142.7, 137.1, 135.1, 130.2, 129.2, 127.4, 126.8, 125.7, 124.9, 124.8, 
107.9, 60.4, 55.4, 38.6, 30.9, 26.1, 24.1, 21.4, 18.7, -4.9, -5.4; FT-IR (thin film, cm-1) 
νmax 3185, 3034, 2953, 2929, 2857, 1481, 1256, 1164, 1092, 1060, 838, 811, 668; 
HRMS calc’d for C26H37NO4SSi [M+] 487.2213; found 487.2215. 
 
N-(8-(2-((tert-butyldimethylsilyl)oxy)ethyl)-6,7-dihydroxy-4methoxy 
-5,6, 7,8 -tetrahydronaphthalen-1-yl)-4-methylbenzenesulfonamide 
(2-171): Dihydronaphthalenamine 2-170 (9.75 g, 20 mmol) was 
dissolved in a 4:3 tetrahydrofuran/water mixture (114:86 mL, 0.1 mol/L 
total), and a small crystal of osmium tetroxide was added.  The reaction mixture was 
stirred for 5 minutes at room temperature, and then N-methylmorpholine-N-oxide (2.81 
g, 24 mmol) was added. The reaction stirred for 16 hours before solid sodium sulfite 
(9.08 g, 72 mmol) was added and stirred for an additional 10 minutes. The mixture was 
diluted with H2O, and then extracted with ethyl acetate. The combined organic layers 
were washed with brine, and then dried with anhydrous MgSO4. Removal of the solvent 
in vacuo gave crude diol 2-171 as a brown foam that did not require further purification 
for the next step (a quantitative yield was assumed for next step); Rf = 0.03 (30% 
EtOAc/hexanes); HRMS calc’d for C26H39NO6SSi [M+] 521.2267; found 521.2253. 
 
2-(3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-hydroxy-5-meth- 
oxy-1-tosylindolin-4-yl)acetaldehyde (2-172): To a vigorously 
stirred slurry of NaIO4/SiO2 (42.86 g, 30 mmol) in 
dichloromethane (92 mL, 0.33 mol/L) was added a solution of 
crude diol 2-171 (assumed 20 mmol) in dichloromethane (480 mL, 0.04 mol/L) dropwise 
at room temperature over 30 minutes. After 2 hours of stirring, the solution was filtered 
to remove NaIO4/SiO2, and the solvent removed in vacuo. The crude material was then 
purified by flash column chromatography on silica gel (50% EtOAc/hexanes) to give 
hemiaminal 2-172 (91%, 9.48 g, 18.20 mmol) as a yellow foam; Rf = 0.33 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 9.62 (t, J=1.8 Hz, 1 H), 7.72 (app d, 
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J=8.2 Hz, 2 H), 7.45 (app d, J=9.0 Hz, 1 H), 7.23 (app d, J=8.2 Hz, 2 H), 6.76 (app d, 
J=9.0 Hz, 1 H), 5.64 (d, J=3.9 Hz, 1 H), 3.77 (s, 3 H), 3.64 - 3.45 (m, 4 H), 3.13 (dd, 
J=10.9, 2.7 Hz, 1 H), 3.03 (d, J=3.5 Hz, 1 H), 2.37 (s, 3 H), 1.34 (dtd, J=14.8, 6.3, 6.3, 
2.7 Hz, 1 H), 0.91 (s, 9 H), 0.78 - 0.68 (m, 1 H), 0.06 (s, 3 H), 0.05 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 199.2, 154.9, 144.2, 136.0, 134.9, 132.9, 129.8, 126.8, 118.7, 114.0, 
109.9, 90.6, 60.5, 55.9, 45.6, 41.9, 41.9, 35.7, 25.8, 21.5, 18.2, -5.5, -5.5; FT-IR (thin 
film, cm-1) νmax 3483, 2952, 2929, 2856, 1724, 1480, 1353, 1249, 1166, 1093, 1006, 
913, 837, 743, 667; HRMS calc’d for C26H37NO6SSi [M+] 519.2111; found 519.2111. 
 
2-(3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-5-methoxy-1-tosyl-
1H-indol-4-yl)acetaldehyde (2-162a): Hemiaminal 2-172 (1.5 g, 
2.88 mmol) and camphorsulfonic acid (689 mg, 2.96 mmol) in 
toluene (25 mL, 0.12 mol/L) were stirred at room temperature for 
1 hour. After which sodium bicarbonate (1.12 g, 8.88 mmol) was added to the mixture 
and the reaction was stirred for an additional 10 minutes. The mixture was diluted with 
H2O, and then extracted with ethyl acetate. The combined organic layers were washed 
with brine, and then dried with anhydrous MgSO4. Indole 2-162a did not require further 
purification for the next step (a quantitative yield was assumed for next step) However, 
the indole can be purified by flash column chromatography on silica gel (30% 
EtOAc/hexanes) to give the indole 2-162a (96%, 1.39 g, 2.76 mmol) as a light brown 
foam; Rf = 0.46 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 9.64 (t, J=1.8 Hz, 
1 H), 7.91 (app d, J=9.0 Hz, 1 H), 7.72 (app d, J=8.2 Hz, 2 H), 7.40 (s, 1 H), 7.20 (app d, 
J=8.2 Hz, 2 H), 6.94 (app d, J=9.0 Hz, 1 H), 4.00 (d, J=2.0 Hz, 2 H), 3.87 (t, J=6.4 Hz, 2 
H), 3.83 (s, 3 H), 2.91 (td, J=6.5, 1.0 Hz, 2 H), 2.34 (s, 3 H), 0.87 (s, 9 H), 0.01 (s, 6 H); 
13C NMR (100 MHz, CDCl3) δ 200.1, 154.0, 144.7, 135.2, 131.0, 130.6, 129.8, 126.8, 
125.7, 119.8, 113.3, 113.1, 108.7, 62.6, 56.4, 41.1, 30.6, 25.9, 21.5, 18.2, -5.4; FT-IR 
(thin film, cm-1 ) νmax 2953, 2928, 2856, 1723, 1463, 1422, 1255, 1174, 1094, 913, 837, 
743, 666; HRMS calc’d for C26H35NO5SSi [M+] 501.2005; found 501.2020. 
 
2-(3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-5-methoxy-1-tosyl-
1H-indol-4-yl)acetic acid (2-173): Crude indole 2-162a was 
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dissolved in a 8:3:1 tetrahydrofuran/t-butanol/water mixture (14:5.25:1.75 mL, 0.14 
mol/L total). At room temperature, sodium dihydrogen phosphate (1.04 g, 8.64 mmol) 
and 2-methyl-2-butene (2.44 mL, 23.04 mmol) were added to the reaction mixture, 
followed by sodium chlorite (781 mg, 8.64 mmol). The reaction stirred for 3 hours and 
then diluted with a saturated aqueous solution of sodium bisulfite (pre-chilled to 0 °C). 
The mixture was then extracted with diethyl ether, and the combined organic layers were 
washed with brine, and then dried with anhydrous MgSO4. The solvent was removed in 
vacuo, and the product was purified by crystallization (DCM/hexanes) and filtered to 
obtain indole acid 2-173 as a white solid (melting point: 127-128 °C) in a 70% yield over 
two steps (1.04 g, 2.00 mmol); Rf = 0.03 (30% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3) δ 7.88 (app d, J=9.4 Hz, 1 H), 7.71 (app d, J=8.6 Hz, 2 H), 7.39 (s, 1 H), 7.19 
(app d, J=8.2 Hz, 2 H), 6.92 (app d, J=9.4 Hz, 1 H), 4.00 (s, 2 H), 3.88 (t, J=6.6 Hz, 2 H), 
3.82 (s, 3 H), 2.94 (t, J=6.3 Hz, 2 H), 2.33 (s, 3 H), 0.86 (s, 9 H), -0.01 (s, 6 H); 13C 
NMR (100 MHz, CDCl3) δ 177.3, 154.0, 144.7, 135.2, 130.7, 130.4, 129.8, 126.7, 125.6, 
119.8, 114.3, 113.2, 108.9, 62.8, 56.6, 31.5, 30.3, 25.9, 21.5, 18.2, -5.5; FT-IR (thin film, 
cm-1 ) νmax 2953, 2940, 2857, 1710, 1653, 1423, 1368, 1257, 1174, 1094, 913, 835, 
740, 667, 542; HRMS calc’d for C26H35NO6SSi [M+] 517.1954; found 517.1928. 
 
methyl ((3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-5-methoxy-
1-tosyl-1H-indol-4-yl)methyl)carbamate (2-163b): Indole acid 
2-173 (1g, 1.93 mmol) was placed in dry toluene (7.7 mL, 0.25 
mol/L), along with triethylamine (400 μL, 2.9 mmol) and 
diphenylphosphoryl azide (622 μL, 2.9 mmol), and heated to reflux for 30 minutes. The 
reaction was then cooled for a few minutes and methanol was slowly added to the 
reaction flask (3.9 mL, 0.13 mol/L). The reaction was heated to reflux again for another 
30 minutes, and then the contents of the flask were transferred to a sealed tube (another 
3.9 mL of methanol were used to rinse the original flask) and heated to 155 °C for 16 
hours.  The contents of the sealed tube were diluted with saturated NaHCO3(aq), and then 
extracted with ethyl acetate. The combined organic layers were washed with brine, and 
then dried with anhydrous MgSO4. Removal of the solvent in vacuo gave crude Curtius 
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product 2-163b (1.01 g) as a brown oil that was used crude for the next step; HRMS 
calc’d for C27H38N2O6SSi [M+] 546.2220; found 546.2215.  
 
methyl((3-(2-hydroxyethyl)-5-methoxy-1-tosyl-1H-indol-4-yl)me- 
thyl) carbamate (2-163c): Crude 2-163b (1.01 g) was dissolved in 
1.0 molar tetrabutylammonium fluoride solution in THF (7.4 mL, 
3.83 mmol), and stirred at room temperature for 20 hours. The 
reaction was then diluted in water, and then extracted with ethyl acetate. The combined 
organic layers were washed with brine, and then dried with anhydrous MgSO4. The 
product was then purified by flash column chromatography on silica gel (100% EtOAc) 
to give indole 2-163c in 66% yield over the two steps (554 mg, 1.27 mmol) as a white 
solid; Rf = 0.31 (100% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.91 (app d, 
J=9.0 Hz, 1 H), 7.71 (app d, J=8.2 Hz, 2 H), 7.41 (s, 1 H), 7.20 (app d, J=8.2 Hz, 2 H), 
6.92 (app d, J=9.0 Hz, 1 H), 5.39 (br s, 1 H), 4.64 (br d, J=5.9 Hz, 2 H), 3.87 (s, 3 H), 
3.81 (br s, 2 H), 3.63 (s, 3 H), 3.18 (br t, J=6.8 Hz, 2 H), 2.33 (s, 3 H); 13C NMR (100 
MHz, CDCl3) δ 157.1, 154.8, 144.8, 135.0, 130.8, 129.8, 129.6, 126.7, 126.3, 119.3, 
117.9, 113.8, 108.6, 62.4, 56.3, 52.2, 36.5, 30.6, 21.6; FT-IR (thin film, cm-1 ) νmax 
3407, 2953, 1701, 1519, 1458, 1422, 1364, 1257, 1173, 1062, 913, 736, 668; HRMS 
calc’d for C21H24N2O6S [M+] 432.1355; found 432.1349. 
 
2-(5-methoxy-4-(((methoxycarbonyl)amino)methyl)-1-tosyl-1H-
indol-3-yl)ethyl methanesulfonate (2-163d): Indole 2-163c (200 
mg, 0.46 mmol) was dissolved in dichloromethane (15 ml, 0.03 
mol/L) and cooled to 0 °C. A few crystals of DMAP were added 
along with triethylamine (194 μL, 1.4 mmol). Methanesulfonyl chloride (143 μL, 1.85 
mmol) was added drop wise. The reaction stirred at 0 °C for 30 minutes and then diluted 
with water. The mixture was then extracted with dichrlomethane, and the combined 
organic layers were washed with brine, and then dried with anhydrous MgSO4. The 
solvent was removed in vacuo, and the product was purified by crystallization 
(DCM/hexanes) and filtered to obtain indole 2-163d (83%, 196 mg, 0.38 mmol) as a 
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white solid (melting point: 127-128 °C); Rf = 0.49 (100% EtOAc); 1H NMR (400 MHz, 
CDCl3) δ 7.91 (app d, J=9.0 Hz, 1 H), 7.72 (app d, J=8.2 Hz, 2 H), 7.45 (s, 1 H), 7.21 
(app d, J=8.2 Hz, 2 H), 6.93 (app d, J=9.4 Hz, 1 H), 5.32 (br s, 1 H), 4.57 (br d, J=5.9 Hz, 
2 H), 4.52 (br t, J=6.3 Hz, 2 H), 3.86 (s, 3 H), 3.60 (s, 3 H), 3.46 (br t, J=6.3 Hz, 2 H), 
2.93 (s, 3 H), 2.33 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 156.8, 154.7, 144.9, 134.8, 
130.5, 129.9, 129.1, 126.8, 126.5, 118.0, 117.4, 113.7, 108.8, 68.7, 56.3, 52.1, 37.4, 36.6, 
26.7, 21.5; FT-IR (thin film, cm-1 ) νmax 3399, 2938, 1717, 1558, 1423, 1354, 1258, 
1173, 1131, 985, 913, 743, 668; HRMS calc’d for C22H26N2O8S2 [M+] 510.1131; found 
510.1133. 
 
methyl 9-methoxy-6-tosyl-1,3,4,6-tetrahydro-2H-azepino[5,4,3-
cd]indole-2-carboxylate (2-164): Indole 2-163d  (840 mg, 1.65 mmol) 
was dissolved in dry DMF (6.6 ml, 0.25 mol/L), and added dropwise to 
a room temperature solution of NaH (60% NaH in mineral oil) (197 mg, 
4.94 mmol) in dry DMF (7.9 mL, 0.62 mol/L). After the reaction stirred 
for three hours at room temperature, the mixture was diluted with water, and extracted 
with ethyl acetate. The combined organic layers were washed with brine, and then dried 
with anhydrous MgSO4. Removal of the solvent in vacuo gave crude 2-164 (600 mg) as a 
brown oil that was used crude for the next step; Rf = 0.65 (100% EtOAc); HRMS calc’d 
for C21H22N2O5S [M+] 414.1249; found 414.1256. A crude 
1H NMR spectrum is 
provided as a reference: 1H NMR (400 MHz, CDCl3) δ 7.84 (t, J=8.8 Hz, 1H), 7.71 (t, 
J=7.6 Hz, 2H), 7.31 (d, J=10.6 Hz, 1H), 7.19 (d, J=8.2 Hz, 2H), 6.89 (dd, J=9.0, 7.0 Hz, 
1H), 4.83 (d, J=20.7 Hz, 2H), 3.84 (d, J=3.8 Hz, 3H), 3.70-3.63 (m, 6H), 3.10-3.01 (m, 
2H), 2.33 (s, 3H). 
 
methyl 9-methoxy-1,3,4,6-tetrahydro-2H-azepino[5,4,3-cd]indole-2-
carboxylate (2-174): Crude indole 2-164 (600 mg) was dissolved in 1.0 
molar tetrabutylammonium fluoride solution in THF (10 mL, 6.9 mmol) 
and heated to 130 °C in a microwave reactor for 25 minutes. The 
reaction mixture was diluted with water, and then extracted with ethyl acetate. The 
combined organic layers were washed with brine, and then dried with anhydrous MgSO4. 
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Removal of the solvent in vacuo gave crude 2-168 which was not further purified for the 
next step (a quantitative yield was assumed for next step); HRMS calc’d for C14H16N2O3 
[M+] 260.1161; found 260.1152. 
 
9-methoxy-2-methyl-2,3,4,6-tetrahydro-1H- azepino [5,4,3-cd ]indole 
(2-165): Crude indole 2-1174 (assumed 1.45 mmol) was dissolved in dry 
THF (29 mL, 0.05 mol/L), and to the reaction flask at room temperature 
was added LAH (549 mg, 14.5 mol). The reaction was then heated to reflux, and 
continued heating for three hours. After this time the reaction was cooled to 0 °C, and to 
the reaction flask was added (drop-wise) for every gram of LAH, a milliliter of water, a 
milliliter of 20% NaOH(aq), and lastly three milliliters of water. The reaction was allowed 
to cool to room temperature for 30 minutes, and then filtered through celite. Further 
purification of the product by flash column chromatography (100% EtOAc) afforded 
indole 2-165 as a yellow solid in a 75% yield over the three steps (265 mg, 1.22 mmol); 
Rf = 0.63 (100% EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.95 (br s, 1 H), 7.16 (d, J=9.0 
Hz, 1 H), 6.97 (d, J=2.0 Hz, 1 H), 6.87 (d, J=8.6 Hz, 1 H), 4.18 (s, 2 H), 3.84 (s, 3 H), 
3.07 (s, 4 H), 2.61 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 147.9, 133.4, 127.8, 123.8, 
114.3, 113.6, 112.5, 111.5, 59.6, 59.4, 45.7, 27.1; FT-IR (thin film, cm-1 ) νmax 3049, 
2919, 2771, 1579, 1458, 1369,1265, 1236, 1130, 1055, 972, 902, 782; HRMS calc’d for 
C13H16N2O [M+] 216.1263; found 216.1256. 
 
methyl 9-hydroxy-6-tosyl-1,3,4,6-tetrahydro-2H-azepino[5,4,3-
cd]indole-2-carboxylate (2-178): Crude indole 2-164 (200 mg, 0.48 
mmol) was dissolved in dry dichloromethane (12 mL, 0.04 mol/L) and 
cooled to -78 °C. To this solution was added 1.0 molar boron tribromide 
in dichloromethane (1.45 mL, 1.45 mmol) drop wise. The reaction was 
then allowed to stir to room temperature over 12 hours. After this time the reaction was 
diluted with water and extracted with dichloromethane. The combined organic layers 
were washed with brine and then dried with anhydrous MgSO4. Removal of the solvent 
in vacuo gave crude 2-178 (188 mg) as a purple solid. The crude material must be 
immediately carried forward to the next step; Rf = 0.62 (100% EtOAc); A crude 1H 
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NMR spectrum is provided as a reference: 1H NMR (600 MHz, CDCl3) δ 7.71 (br t, 
J=8.5 Hz, 2 H), 7.31 (br d, J=18.8 Hz, 1 H), 7.21 (br d, J=6.5 Hz, 2 H), 6.74 (br dd, 
J=13.2, 8.5 Hz, 1 H), 4.85 (br d, J=16.4 Hz, 2 H), 3.73-3.65 (m, 6 H), 3.10-3.03 (m, 2 H), 
2.35 (s, 3 H) 
 
2-methyl-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-9-ol (2-176): 
Crude indole 2-178 (75 mg, 0.19 mmol) was dissolved in dry THF (3.75 
mL, 0.05 mol/L), and to this was added LAH (71 mg, 1.88 mmol). The 
reaction was heated at 60 °C in the microwave for three hours. After this 
time the reaction was cooled to 0 °C, and to the reaction flask was added (drop-wise) for 
every gram of LAH, a milliliter of water, a milliliter of 20% NaOH(aq), and lastly three 
milliliters of water. The reaction was allowed to cool to room temperature for 30 minutes, 
and then filtered through celite. Further purification of the product by flash column 
chromatography (75% DCM/Methanol, and 5% NH4OH) afforded indole 2-176 (77%, 29 
mg, 1.44 mmol)as a yellow oil; Rf = 0.5 (75% DCM/Methanol, and 5% NH4OH); 1H 
NMR (400 MHz, CD3OD) δ 7.08 (app d, J=8.6 Hz, 1 H), 6.99 (s, 1 H), 6.67 (app d, 
J=8.6 Hz, 1 H), 4.92 (s, 3 H), 4.24 (s, 2 H), 3.20 - 3.17 (m, 2 H), 3.14 - 3.07 (m, 2 H), 
2.66 (s, 3 H); 13C NMR (100 MHz, CD3OD) δ 147.9, 133.4, 127.8, 123.8, 114.3, 113.6, 
112.5, 111.5, 59.6, 59.4, 45.7, 27.1; FT-IR (thin film, cm-1 ) νmax 3393, 2922, 2532, 
1684, 1646, 1436, 1363, 1243, 793; HRMS calc’d for C12H14N2O [M+] 202.1106; found 
202.1098. 
 
tert-butyl (2-methyl-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-
9-yl) carbonate (2-158): Crude indole 2-172 (10 mg, 0.05 mmol), and 
DMAP (3 mg, 0.03 mmol), were dissolved in dry DMF (3 mL, 0.02 
mol/L). Di-tert-butyl dicarbonate (13 mg, 0.06 mmol) was added and 
the reaction stirred for 16 hours and then diluted with water, and extracted with ethyl 
acetate. The combined organic layers were washed with brine, dried with anhydrous 
MgSO4 and the solvent removed in vacuo gave crude 2-158 which was further 
purification was done by flash column chromatography (95% DCM/Methanol) afforded 
2-158 (41%, 6 mg, 0.02 mmol) as a yellow oil, with 1H NMR spectral data matching the 
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literature;47 1H NMR (400 MHz, CDCl3) δ 8.18 (br s, 1 H), 7.19 (d, J=8.6 Hz, 1 H), 7.01 
(d, J=1.2 Hz, 1 H), 6.91 (d, J=8.6 Hz, 1 H), 4.18 (s, 2 H), 3.19 (t, J=5.1 Hz, 2 H), 3.10 (t, 
J=5.1 Hz, 2 H), 2.57 (s, 3 H), 1.56 (s, 9 H). 
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2.8.2 Progress towards the total synthesis of fumimycin 
General considerations: 
All reactions were performed under an atmosphere of Ar unless otherwise indicated.  
Toluene, acetonitrile, N,N-dimethylformamide (DMF), and dichloromethane were dried 
and deoxygenated by passing the nitrogen purged solvents through activated alumina 
columns. All other reagents and solvents were used as purchased from Sigma Aldrich, 
Alfa Aesar, Caledon, Strem or VWR and used as received.  Reaction progress was 
monitored by TLC (EM Science, silica gel 60 F254), visualizing with UV light, and the 
plates developed with p-anisaldehyde stain.  Column chromatography was performed 
using silica gel (230-400 mesh, Silicycle Chemical Division Inc).   
NMR experiments were performed on Varian Mercury 400, Inova 400 MHz instruments 
with 13C operating frequencies of 100 MHz.  Chemical shifts are reported in ppm relative 
to the residual solvent signal (CDCl3, referenced to residual CHCl3 at δ = 7.26 for 1H and 
δ = 77.0 for 13C).  Coupling constants (J) are reported in Hz, and multiplicities of the 
signals are described using the following abbreviations: s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet, br = broad.  High resolution mass spectra (HRMS) 
were obtained on a Thermo Scientific DFS™ Magnetic Sector GC-HRMS.  Melting 
points were determined using a Gallenkamp melting point apparatus and are uncorrected.  
Infrared spectra were obtained as thin films on NaCl plates using a Bruker Vector 33 FT-
IR instrument and are reported in frequency of absorption (cm-1). High-pressure reactions 
were carried out on a LECOTM Tempres High-Pressure chemical reactor. 
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4,4-dimethoxy-8-methyl-4a,5,8,8a-tetrahydronaphthalen-1(4H)-one (2-
243): Quinone ketal 2-242 (462.5 mg, 3 mmol) and piperylene (613 mg, 9 
mmol) were measured into a length of heat shrinkable Teflon tubing, which 
was closed at one end with a brass clamp. Dichloromethane (2 mL, 1.5 mol/L) was then 
added to the mixture and the tube was sealed with another clamp and placed in a LECO 
Tempres high-pressure chemical reactor, and pressurized at room temperature. After 12 
hours the mixture was depressurized and the solvent removed. The crude 2-243 white 
solid material could be used without further purification for the subsequent step; Rf = 
0.53 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 6.48 (dd, J=10.6, 2.3 Hz, 1 
H), 5.87 (d, J=10.2 Hz, 1 H), 5.63 - 5.43 (m, 2 H), 3.33 (s, 3 H), 3.26 (s, 3 H), 3.04 (t, 
J=3.9 Hz, 1 H), 2.74 - 2.63 (m, 1 H), 2.50 - 2.37 (m, 1 H), 2.11 - 1.85 (m, 2 H), 1.39 (d, 
J=7.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 200.5, 142.3, 132.3, 130.9, 123.7, 99.6, 
49.7, 48.1, 47.6, 43.7, 33.8, 24.1, 18.6; FT-IR (thin film, cm-1 ) νmax 3021, 2933, 2831, 
1690, 1454, 1377, 1193, 1107, 938, 601, 561, 435; HRMS calc’d for C13H18O3 [M+] 
222.1256; found 222.1265. 
 
4-methoxy-8-methyl-5,8-dihydronaphthalen-1-ol (2-244): The crude 
mixture of 2-243, was assumed to be a quantitative yield (3 mmol) and was 
dissolved in dry toluene (30 mL, 0.1 mol/L). To the reaction flask was added 
p-Toluenesulfonic acid (< 10 mg), and the reaction stirred for 30 minutes at room 
temperature. After this time, solid NaHCO3 (1 g) was added to the flask and was stirred 
for another 10 minutes. The mixture was diluted with H2O, and then extracted with ethyl 
acetate. The combined organic layers were washed with brine, and then dried with 
anhydrous MgSO4. Purification by flash chromatography on silica gel (30% 
EtOAc/hexanes) gave 2-244 (76% two steps, 431 mg, 2.26 mmol) as an orange solid; Rf 
= 0.50 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 6.64 - 6.57 (m, 2 H), 5.95 - 
5.86 (m, 2 H), 4.54 (d, J=1.6 Hz, 1 H), 3.79 (s, 3 H), 3.66 - 3.53 (m, 1 H), 3.43 - 3.34 (m, 
1 H), 3.19 - 3.08 (m, 1 H), 1.28 (d, J=7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
150.9, 146.6, 130.5, 128.3, 124.5, 122.9, 112.2, 107.7, 55.7, 29.3, 24.3, 22.0; FT-IR (thin 
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film, cm-1 ) νmax 3413, 3027, 2957, 2925, 2866, 1488, 1460, 1257, 1108, 1074, 799, 
724, 704; HRMS calc’d for C12H14O3 [M+] 190.0994; found 190.0997. 
 
tert-butyl((4-methoxy-8-methyl-5,8-dihydronaphthalen-1-
yl)oxy)dimethylsilane (2-245): Compound 2-244 (813 mg, 4.3 mmol) and 
imidazole (350 mg, 5.13 mmol) were dissolved in dimethylformamide (10.5 
mL, 0.25 mol/L). Slowly, tert-butyldimethylsilyl chloride (804 mg, 5.13 mmol) was 
added to the reaction flask and the mixture stirred for 12 hours at room temperature. The 
mixture was diluted with H2O, and then extracted with ethyl acetate. The combined 
organic layers were washed with brine, and then dried with anhydrous MgSO4. 
Purification by flash chromatography on silica gel (30% EtOAc/hexanes) gave 2-245 
(58%, 759 mg, 2.59 mmol) as a yellow oil; Rf = 0.63 (30% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3) δ 6.64-6.56 (m, 2H), 5.92-5.85 (m, 2H), 3.77 (s, 3H), 3.59-3.54 (m, 1 
H), 3.38-3.08 (m, 2H), 1.22 (d, J=7.0 Hz, 3H), 1.02 (s, 9H), 0.27 (s, 3H), 0.18 (s, 3H) ; 
13C NMR (100 MHz, CDCl3) δ 150.9, 146.6, 132.2, 131.0, 124.5, 122.8, 115.0, 107.1, 
55.5, 29.8, 25.9, 24.5, 22.2, 18.2, -3.8, -4.3; FT-IR (thin film, cm-1 ) νmax 3027, 2956, 
2929, 2851, 1594, 1479, 1255, 1110, 1075, 1044, 862, 839, 779, 734, 698; HRMS calc’d 
for C18H28O2Si [M+] 304.1859; found 304.1873. 
 
8-((tert-butyldimethylsilyl)oxy)-5-methoxy-1-methyl-1,2,3,4-
tetrahydronaphthalene-2,3-diol (2-246): Compound 2-245 (748 mg, 
2.46 mmol) was dissolved in a 4:3 tetrahydrofuran/water mixture 
(14:11 mL, 0.1 mol/L total), and a small crystal of osmium tetroxide was added.  The 
reaction mixture was stirred for 5 minutes at room temperature, and then N-
methylmorpholine-N-oxide (345 mg, 2.95 mmol) was added. The reaction stirred for 16 
hours before solid sodium sulfite (1.12 g, 8.85 mmol) was added and stirred for an 
additional 10 minutes. The mixture was diluted with H2O, and then extracted with ethyl 
acetate. The combined organic layers were washed with brine, and then dried with 
anhydrous MgSO4. Removal of the solvent in vacuo gave 2-246 (93%, 774 mg, 2.30 
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mmol), with no further purification required, as a white solid; Rf = 0.16 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 6.59 (app dd, J=23.8, 8.6 Hz, 2 H), 4.12 
(ddd, J=10.3, 6.9, 2.3 Hz, 1 H), 3.96 (dd, J=2.3, 2.3 Hz, 1 H), 3.76 (s, 3 H), 3.30 (qd, 
J=7.2, 2.5 Hz, 1 H), 3.16 (dd, J=17.2, 6.6 Hz, 1 H), 2.53 (dd, J=17.4, 10.4 Hz, 1 H), 1.20 
(d, J=7.4 Hz, 3 H), 1.01 (s, 9 H), 0.26 (s, 3 H), 0.20 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 151.0, 147.7, 129.7, 123.4, 115.3, 107.8, 74.2, 66.0, 55.5, 37.0, 27.6, 25.8, 19.1, 
18.2, -3.9, -4.4; FT-IR (thin film, cm-1 ) νmax 3382 2957, 2930, 2856, 1477, 1252, 
1103, 1058, 1029, 913, 861, 839, 743; HRMS calc’d for C18H30O4Si [M+] 338.1913; 
found 338.1924. 
 
2-(6-((tert-butyldimethylsilyl)oxy)-3-methoxy-2-(2 oxoethyl)phenyl) 
propanal (2-247): To a vigorously stirred slurry of NaIO4/SiO2 (5.06 g, 
3.5 mmol) in dichloromethane (16 mL, 0.22 mol/L) was added a solution 
of diol 2-246 (800 mg, 2.36 mmol) in dichloromethane (44 mL, 0.05 mol/L) dropwise at 
room temperature over 30 minutes. After 2 hours of stirring, the solution was filtered to 
remove NaIO4/SiO2, and the solvent removed in vacuo. The crude material was then 
purified by flash chromatography on silica gel (30% EtOAc/hexanes) to give 2-247 
(79%, 627 mg, 1.86 mmol) as a yellow oil; Rf = 0.46 (30% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3) δ 9.66 - 9.64 (two overlapping aldehyde peaks, 2 H), 6.78 (app dd, 
J=24.2, 9.0 Hz, 2 H), 3.78 (s, 3 H), 3.74 - 3.60 (m, 2 H), 3.52 (q, J=7.0 Hz, 1 H), 1.33 (d, 
J=7.0 Hz, 3 H), 0.96 (s, 9 H), 0.25 (s, 3 H), 0.22 (s, 2 H); 13C NMR (100 MHz, CDCl3) δ 
201.6, 199.3, 151.9, 147.5, 130.9, 121.7, 117.0, 109.8, 55.9, 46.5, 41.9, 25.9, 18.5, 13.3, -
4.0, -4.2; FT-IR (thin film, cm-1 ) νmax 2932, 2886, 2858, 1727, 1592, 1477, 1248, 
1211, 1051, 840, 782; HRMS calc’d for C18H28O4Si [M+] 336.1757; found 336.1766. 
   
4-methoxy-8-methyl-5,8-dihydronaphthalen-1-yl acetate (2-249):  The 
crude mixture of 2-243, was assumed to be a quantitative yield (3 mmol) and 
was dissolved in acetic anhydride (3 mL, 1 mol/L). One drop of sulfuric acid 
was then added at room temperature and the reaction stirred for 1 minute. The reaction 
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mixture was then placed into an aqueous NaOH solution (0.1 mol/L), and then extracted 
with diethyl ether. The combined organic layers were washed with brine, and then dried 
with anhydrous MgSO4. Removal of the solvent in vacuo gave 2-249 (86%, 600 mg, 2.58 
mmol), with no further purification required, as a white foam; Rf = 0.47 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 6.93 (d, J=9.0 Hz, 1 H), 6.73 (d, J=9.0 
Hz, 1 H), 5.95 - 5.85 (m, 2 H), 3.83 (s, 3 H), 3.50 - 3.36 (m, 2 H), 3.20 - 3.10 (m, 1 H), 
2.34 (s, 3 H), 1.24 (d, J=7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 169.8, 154.2, 
141.6, 132.9, 129.9, 124.3, 122.7, 119.8, 107.2, 55.3, 29.5, 24.1, 22.3, 20.8; FT-IR (thin 
film, cm-1 ) νmax 3029, 2960, 2934, 2837, 1758, 1589, 1479, 1368, 1338, 1253, 1209, 
1108, 1074, 1029, 885, 807, 203; HRMS calc’d for C14H16O3 [M+] 232.1099; found 
232.1106. 
 
6,7-dihydroxy-4-methoxy-8-methyl-5,6,7,8-tetrahydronaphthalen-1-
yl acetate (2-250): Compound 2-249 (307 mg, 1.32 mmol) was 
dissolved in a 4:3 tetrahydrofuran/water mixture (7.5:5.5 mL, 0.1 mol/L 
total), and a small crystal of osmium tetroxide was added.  The reaction mixture was 
stirred for 5 minutes at room temperature, and then N-methylmorpholine-N-oxide (185 
mg, 1.59 mmol) was added. The reaction stirred for 16 hours before solid sodium sulfite 
(601 mg, 4.77 mmol) was added and stirred for an additional 10 minutes. The mixture 
was diluted with H2O, and then extracted with ethyl acetate. The combined organic layers 
were washed with brine, and then dried with anhydrous MgSO4. Removal of the solvent 
in vacuo gave 2-250 (100%, 350 mg, 1.32 mmol), with no further purification required, 
as a white foam; Rf = 0.03 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 6.89 
(app d, J=8.6 Hz, 1 H), 6.70 (app d, J=9.0 Hz, 1 H), 4.08 (ddd, J=10.1, 6.7, 2.3 Hz, 1 H), 
3.90 (dd, J=2.3 Hz, 1 H), 3.81 (s, 3 H), 3.18 - 3.07 (m, 2 H), 2.52 (dd, J=17.2, 10.2 Hz, 1 
H), 2.30 (s, 4 H), 1.17 (d, J=7.4 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 170.0, 154.6, 
142.7, 130.9, 123.7, 120.4, 107.9, 73.7, 65.7, 55.5, 36.9, 27.6, 21.0, 19.4; FT-IR (thin 
film, cm-1 ) νmax 3404, 2935, 2837, 1751, 1590, 1478, 1369, 1207, 1055, 913, 742; 
HRMS calc’d for C14H18O5 [M+] 266.1154; found 266.1149. 
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4-methoxy-3-(2-oxoethyl)-2-(1-oxopropan-2-yl)phenyl acetate (2-251): 
To a vigorously stirred slurry of NaIO4/SiO2 (2.33 g, 1.63 mmol) in 
dichloromethane (7 mL, 0.23 mol/L) was added a solution of diol 2-250 
(290 mg, 1.09 mmol) in dichloromethane (20 mL, 0.05 mol/L) dropwise at room 
temperature over 30 minutes. After 2 hours of stirring, the solution was filtered to remove 
NaIO4/SiO2, and the solvent removed in vacuo. The crude material was then purified by 
flash chromatography on silica gel (50% EtOAc/hexanes) to give 2-251 (74%, 563 mg, 
0.81 mmol) as a yellow oil; Rf = 0.20 (30% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3) δ 9.66 (X of ABX, JAX=1.5 Hz, JBX=1.6 Hz, 1 H), 9.61 (s, 1 H), 7.05 (app d, 
J=9.0 Hz, 1 H), 6.89 (app d, J=9.0 Hz, 1 H), 3.82 (s, 3 H), 3.86 (A of ABX, JAB=17.1 Hz, 
JAX=1.5 Hz, 1 H), 3.68 (B of ABX, JAB=17.1 Hz, JBX=1.6 Hz, 1 H), 3.47 (q, J=6.8 Hz, 1 
H), 2.16 (s, 3 H), 1.25 (d, J=7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 200.1, 198.7, 
169.6, 155.5, 142.3, 131.8, 122.9, 121.6, 110.1, 55.9, 47.0, 41.5, 20.7, 13.0; FT-IR (thin 
film, cm-1 ) νmax 2981, 2940, 2839, 2726, 1763, 1725, 1590, 1477, 1370, 1271, 1199, 
1182, 1045, 815, 732; HRMS calc’d for C14H16O5 [M+] 264.0998; found 264.0992. 
 
4-methoxy-8-methyl-5,6,7,8-tetrahydronaphthalene-1,6,7-triol (2-
253): From acetate 2-250: Compound 2-250 (572 mg, 2.15 mmol) was 
dissolved in methanol (27 mL, 0.08 mol/L) at room temperature, and then 
potassium hydroxide (200 mg, 3.57 mmol) was added to the reaction flask. The reaction 
stirred for two hours. After this time, the mixture was diluted with brine, and then 
extracted with diethyl ether. The combined organic layers were then dried with 
anhydrous MgSO4, and removal of the solvent in vacuo gave 2-250 (88%, 422 mg, 1.88 
mmol), with no further purification required, as a brown foam; Rf = 0.0 (30% 
EtOAc/hexanes). 
From 2-244: Compound 2-244 (242 mg, 1.27 mmol) was dissolved in a 4:3 
tetrahydrofuran/water mixture (7.5:5.5 mL, 0.1 mol/L total), and a small crystal of 
osmium tetroxide was added.  The reaction mixture was stirred for 5 minutes at room 
temperature, and then N-methylmorpholine-N-oxide (176 mg, 1.5 mmol) was added. The 
reaction stirred for 16 hours before solid sodium sulfite (1.9 mg, 15 mmol) was added 
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and stirred for an additional 10 minutes. The mixture was diluted with H2O, and then 
extracted with ethyl acetate. The combined organic layers were washed with brine, and 
then dried with anhydrous MgSO4. Removal of the solvent in vacuo gave 2-253 (93%, 
266 mg, 1.19 mmol), with no further purification required, as a brown foam; Rf = 0.0 
(30% EtOAc/hexanes); 1H NMR (400 MHz, CD3OD) δ 6.59 (app dd, J=11.5, 8.8 Hz, 2 
H), 4.06 (ddd, J=10.7, 6.4, 2.0 Hz, 1 H), 3.90 (dd, J=2.3 Hz, 1 H), 3.76 (s, 3 H), 3.29 (qd, 
J=7.2, 2.7 Hz, 1 H), 3.03 (dd, J=17.0, 6.4 Hz, 1 H), 2.58 (dd, J=17.2, 10.9 Hz, 1 H), 1.24 
(d, J=7.0 Hz, 3 H); 13C NMR (100 MHz, CD3OD) δ 152.5, 151.4, 128.8, 125.9, 113.8, 
110.0, 76.2, 67.8, 57.0, 39.1, 28.9, 20.4; FT-IR (thin film, cm-1 ) νmax 3349, 2912, 
2486, 1481, 1436, 1255, 1089, 1054, 984; HRMS calc’d for C12H16O4 [M+] 224.1049; 
found 224.1048. 
 
2-(2-hydroxy-5-methoxy-3-methyl-2,3-dihydrobenzofuran-4-
yl)acetaldehyde (2-254): Triol 2-253 (427 mg, 1.9 mmol) was 
dissolved in a 3.4:1 tetrahydrofuran/water mixture  (135:40 mL, 0.01 
mol/L total) at room temperature, and to this was added NaIO4 (6.1 g, 28.6 mmol). The 
reaction was stirred at room temperature for 16 hours. The mixture was diluted with H2O, 
and then extracted with ethyl acetate. The combined organic layers were washed with 
brine, and then dried with anhydrous MgSO4. Removal of the solvent in vacuo gave 2-
254 (99%, 417 mg, 1.88 mmol), with no further purification required, as a yellow oil; Rf 
= 0.65 (100% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 9.68 (t, J=2.0 Hz, 1 H), 
6.75 (app d, J=20.7, 8.6 Hz, 2 H), 5.56 (d, J=3.1 Hz, 1 H), 3.77 (s, 3 H), 3.69 - 3.54 (m, 2 
H), 3.19 (q, J=7.3 Hz, 1 H), 3.11 (br d, J=4.3 Hz, 1 H), 1.59 (s, 3 H), 1.21 (d, J=7.4 Hz, 3 
H);13C NMR (100 MHz, CDCl3) δ 199.7, 152.7, 151.2, 131.9, 118.3, 110.1, 109.0, 107.0, 
56.1, 44.0, 29.7, 17.9; FT-IR (thin film, cm-1) νmax 3399, 2919, 2849, 2340, 1719, 
1480, 1463, 1439, 1227, 1078, 1035, 913, 804, 743; HRMS calc’d for C12H14O4 [M+] 
222.0892; found 222.0895. 
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9b-methoxy-6-methyl-6,9,9a,9b-tetrahydronaphtho[1,2-d][1,3]dioxol-
5(5aH)-one (2-260): Quinone ketal 2-223 (504.45 mg, 3 mmol) and  
piperylene (613 mg, 9 mmol) were measured into a length of heat 
shrinkable Teflon tubing, which was closed at one end with a brass clamp. 
Dichloromethane (3 mL, 1 mol/L) was then added to the mixture and the tube was sealed 
with another clamp and placed in a LECO Tempres high-pressure chemical reactor, and 
pressurized at room temperature. After 19 hours the mixture was depressurized and the 
solvent removed. Purification by flash chromatography on silica gel (30% 
EtOAc/hexanes) gave 2-260 (83%, 616 mg, 2.50 mmol) as a white solid; Rf = 0.52 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) 5.64 - 5.58 (m, 1 H), 5.55 - 5.48 (m, 3 H), 
5.28 (s, 1 H), 3.44 (s, 3 H), 3.00 (ddd, J=10.6, 6.7, 3.7 Hz, 1 H), 2.88 (dd, J=4.1 Hz, 1 H), 
2.47 - 2.58 (m, 1 H), 2.17 - 2.08 (m, 1 H), 1.95 - 1.83 (m, 1 H), 1.46 (d, J=7.4 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 198.7, 166.2, 132.7, 123.7, 105.1, 100.4, 98.2, 50.2, 45.4, 
38.6, 33.9, 24.2, 19.1; FT-IR (thin film, cm-1 ) νmax 3021, 2926, 2845, 1666, 1462, 
1405, 1352, 1305, 1253, 1179, 1098, 1029, 938, 917, 653; HRMS calc’d for C13H16O4 
[M+] 236.1049; found 236.1050. 
 
6-methyl-6,9-dihydronaphtho[1,2-d][1,3]dioxol-5-yl acetate (2-255): 
Diels-Alder adduct 2-260 (2.1 g, 8.88 mmol) was dissolved in acetic 
anhydride (8.9 mL, 1 mol/L). Three drops of sulfuric acid was then added 
at room temperature and the reaction stirred for 16 hours. The reaction mixture was then 
placed into an aqueous NaOH solution (0.1 mol/L), and then extracted with diethyl ether. 
The combined organic layers were washed with brine, and then dried with anhydrous 
MgSO4. Purification by flash chromatography on silica gel (30% EtOAc/hexanes) gave 
2-255 (73%, 1.59 g, 6.48 mmol) as a brown oil; Rf = 0.58 (30% EtOAc/hexanes); 1H 
NMR (400 MHz, CDCl3) δ 6.49 (s, 1 H), 5.97 (A of AB, J=8.1 Hz, 1 H), 5.95 (B of AB, 
J=8.1 Hz, 1 H), 5.91-5.81 (m, 2 H), 3.39-3.10 (m, 3 H), 2.31 (s, 3 H), 1.17 (d, J=7.0 Hz, 
3 H); 13C NMR (100 MHz, CDCl3) δ 169.9, 144.8, 142.5, 141.8, 131.1, 125.3, 121.5, 
116.9, 102.1, 101.5, 29.3, 23.5, 22.3, 20.9; FT-IR (thin film, cm-1) νmax 2963, 2871, 
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1761, 1646, 1469, 1370, 1334, 1203, 1174, 1057, 957, 893, 706; HRMS calc’d for 
C14H14O4 [M+] 246.0892; found 246.0898. 
 
7,8-dihydroxy-6-methyl-6,7,8,9-tetrahydronaphtho[1,2-
d][1,3]dioxol-5-yl acetate (2-256): Acetate 2-255 (738 mg, 3 mmol) 
was dissolved in a 4:3 tetrahydrofuran/water mixture (17:13 mL, 0.1 
mol/L total), and a small crystal of osmium tetroxide was added.  The reaction mixture 
was stirred for 5 minutes at room temperature, and then N-methylmorpholine-N-oxide 
(527 mg, 4.5 mmol) was added. The reaction stirred for 16 hours before solid sodium 
sulfite (1.13 g, 9 mmol) was added and stirred for an additional 10 minutes. The mixture 
was diluted with H2O, and then extracted with ethyl acetate. The combined organic layers 
were washed with brine, and then dried with anhydrous MgSO4. Removal of the solvent 
in vacuo gave 2-256 (89%, 749 mg, 2.67 mmol), with no further purification required, as 
a orange foam; Rf = 0.0 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 6.49 (s, 1 
H), 5.97 (A of AB, J=6.5 Hz, 1 H), 5.95 (B of AB, J=6.5 Hz, 1 H), 4.12 (ddd, J=10.2, 
6.8, 2.1 Hz, 1 H), 3.93 (dd, J=2.3 Hz, 1 H), 3.07 (qd, J=7.4, 3.1 Hz, 1 H), 3.03 (dd, 
J=16.8, 6.6 Hz, 1 H), 2.64 (dd, J=16.8, 10.2 Hz, 1 H), 2.29 (s, 3 H), 1.14 (d, J=7.4 Hz, 3 
H); 13C NMR (100 MHz, CDCl3) δ 169.9, 145.3, 143.1, 142.8, 122.9, 116.0, 102.6, 
101.6, 74.0, 65.1, 36.7, 27.0, 20.9, 19.5; FT-IR (thin film, cm-1 ) νmax 3372, 2901, 
1755, 1634, 1468, 1369, 1283, 1200, 1167, 1076, 1052, 905, 734; HRMS calc’d for 
C14H16O6 [M+] 280.0947; found 280.0944. 
 
6-methyl-6,7,8,9-tetrahydronaphtho[1,2-d][1,3]dioxole-5,7,8-triol 
(2-257): Acetate 2-256 (750 mg, 2.68 mmol) was dissolved in 
methanol (34 mL, 0.08 mol/L) at room temperature, and then 
potassium hydroxide (250 mg, 4.45 mmol) was added to the reaction flask. The reaction 
stirred for two hours. After this time, the mixture was diluted with brine, and then 
extracted with ethyl acetate. The combined organic layers were then dried with 
anhydrous MgSO4, and removal of the solvent in vacuo gave 2-257 (69%, 436 mg, 1.84 
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mmol), with no further purification required, as a white foam; Rf = 0.03 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CD3OD) δ 6.23 (s, 1 H), 5.80 (app dd, J=14.5, 1.2 
Hz, 2 H), 4.05 (ddd, J=10.8, 6.4, 2.0 Hz, 1 H), 3.86 (dd, J=2.2, 2.1 Hz, 1 H), 3.21 (qd, 
J=7.2, 2.7 Hz, 1 H), 2.90 - 2.60 (m, 2 H), 1.18 (d, J=7.0 Hz, 3 H); 13C NMR (100 MHz, 
CD3OD) δ 152.0, 147.1, 139.9, 119.8, 118.7, 102.6, 97.3, 76.5, 67.2, 38.8, 28.4, 20.4; 
FT-IR (thin film, cm-1 ) νmax 3407, 2914, 2510, 2244, 2074, 1643, 1471, 1366, 1296, 
1216, 1182, 1119, 1057, 973; HRMS calc’d for C12H14O5 [M+] 238.0841; found 
238.0838. 
 
7,8-dihydroxy-9b-methoxy-6-methyl-6,7,8,9,9a,9b-
hexahydronaphtho[1,2-d][1,3]dioxol-5(5aH)-one (2-261): Diels-
Alder adduct 2-260 (100 mg, 0.42 mmol) was dissolved in a 4:3 
tetrahydrofuran/water mixture (2.8:2.2 mL, 0.1 mol/L total), and a small crystal of 
osmium tetroxide was added.  The reaction mixture was stirred for 5 minutes at room 
temperature, and then N-methylmorpholine-N-oxide (60 mg, 0.51 mmol) was added. The 
reaction stirred for 16 hours before solid sodium sulfite (128 mg, 1.02 mmol) was added 
and stirred for an additional 10 minutes. The mixture was diluted with H2O, and then 
extracted with ethyl acetate. The combined organic layers were washed with brine, and 
then dried with anhydrous MgSO4. Removal of the solvent in vacuo gave 2-261 (88%, 
100 mg, 0.37 mmol), with no further purification required, as a brown foam; Rf = 0.03 
(30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 5.51 (d, J=10.9 Hz, 2 H), 5.33 (s, 
1 H), 3.99 (br d, J=2.3 Hz, 1 H), 3.65 (dd, J=11.3, 2.7 Hz, 1 H), 3.42 (s, 3 H), 3.11 (dt, 
J=12.5, 3.5 Hz, 1 H), 2.84 - 2.76 (m, 1 H), 2.17 - 1.98 (m, 2 H), 1.42 (d, J=7.0 Hz, 3 H), 
1.34 (td, J=13.7, 2.3 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 198.9, 166.7, 104.3, 
100.9, 98.1, 72.2, 68.6, 50.0, 47.5, 35.4, 34.7, 29.4, 15.6; FT-IR (thin film, cm-1 ) νmax 
3391, 2965, 2915, 1676, 1655, 1407, 1355, 1254, 1181, 1072, 1047, 1030, 914, 731; 
HRMS calc’d for C13H18O6 [M+] 270.1103; found 270.1098. 
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2-(3a-methoxy-6-oxo-4-(2-oxoethyl)-3a,4,5,6-
tetrahydrobenzo[d][1,3]dioxol -5-yl)propanal (2-262): To a 
vigorously stirred slurry of NaIO4/SiO2 (1.4 g, 1.11 mmol, 0.8 mmol/g) 
in dichloromethane (5 mL, 0.23 mol/L) was added a solution of diol 2-261 (200 mg, 0.74 
mmol) in dichloromethane (20 mL, 0.05 mol/L) dropwise at room temperature over 30 
minutes. After 2 hours of stirring, the solution was filtered to remove NaIO4/SiO2, and 
the solvent removed in vacuo to give 2-262 (100%, 198 mg, 0.74 mmol) as a yellow 
foam; Rf = 0.0 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) 9.86 (d, J=2.3 Hz, 1 
H), 9.75 (d, J=1.6 Hz, 1 H), 5.54 (d, J=1.2 Hz, 2 H), 5.48 (s, 1 H), 3.62 (ddd, J=9.8, 4.3, 
2.7 Hz, 1 H), 3.50 (s, 3 H), 3.37 (dd, J=10.7, 4.1 Hz, 1 H), 2.61 - 2.51 (m, 1 H), 2.47 
(ddd, J=18.0, 9.8, 2.0 Hz, 1 H), 2.20 (dd, J=18.0, 2.7 Hz, 1 H), 1.05 (d, J=7.4 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 201.6, 198.7, 196.2, 167.8, 104.8, 99.8, 98.5, 50.5, 48.4, 
42.4, 38.9, 12.0; FT-IR (thin film, cm-1 ) νmax 3405, 2971, 2917, 2838, 2730, 1720, 
1655, 1460, 1408, 1186, 1097, 903; HRMS calc’d for C13H16O6 [M+] 268.0947; found 
268.0937. 
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Appendix I – Ring opening of DA cyclopropanes with 
potassium organotrifluoroborates 
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Compound 1-86a 
1H NMR (CDCl3, 400 MHz) 
Compound 1-86a 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-86a 
11B NMR (CDCl3, 128 MHz) 
Compound 1-86a 
19F NMR (CDCl3, 376 MHz) 
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Compound 1-86a gCOSY 
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Compound 1-86a gHMBCAD 
Compound 1-86a gHSQC 
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Compound 1-86b 
1H NMR (CDCl3, 400 MHz) 
Compound 1-86b 
13C NMR (CDCl3, 100 MHz) 
180 
 
 
 
 
 
 
 
 
 
 
 
  
 
Compound 1-86b 
11B NMR (CDCl3, 128 MHz) 
Compound 1-86b 
19F NMR (CDCl3, 376 MHz) 
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Compound 1-82a 
1H NMR (CDCl3, 400 MHz) 
Compound 1-82a 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-82b 
1H NMR (CDCl3, 400 MHz) 
Compound 1-82b 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-82c 
1H NMR (CDCl3, 400 MHz) 
Compound 1-82c 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-82e 
1H NMR (CDCl3, 400 MHz) 
Compound 1-82e 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-82f 
1H NMR (CDCl3, 400 MHz) 
Compound 1-82f 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-82g 
1H NMR (CDCl3, 400 MHz) 
Compound 1-82g 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-82h 
13C NMR (CDCl3, 100 MHz) 
Compound 1-82h 
1H NMR (CDCl3, 400 MHz) 
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Compound 1-82i 
1H NMR (CDCl3, 400 MHz) 
Compound 1-82i 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-82j 
1H NMR (CDCl3, 400 MHz) 
Compound 1-82j 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-82k 
1H NMR (CDCl3, 400 MHz) 
Compound 1-82k 
13C NMR (CDCl3, 100 MHz) 
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Appendix II – Synthesis of pyrroles from DA cyclopropane
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Compound 1-221a 
1H NMR (CDCl3, 400 MHz) 
Compound 1-221a 
13C NMR (CDCl3, 100 MHz) 
193 
 
 
Compound 1-221c 
1H NMR (CDCl3, 400 MHz) 
Compound 1-221c 
13C NMR (CDCl3, 100 MHz) 
194 
 
 
Compound 1-221d 
13C NMR (CDCl3, 100 MHz) 
Compound 1-221d 
1H NMR (CDCl3, 400 MHz) 
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Compound 1-223a 
1H NMR (CDCl3, 400 MHz) 
Compound 1-223a 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-223j 
1H NMR (CDCl3, 400 MHz) 
Compound 1-223j 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-223k 
1H NMR (CDCl3, 400 MHz) 
Compound 1-223k 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-223l 
1H NMR (CDCl3, 400 MHz) 
Compound 1-223l 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-223m 
13C NMR (CDCl3, 100 MHz) 
Compound 1-223m 
1H NMR (CDCl3, 400 MHz) 
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Compound 1-223n 
13C NMR (CDCl3, 100 MHz) 
Compound 1-223n 
1H NMR (CDCl3, 400 MHz) 
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Compound 1-223o 
1H NMR (CDCl3, 400 MHz) 
Compound 1-223o 
13C NMR (CDCl3, 100 MHz) 
202 
 
 
Compound 1-226a 
1H NMR (CDCl3, 400 MHz) 
Compound 1-226a 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-231a 
1H NMR (CDCl3, 400 MHz) 
Compound 1-231a 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-231j 
13C NMR (CDCl3, 100 MHz) 
Compound 1-231j 
1H NMR (CDCl3, 400 MHz) 
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Compound 1-231k 
13C NMR (CDCl3, 100 MHz) 
Compound 1-231k 
1H NMR (CDCl3, 400 MHz) 
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Compound 1-231l 
13C NMR (CDCl3, 100 MHz) 
Compound 1-231l 
1H NMR (CDCl3, 400 MHz) 
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Compound 1-231m 
1H NMR (CDCl3, 400 MHz) 
Compound 1-231m 
13C NMR (CDCl3, 100 MHz) 
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Compound 1-231n 
13C NMR (CDCl3, 100 MHz) 
Compound 1-231n 
1H NMR (CDCl3, 400 MHz) 
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Compound 1-231n 
1H NMR (CDCl3, 400 MHz) 
Compound 1-231n 
13C NMR (CDCl3, 100 MHz) 
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Appendix III – Formal synthesis of fargesine 
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Compound 2-169 
1H NMR (CDCl3, 400 MHz) 
Compound 2-169 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-170 
1H NMR (CDCl3, 400 MHz) 
Compound 2-170 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-172 
1H NMR (CDCl3, 400 MHz) 
Compound 2-172 
13C NMR (CDCl3, 100 MHz) 
214 
 
 
Compound 2-162a 
1H NMR (CDCl3, 400 MHz) 
Compound 2-162a 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-173 
1H NMR (CDCl3, 400 MHz) 
Compound 2-173 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-163c 
1H NMR (CDCl3, 400 MHz) 
Compound 2-163c 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-163d 
1H NMR (CDCl3, 400 MHz) 
Compound 2-163d 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-164 
1H NMR (CDCl3, 400 MHz) 
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Compound 2-165 
1H NMR (CDCl3, 400 MHz) 
Compound 2-165 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-178 
1H NMR (CDCl3, 600 MHz) 
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Compound 2-176 
1H NMR (CD3OD, 400 MHz) 
Compound 2-176 
13C NMR (CD3OD, 100 MHz) 
222 
 
 
 
 
 
 
 
 
 
 
 
Compound 2-158 
1H NMR (CDCl3, 400 MHz) 
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Appendix IV – Progress towards the total synthesis of 
fumimycin 
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Compound 2-243 
1H NMR (CDCl3, 400 MHz) 
Compound 2-243 
13C NMR  
(CDCl3, 100 MHz) 
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Compound 2-244 
1H NMR (CDCl3, 400 MHz) 
Compound 2-244 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-245 
1H NMR (CDCl3, 400 MHz) 
Compound 2-245 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-246 
1H NMR (CDCl3, 400 MHz) 
Compound 2-246 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-247 
1H NMR (CDCl3, 400 MHz) 
Compound 2-247 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-249 
1H NMR (CDCl3, 400 MHz) 
Compound 2-249 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-250 
1H NMR (CDCl3, 400 MHz) 
Compound 2-250 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-251 
1H NMR (CDCl3, 400 MHz) 
Compound 2-251 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-253 
1H NMR (CD3OD, 400 MHz) 
Compound 2-253 
13C NMR (CD3OD, 100 MHz) 
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Compound 2-254 
1H NMR (CDCl3, 400 MHz) 
Compound 12 
13C NMR (CDCl3, 100 MHz) 
Compound 2-254 
13C NMR (CDCl3, 100 MHz) 
234 
 
 
Compound 2-260 
1H NMR (CDCl3, 400 MHz) 
Compound 2-260 
13C NMR (CDCl3,  
100 MHz) 
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Compound 2-255 
1H NMR (CDCl3, 400 MHz) 
Compound 2-255 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-256 
1H NMR (CDCl3, 400 MHz) 
Compound 2-256 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-257 
1H NMR (CD3OD, 400 MHz) 
Compound 2-257 
13C NMR (CD3OD, 100 MHz) 
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Compound 2-261 
1H NMR (CDCl3, 400 MHz) 
Compound 2-261 
13C NMR (CDCl3, 100 MHz) 
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Compound 2-262 
1H NMR (CDCl3, 400 MHz) 
Compound 2-262 
13C NMR (CDCl3, 100 MHz) 
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